Should you admit a childs obesity problem…

Parents denial of their children’s obesity problems is a major risk factor and could have lifelong repercussions. Confronting the problem of child obesity and preventing children from becoming obese in the first place should be the main goal.

Implementing simple lifestyle changes can help to improve your child’s behavior, mood swings and well-being. Putting your child on the right path to good health can promote higher concentration levels and better performance levels in school.

The increasing number of obesity levels in children is a major cause for concern and can be the main contributing factor to serious health problems, such as type 2 diabetes, high blood cholesterol and a higher risk of heart disease.

Children suffering from a rare blood pressure disorder (Pulmonary Arterial Hypertension) can be treated with a drug called Sildenafil, more commonly known as Viagra. The drug is taken orally and can lower the pressure in the pulmonary artery.

Viagra, originally developed to help with Pulmonary Arterial Hypertension, was also discovered to help men (under medical supervision) suffering from the symptoms of erectile dysfunction.

Correspondence: Children, Families and Maternity e-bulletin: May 2013

Children, Families and Maternity e-bulletin: May 2013

Children, Families and Maternity bulletin for May 2013.

This file may not be suitable for users of assistive technology.
Request a different format.

To request this document in an alternative format such as braille, audio
or a different file type please email
publications@dh.gsi.gov.uk
quoting your address, telephone number along with the title of the
publication (“Children, Families and Maternity e-bulletin: May 2013″).

Article source: https://www.gov.uk/government/publications/children-families-and-maternity-e-bulletin-may-2013

UCSF Opens New Pediatric Emergency Department

New signs and fresh arrows painted on the sidewalks of Parnassus Avenue mark the important opening of a new, child-friendly, Pediatric Emergency Department (ED) at UCSF Benioff Children’s Hospital, on UCSF’s Parnassus campus. 

In late April, a new, eight-bed pediatric ED opened its doors — most of which are covered in dinosaur wall stickers or painted with under the sea vignettes — to the San Francisco community, to help fill the need for child-focused emergency services.

Prior to its opening, pediatric patients with emergency health problems were seen by pediatric or emergency medicine providers in the main ED. The whitewashed rooms with adult-sized equipment made for a setting that was often stressful for children, who are often terrified at the prospect of being in the emergency room in the first place.

For walk-in pediatric patients and their parents, the new entrance, check-in and triage are separate from the main ED; the Pediatric ED entrance is just around the corner from the gift shop on the first floor of Moffitt Hospital.

It is located in a former Adult Prepare space, which was used for adult anesthesia pre-operation. The space also houses the lower acuity Pediatric ED beds, as well as the Pediatric Urgent Care facility and a family-friendly waiting area with toys and games.

Because the Urgent Care unit is located within the same space as the Pediatric ED, patients who arrive at check-in can be quickly triaged and screened for the appropriate level of care. The four higher-acuity Pediatric ED beds are located just across the hall and adjacent to the main ED, but are outfitted with equipment designed for children and their unique needs — as well as the stickers, Disney DVDs and painted walls that make it a more welcoming setting for kids.

To staff the new department, UCSF has brought on two new physicians who are board-certified in Pediatric Emergency Medicine, in addition to two who were already on the faculty. Residents from both the Emergency Medicine and Pediatrics programs rotate through the Pediatric ED as part of their training at the academic medical center. 

Child Life Specialists from UCSF Benioff Children’s Hospital are also available in the Pediatric ED to ensure that each child’s developmental and emotional needs are met during their stay. They are able to offer support, answer questions and prepare children and their families before and during medical procedures, in addition to providing other helpful services.  

The nursing and support staff specialize in pediatrics as well, making the entire experience child-centered.

The main difference between being seen in the pediatric Urgent Care room versus the Pediatric ED is the acuity level of the patient’s illness or injury, so having a dedicated Pediatric ED allows UCSF to provide child-centered care to children presenting with more serious symptoms.

Christine Cho, MD, MPH, who is trained in Pediatric Emergency Medicine and has overseen much of the new Pediatric ED project, says that “cohorting patients in one service allows for expertise to be further developed and enhanced” pediatric emergency nursing, child-life services, physician coverage. In this way, the new Pediatric ED benefits both UCSF patients and learners alike.

Since its opening in late April, it’s been providing care 24 hours a day, 7 days a week. Evelyn Porter, MS, MD, says that use of the new Pediatric ED “ebbs and flows,” with some shifts bustling and others quieter.

This new Pediatric ED on the Parnassus campus also foreshadows what’s to come at UCSF’s Mission Bay campus, where the new medical center to serve women, children and cancer patients, is set to open in February 2015. The Mission Bay medical center will include a Pediatric ED as well, with 19 beds (two of which will be in resuscitation rooms) and a dedicated procedural room. 

Once the Mission Bay medical center is up and running, the dedicated Pediatric ED at Parnassus will close and the main ED at Parnassus will again see pediatric patients as needed. Until then, the new Pediatric ED at the Parnassus campus is UCSF’s primary location for specialized pediatric emergency care.

Theresa Poulos is a third-year medical student and executive editor of Synapse, which previously ran this story.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/DalyNNJXSvg/ucsf-opens-new-pediatric-emergency-department

Policy paper: National child measurement programme: operational guidance for the 2012 to 2013 school year

National child measurement programme: operational guidance for the 2012 to 2013 school year

National child measurement programme: operational guidance for the 2012 to 2013 school year.

This file may not be suitable for users of assistive technology.
Request a different format.

To request this document in an alternative format such as braille, audio
or a different file type please email
publications@dh.gsi.gov.uk
quoting your address, telephone number along with the title of the
publication (“National child measurement programme: operational guidance for the 2012 to 2013 school year “).

Article source: https://www.gov.uk/government/publications/national-child-measurement-programme-operational-guidance-for-the-2012-13-school-year

Independent report: Children and Young People’s Health Outcomes Forum: Recommendations to improve children and young people’s health results

Report of the Children and Young People’s Health Outcomes Forum

This report, along with supporting documents, sets out the Forum’s proposals on improving health-related care for children and young people.

Article source: https://www.gov.uk/government/publications/independent-experts-set-out-recommendations-to-improve-children-and-young-people-s-health-results

Nearly Half of Adolescents Lack a Patient-Centered Medical Home

Adolescence is a unique period of change when many mental health disorders are known to first emerge.

According to experts, approximately 20 percent of adolescents report symptoms of mental health problems, and half of lifetime cases of mental health disorders begin showing symptoms by age 14.

Yet despite the known prevalence of mental health issues during this critical time in a young person’s life, nearly half of adolescents are lacking a medical home – family-centered, coordinated and continuous health care – according to a new study from UC San Francisco’s Department of Pediatrics. This study is timely as expansion of medical home models are being implemented through the Patient Project and Affordable Care Act.

“A higher percentage of adolescents have mental health conditions rather than physical conditions, which really drives home the importance of coordinating care and giving referrals,“ said lead author Sally Adams, RN, PhD, a specialist in the Division of Adolescent Medicine at UCSF.  

“There’s a big problem with trying to coordinate mental health care and the system is failing families,” she added. “If mental health is addressed early, it can lessen the impact, so it’s important to be proactive.” 

The American Academy of Pediatrics recommends that all infants, children and adolescents should receive their care in the medical home model.

The model provides comprehensive team-based care led by a primary care physician who coordinates all elements of a patient’s care.  The pediatric care team works together to help a patient and family coordinate, and understand specialty care, educational services, out-of-home care, family support, and other public and private community services that are important for the overall health of the child and family.

Racial and Economic Disparities

UCSF researchers conducted the first study ever to comprehensively examine medical homes for adolescents. They reviewed the rates of medical home attainment from the 2007 National Survey of Children’s’ Health (NSCH), a national survey of 91,642 parents, including roughly 45,000 who had children aged 10 to 17.

The researchers then analyzed the past-year medical home rates, whether they varied by age, and whether or not the medical home status was related to an adolescents’ mental health status. They also looked at whether the adolescents were given referrals when necessary.

The researchers found that 46 percent of adolescents lacked a past-year medical home, with lower rates for lower-income, minority and uninsured youth. Adolescents with depression, anxiety, ADHD, learning disabilities, developmental delays are autism diagnoses all had lower medical home rates than those without mental health conditions.  

Medical home rates for Hispanic (33 percent) and black (42 percent) adolescents were significantly lower than rates for white (64 percent) adolescents. Those from non-English speaking households were less likely to have a medical home, receive family centered care and referrals when necessary.  

The study, “Medical home for adolescents: low attainment rates for those with mental health problems and other vulnerable groups,” was published in the March-April issue of Academic Pediatrics.

The study provides an important national baseline for the proportion of adolescents receiving care in a medical home, and can be used to measure progress.

The next phase of research will involve analyzing data from the recently released 2011 NSCH which will provide an initial evaluation of changes in medical home status following initiation of the Affordable Care Act.

“Our results document significant shortcomings in adolescents’ receipt of care within a medical home,” said Adams. “Now that we’ve highlighted the disparities it is clear there are huge needs for families with adolescents struggling with mental illness.” 

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/g4rp5Oo_LmE/nearly-half-adolescents-lack-patient-centered-medical-home

Press release: School nurses to play a bigger role in improving children’s health

School nurses will play a bigger and more important role in improving the health of children and young people, according to plans announced today by the children’s Health Minister, Dr Dan Poulter.

England’s 1,200 school nurses and their teams will lead a new, strengthened and more tailored school nursing service which means better care and support for children, including those with disabilities and complex emotional needs.

For the first time ever, children who are carers will themselves train school nurses in how to provide the best support for young carers. As part of the plans, school nurses will:

  • Get more training to make sure their skills are constantly improved and updated so they can support children with more complex health needs;

  • Become local leaders in children’s health and be given the expertise to improve what school nurses offer to children. This could mean being available outside of school hours; and

  • Be champions for children who care for others to make sure they get the right support. Young carers themselves will train school nurses so they know exactly what support to provide.

The best school nurses will also be rewarded for their work through a new, national school nurse award.

Children’s Health Minister Dr Dan Poulter who is responsible for the Government’s programme for improving children’s health said:

School nurses play a crucial role in improving health and supporting young people. I want them to have an even bigger role and provide even better support for more young people with different health needs and conditions.

Young carers are often under incredible pressure both at home and at school. School nurses can do a lot to give young carers a voice and help ease that pressure. Our plans will help them do just that.

We continue to lead work with the NHS, Royal College of Paediatrics and Child Health and local authorities to do everything possible to improve children’s health and to give each and every child the very best start in life.

There are as many as 700,000 young carers in the UK, and their caring responsibilities – which could be as intense as 50 hours a week – are often a hidden cause of health problems, bullying, truancy and not doing well at school. School staff can sometimes be unaware that children are carers, and school nurses are in a perfect position to provide the right support that young carers need to help them be happier and do better at school.

Dr Moira Fraser, Director of Policy and Research at Carers Trust:

Over 60 per cent of young carers are bullied in schools while nearly 30 per cent miss school or experience educational difficulties – often due to their caring responsibilities. Many don’t feel able to tell staff members at their school that they are a young carer.

These are worrying numbers and so we are heartened at the government’s plans to strengthen the role of school nurses in supporting young carers.

School nurses are ideally positioned to play a pivotal role in the lives of young people. They are well placed to identify young carers earlier and implement preventative support while reducing the negative impact on the health and wellbeing of young carers by initiating support for the whole family. We are pleased that young carers themselves will shape the work of school nurses by training them in how to provide the best support.

Today’s announcement builds on last year’s School Nursing Vision, which promised to make it easier to contact school nurses – including texting to make appointments. We continue to work with nursing bodies – including the School and Public Health Nurses’ Association – on the implementation of the vision.

Edward Timpson, Minister for Children and Families said:

Young carers have told us time and time again that they want their teachers and schools to be more ‘carer aware’, which is why we are determined to ensure that they are provided with the best support possible.
“We know that some schools already have excellent systems in place to identify and respond to young carers needs. Unfortunately these pockets of excellence are too few and far between, leaving many vulnerable young people without the support they need to thrive.

Today’s announcement will mean that young carers across the country are being given a voice to help shape their own services – truly empowering these dedicated children and young people whose daily lives are dramatically affected by caring for family members.

Three hundred young people who have offered to become ‘school nurse champions’ and help shape the way the School Nursing Vision is implemented have also been trained and are beginning their work.

Notes to editors

• For more information, please contact the Department of Health press office on 020 7210 5703.

Article source: https://www.gov.uk/government/news/school-nurses-to-play-a-bigger-role-in-improving-childrens-health

Guidance: Routine immunisations for children: information on vaccines and timing

Routine childhood immunisation poster (A4 version)

Routine childhood immunisation schedule for diseases such as tetanus, diphtheria and polio.

This file may not be suitable for users of assistive technology.
Request a different format.

To request this document in an alternative format such as braille, audio
or a different file type please email
publications@dh.gsi.gov.uk
quoting your address, telephone number along with the title of the
publication (“Routine childhood immunisation poster (A4 version)”).

Article source: https://www.gov.uk/government/publications/routine-childhood-immunisation-from-november-2010

Pediatric Residents Training in New ‘Handoff’ Curriculum

In response to mounting evidence that serious errors in hospitals often could be prevented by enhancing communication, UCSF Benioff Children’s Hospital is participating in the nine-center I-PASS study to determine how to best teach residents to properly hand off pediatric patients to reduce errors.

Currently, there is no national standard for the transition of care of patients. Hospital handoffs occur upon admission, at shift changes, before and after procedures, upon unit changes, and at discharge. Most residents are never taught how to hand off patients, but simply learn it by observing senior residents without any formal protocol. 

“This new handoff curriculum has been developed, and because of it, we now have measures to document that our residents are acquiring these new skills,” said Glenn Rosenbluth, MD, the I-PASS site director at UCSF and director of Quality and Safety Programs for the UCSF School of Medicine’s Graduate Medical Education team. “It is really unique as an NIH [National Institutes of Health]-funded study, in that we put together a combination of health service researchers, medical educators and clinicians all collaborating to increase patient safety.”

The I-PASS initiative was developed at Boston Children’s Hospital, and is supported by a $3 million grant from the U.S. Department of Health and Human Services.

The next phase of the research at UCSF includes a study this summer with medical students, and the creation of Ob/Gyn-specific modules developed in conjunction with UCSF Obstetrics Gynecology.

The UCSF researchers continue to present this work at national conferences outside of pediatrics, including the meeting of the Accreditation Council for Graduate Medical Education (ACGME) and the Society of Hospital Medicine 2013 meeting later this year.

  

Read more about UCSF’s participation in the I-PASS study:  

New Curriculum Teaches Pediatric Residents Proper Handoffs to Maximize Patient Safety

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/LMfCUuVt-n4/pediatric-residents-training-new-handoff-curriculum

Artificial Kidney Holds Promise for Vast Majority on Dialysis

Two key contributors to the UCSF-led effort to create an implantable artificial kidney for dialysis patients are on Capitol Hill today to inform key congressional staff about the project.

Shuvo Roy, PhD, a bioengineer on the faculty of the UCSF School of Pharmacy and the project’s technical director, and William Fissell, MD, an associate professor of clinical medicine at Vanderbilt University Medical Center and the project’s medical director, are in Washington, DC, to explain the importance of the device to treat patients with end-stage renal disease (ESRD).

Affecting 2 million people worldwide, ESRD – or chronic kidney failure – is fatal unless treated and costs the nation almost $40 billion each year for treatment. And while transplantation is the most effective treatment option, donor organs are in short supply. Further, kidney dialysis is a short-term and costly treatment.

“We can provide an alternative therapy and a treatment option that doesn’t exist today for the vast majority of people today that are forced to rely on dialysis,” Roy said.

The artificial kidney project aims to combine nano-scale engineering with the most recent advances in cellular biology to create an implantable device that would enable patients with chronic kidney failure to lead healthier and more productive lives, without external dialysis or immune suppressant medication.

The kidney project is now featured in the UC Office of the President’s Onward California campaign, which aims to educate Californians about the impact the University has in their lives and to remind them of the importance of supporting the UC system.

Kidney Project Put on Fast-Track by FDA

Last year, the artificial kidney project was selected as one of the first projects to undergo more timely and collaborative review at the Food and Drug Administration (FDA). The FDA chose three renal device projects to pilot a new regulatory approval program called Innovation Pathway 2.0, intended to bring breakthrough medical device technologies to patients faster and more efficiently.

The artificial kidney project, which is targeted for clinical trials in 2017, was selected for its transformative potential in treating ESRD and for its potential to benefit from early interactions with the FDA in the approval process.

The UCSF artificial kidney, or implantable Renal Assist Device (iRAD) would include thousands of microscopic filters as well as a bioreactor to mimic the metabolic and water-balancing roles of a real kidney.

The combined treatment has been proven to work for the sickest patients using a room-sized external model developed by a team member at the University of Michigan. Roy’s goal is to apply silicon fabrication technology, along with specially engineered compartments for live kidney cells, to shrink that large-scale technology into a device the size of a coffee cup. The device would then be implanted in the body, allowing the patient to live a more normal life.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/roRSfYHFdkM/artificial-kidney-holds-promise-vast-majority-dialysis

Pediatric Diabetes Clinic Marks 2nd Anniversary in New Mission Bay Home

Kendall Layous, and her mother Shonda, make drawings that are used as table-top covers, part of an art therapy program at the Madison Clinic for Pediatric Diabetes.

In the two years since the Madison Clinic for Pediatric Diabetes was established through an anonymous, $10 million gift, it has evolved into a state-of-the-art facility with innovative programs and a new home on the Mission Bay campus.

The Madison Clinic at Mission Bay, now located steps away from the future UCSF Benioff Children’s Hospital, offers comprehensive care for children and young adults with diabetes, with an emphasis on patient education, empowerment and the use of advanced technologies. It also has a commitment to advancing research in the management of diabetes in children.

A multidisciplinary team – including endocrinologists, clinical psychologists, nurses, diabetes educators, social workers, dietitians, and administrative staff – ensures patients’ varying needs are met.

“I don’t really manage diabetes. The parents do it all day, every day,” said Saleh Adi, MD, medical director of the Madison Clinic and a pediatric endocrinologist. “Our job is to teach them how and provide them with the tools they need, and to be there for support and feedback whenever they need it.”

Kendall Layous, diagnosed with Type 1 diabetes, at the Madison Clinic

Two-and-a-half-year-old Kendall Layous, diagnosed with Type 1 diabetes, gets her blood pressure checked during a visit at the Madison Clinic for Pediatric Diabetes.

Shonda and Brad Layous know firsthand how much is required of parents with diabetic children. Their daughter Kendall was diagnosed with type 1 diabetes in April 2012, two days after her second birthday.

“Having a child with a serious health condition takes its toll on the entire family, so a bright spot in this emotional year for us was finding the Madison Clinic,” said Shonda Layous. “Our family knows that we are in the best care possible at the UCSF Madison Clinic, and its amazing staff and wonderful space give us comfort and confidence that we will partner with them for life to best manage her disease.”

There currently are 25.8 million children and adults in the United States, or 8.3 percent of the population, living with diabetes, according to the American Diabetes Association. One in every 400 children and adolescents younger than age 20 has the chronic disease, which is characterized by the body’s inability to regulate blood glucose, or blood sugar, levels.

With the incidence of both type 1 and type 2 diabetes in children on the rise, it is increasingly important to have skilled teams of diabetes health care providers who specialize in treating young people.

A ‘Living Room’ For Patients

The new Madison Clinic at Mission Bay was designed with the patient experience and clinician workflow in mind, according to Theresa Garnero, a nurse as well as the clinic’s practice manager.

Patient Kendall Layous with Saleh Adi, MD

Kendall Layous meets with her doctor, Saleh Adi, MD, a pediatric endocrinologist, at the Madison Clinic while Kendall’s mother, Shonda, far left, and nurse practitioner Nicole Rotter, PNP, CDE, look on in the background.

Upon entering, visitors are greeted with warm colors and an open, friendly environment. A Wii Fit video game station and therapeutic art room add to the relaxed ambience.

“We call it the ‘living room’ instead of the waiting room,” Adi said. “I wanted a place that feels nothing like a clinic or a doctor’s office, a place that kids remember fondly and look forward to coming to. This is exactly what’s happening.”

“The space at Mission Bay is wonderful. There is plenty of space for doctor and specialist consultation, and the warm and kid-friendly environment provides for a peaceful experience during appointments that could otherwise be quite challenging,” Layous added.

Staff benefit from a communal office space in the back of the clinic that promotes collaboration and a greater number of dedicated consultation rooms for patient meetings. The clinic also offers a classroom for patient-related educational activities, such as insulin pump classes.

“I think the new Madison Clinic at Mission Bay really succeeds at evoking feelings of peace and playfulness, which is a great combination when you are dealing with this challenging disease,” Garnero said. “As a nurse, I always believe that outcomes are the result of having a solid structure in place. We have this amazing physical structure now that sets the overall tone and will encourage positive outcomes.”

New Programs to Enhance Care

The Madison Clinic also offers several innovative new clinical programs, designed to improve the patient experience and outcomes.

One such program is a revised model of case management, in which each child and his or her family is paired with a specific nurse and physician team for the duration of their care in order to optimize a patient’s health.

The UCSF team also plans to set up satellite clinics in different parts of California to bring services closer to patient populations in the Monterey peninsula, Central Valley and elsewhere.

Most recently, the Madison Clinic established a groundbreaking transition program designed to help teens and young adults manage their own diabetes care as they become adults. According to Diana Naranjo, PhD, one of the clinic’s two staff clinical psychologists, countless patients around the country are lost during the shift from pediatric to adult models of care, and this can have devastating consequences on their long-term health.

“Historically, this transition period has been looked at with a ‘tag, you’re it’ kind of approach,” Naranjo said. “Under this new program, we will work closely with patients years before they actually make the transition so that when the time comes, they feel empowered and fully capable to be autonomous with their disease management.”

To provide greater continuity of care, the clinic also recruited two endocrinologists who are dually trained in pediatric and adult medicine. They can care for patients from childhood through young adulthood with a seamless transition.

Diabetes nurse practitioner Nicole Rotter, CPNP, CDE, examines Kendall Layous

Diabetes nurse practitioner Nicole Rotter, CPNP, CDE, examines Kendall Layous during a visit at the Madison Clinic for Pediatric Diabetes.

“Even for children who are cared for by pediatric endocrinologists such as myself, all I have to do when they turn 18 to 21 is simply introduce them to their new doctor, but still within the Madison Clinic,” Adi said. “They remain in the same place they’re so familiar and comfortable with, with the same staff, nurses and educators. Parents love it; it’s one less thing to worry about.”

A key component of the transition program is Marcela Arregui Reyes, who came on board at the beginning of the year as the clinic’s first full-time transition coordinator. The position – guaranteed for two years through a grant from the UCSF Diabetes Family Fund – involves advocating for patients and acting as a liaison between patients and providers throughout the transition process.

Arregui Reyes will meet with patients and their families starting at the age of 14, and conduct annual assessments to better understand each individual’s needs.

“I believe someone with diabetes can do anything they set their mind to as long as they have proper disease management,” she said. “We are all working together to give our patients the tools they need and to make sure they know we are here to help. Our new clinic provides all the resources and technology needed to make this program succeed.”

The transition program also will incorporate regular group meetings with staff psychologists, as well as evening seminars for patients and their families that address topics, such as how to manage diabetes after leaving for college. A newly created Youth Advisory Board will provide a unique outlet for patients to gather informally and share experiences and knowledge.

Photos by Susan Merrell

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/tHPAhAOzkvs/pediatric-diabetes-clinic-marks-2nd-anniversary-new-mission-bay-home

New technology to improve children’s mental health services

Norman Lamb, Care and Support Minister announced £2million today for new handheld computers to boost children’s mental health services.

Children and young people will be able to use tablet computers in their therapy sessions to give them and their therapist instant access to information that details how close they are to achieving treatment goals.

Care and Support Minister, Norman Lamb said:

 “Acting early to help children with mental health problems can prevent a lifetime of suffering as half of those with lifelong mental health problems first experience symptoms before the age of 14.

“This technology helps children and young people see how their treatment is progressing. Where treatment is not going as well as it could, practitioners can then change their approach to get the best results.

“Children and young people have told us how much it helps them to see how their treatment is going and these new devices do just that.”

The new devices will be rolled out to 42 sites across England.

Therapists can also use the handheld computers to record sessions so that their supervisors and clinical tutors can watch the sessions and comment on their techniques to help therapists to improve.

The time therapists and administrators currently spend recording outcomes will also be cut dramatically.

Earlier this year, the department published the Mandate to the NHS Commissioning Board with a clear objective to put mental health on a par with physical health and to extend and ensure more open access to the Improving Access to Psychological Therapies Programme in particular for children and young people and for those out of work.

Article source: http://www.dh.gov.uk/health/2013/03/tech-childrens-mental-health/

Child protection: information sharing project

The Child Protection Information Sharing (CP-IS) project helps the NHS give a higher level of protection to children who present in unscheduled health care settings, including:

  • emergency departments
  • walk-in centres
  • minor injury units
  • GP out of hours services
  • ambulance services
  • maternity
  • paediatric wards.

Appropriate healthcare staff working in these areas will be able to identify if a child is subject to a child protection plan or is looked after by a local authority.

CP-IS will tackle a long standing problem for NHS staff, the lack of ready access to timely information which would help inform a clear assessment of a child’s risk of abuse or neglect.  The information will support the clinician in the decision making process and encourage communication with social care.  It will not be there to override the assessment of the child’s needs.

CP-IS is not another ContactPoint, which was intended to be a database of all children. CP-IS does not introduce a new national database but, rather, is a focused solution which will enable local authorities to share non-clinical child protection information with the NHS.

The project builds on existing infrastructure already in place in the NHS and represents an upgrade to existing systems rather than a wholesale system change.  Information will be stored and transferred securely.  Access to CP-IS information will be controlled by NHS smartcard security, which is already widely used for the secure handling of patients’ demographic and clinical data.

In practice, local authorities will feed information on children who are subject to a child protection plan or are looked after from their social care systems into a secure central data store area in the NHS national Spine.  Then health professionals, during the process of registering a child at their care setting, will be informed of the child’s child protection status.  As soon as basic demographic information is inputted, if the child is looked after or subject to a child protection plan, an indicator flag will appear on screen, with the contact details for the relevant local authority.

Information will only be shared on children who are subject to a child protection plan or are looked after, and on pregnant women who have a child protection plan in place for their unborn child.  Such information is already made available locally to unscheduled care settings through a variety of methods.

As CP-IS will be an England wide solution, healthcare staff in unscheduled care settings will ultimately be able to see whether any child with whom they deal has a child protection plan or is looked after, regardless of where in the country that child normally resides.

A record of who has viewed the indicator flag will be available to social care and healthcare staff, allowing them to see if that child has been visiting a range of different unscheduled healthcare settings.  Serious case reviews have demonstrated that abusive and neglectful parents could mask this behaviour by moving between different healthcare services.

CP-IS will cost £8.6 million over a five year period.  It is sponsored by the Department of Health and supported by the Department for Education, the Association of Directors of Children’s Services, a wide range of health professional bodies and charities including the National Society for the Prevention of Cruelty to Children.

See new child abuse alert system for hospitals published on 27 December 2013.

Article source: http://www.dh.gov.uk/health/2013/03/information-sharing-project/

Pediatric Residents Training in New ‘Handoff’ Curriculum


UCSF Benioff Children's Hospital sign

In response to mounting evidence that serious errors in hospitals often could be prevented by enhancing communication, UCSF Benioff Children’s Hospital is participating in the nine-center I-PASS study to determine how to best teach residents to properly hand off pediatric patients to reduce errors.

Currently, there is no national standard for the transition of care of patients. Hospital handoffs occur upon admission, at shift changes, before and after procedures, upon unit changes, and at discharge. Most residents are never taught how to hand off patients, but simply learn it by observing senior residents without any formal protocol. 

“This new handoff curriculum has been developed, and because of it, we now have measures to document that our residents are acquiring these new skills,” said Glenn Rosenbluth, MD, the I-PASS site director at UCSF and director of Quality and Safety Programs for the UCSF School of Medicine’s Graduate Medical Education team. “It is really unique as an NIH [National Institutes of Health]-funded study, in that we put together a combination of health service researchers, medical educators and clinicians all collaborating to increase patient safety.”

The I-PASS initiative was developed at Boston Children’s Hospital, and is supported by a $3 million grant from the U.S. Department of Health and Human Services.

The next phase of the research at UCSF includes a study this summer with medical students, and the creation of Ob/Gyn-specific modules developed in conjunction with UCSF Obstetrics Gynecology.

The UCSF researchers continue to present this work at national conferences outside of pediatrics, including the meeting of the Accreditation Council for Graduate Medical Education (ACGME) and the Society of Hospital Medicine 2013 meeting later this year.

  

Read more about UCSF’s participation in the I-PASS study:  

New Curriculum Teaches Pediatric Residents Proper Handoffs to Maximize Patient Safety

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/LMfCUuVt-n4/pediatric-residents-training-new-handoff-curriculum

UCSF Awarded $1.75 Million Grant to Fund New Treatments for Pediatric Cancer

UCSF Benioff Children’s Hospital

UCSF Benioff Children’s Hospital has received a grant to support new treatments and training in pediatric cancer.

Researchers at UCSF Benioff Children’s Hospital have received a $1.75 million grant from Alex’s Lemonade Stand Foundation (ALSF) to support the discovery of innovative treatments for childhood cancer.

UCSF has one of the leading programs in childhood cancer research in the United States, with laboratory scientists and clinical researchers collaborating to identify new targets for the treatment of leukemia, brain tumors, neuroblastoma and sarcomas.

In addition to the funding – $350,000 per year, renewable annually for up to five years – UCSF has been named a Center of Excellence (CoE) by the foundation. The CoE program aims to fund the research of leading childhood cancer institutions committed to developing and conducting early phase clinical trials. 

As a Center of Excellence, UCSF will use half of the funds to enhance clinical trial infrastructure and half to support the training of scholars in drug development, allowing the clinical trial program to grow in the field of pediatric oncology. The center applicants were chosen by the foundation and invited to compete for funding. Other CoE institutions selected include Baylor College of Medicine and the Dana-Farber Cancer Institute.

Steven DuBois, assistant professor of pediatrics, and Kate Matthay, professor of

Katherine Matthay, MD, center, chief of pediatric oncology at UCSF Benioff Children’s Hospital, speaks with a faculty member at the hospital.

UCSF’s top-ranked fellowship program currently trains three fellows per year, with at least one fellow dedicated to developing a career in early phase clinical trials. 

“This award will allow us to sustain our local program and to train young investigators in the skills needed to develop and lead early phase clinical trials for the future,” said Katherine Matthay, MD, chief of pediatric oncology at UCSF Benioff Children’s Hospital and the principal investigator for the grant. 

The purpose of the Center of Excellence program is threefold: 

  • Foster the evolution of new therapeutic concepts from the pre-clinical arena into fully developed clinical trials;
  • Rapidly and efficiently conduct phase I and phase II trials of highly innovative therapies;
  • Train individuals in the field of developmental therapeutics and cancer pharmacology. 

“One of our strengths at UCSF is our emphasis on translational research,” said Matthay. “The ability to train new investigators in developmental therapeutics will capitalize on the very strong laboratory translational research at UCSF and bring new agents targeting pediatric cancer into the clinic.” 

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/uiCM6MwOKyE/ucsf-awarded-175-million-grant-fund-new-treatments-pediatric-cancer

New Website Helps Parents Manage Children’s Pain After Surgery

When a young child has surgery, parents rely on doctors and nurses for advice on how to prepare and support children during the procedure and immediately afterwards. But once that child gets home, parents are left with little guidance on how to best help their children cope with pain.

A new website aims to fill that information gap and give parents the framework for how to be more effective caregivers for children after surgery.

Linda Sturla Franck, RN

Linda Sturla Franck, RN, Phd

Created with Linda Franck, RN, PhD, chair of Family Health Care Nursing in UC San Francisco’s School of Nursing, the website My Child is in Pain targets parents of children between the ages of 2 and 6 who want to know how to help manage their child’s post-operative pain.

“There are very few formal resources for parents to learn how to tell if their child is in pain and what they can do to relieve it,” said Franck. 

More than 80 percent of the more than 3 million children’s surgeries in the U.S. are performed on an outpatient basis, leaving parents to manage post-operative pain at home. But returning home can be scary when parents aren’t confident about how to determine if their child is in pain, and children aren’t equipped with the language skills to fully articulate how they are feeling.  

Franck’s research has shown that more than 90 percent of children have pain two days after surgery and as much as 25 percent have pain four weeks after. Children with post-operative pain also were more likely to have problematic behaviors such as not sleeping, eating poorly and being very anxious.

“Parents are not getting enough information or feeling comfortable using the information that’s out there to manage pain at home,” said Franck. “It became clear we needed to put together another resource using the best research evidence available and lots of parent input so that it was practical and useful for parents.” 

Franck has dedicated her career to pioneering pain assessment and management techniques for acutely and chronically ill infants and children. Her research highlights the information needs of parents when their children are in pain, and suggests innovative strategies for enhancing the partnership between parents and professionals to ensure children receive optimal pain care.

Through a series of videos, text and illustrations, the website helps parents understand how children respond to pain and guides them through how to tell if their child is in pain. It provides detailed information and practical advice on some of the simple but effective things they can do to provide effective comfort and manage their child’s pain. The website also explains how pain is signalled to the brain, how common pain medications work, what times are best to administer the medication and what to do if it’s not working. The site is funded by the United Kingdom-based non-profit WellChild.

“When a child’s pain is well managed, he or she usually recovers more quickly,” said Franck. “Simple comfort techniques can be very effective. Gently rocking and stroking their child can be soothing and help their child to relax, and when a child is relaxed and calm, it can help the pain go away. Also, letting their child make some decisions can help them feel less anxious and more in control.”

The project team was based in the U.K., led by Bernie Carter, PhD from the School of Health at the University of Central Lancashire, and including Lucy Bray, PhD, from Edge Hill University and Nic Blackwell, PhD, from OCB Media. 

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/pxkvHDY8yNg/new-website-helps-parents-manage-childrens-pain-after-surgery

New national pledge to improve children’s health and reduce child deaths

A new pledge about making improvements to the health of children and young people has been launched today. The pledge is part of the government’s response to the Children and Young People’s Health Outcomes Forum.

Dr Daniel Poulter MP, Parliamentary Under Secretary of State for Health was first to sign the pledge, at an event at the Evelina Children’s Hospital – part of Guy’s and St Thomas NHS  Foundation Trust.

At the event, Health Minister Dr Dan Poulter said:

“It is a shocking fact that child mortality in Britain is the worst when compared to other similar European countries.  There is unacceptable variation across the country in the quality of care for children – for example in the treatment of long-term conditions such as asthma and diabetes.

“We are determined that children and young people will be at the heart of the new health and care system. Too often in the past their needs have been an afterthought.

“Our pledge demonstrates how all parts of the system will play their part and work together to improve children’s health. There is already a lot of good work going on but we want the NHS to do even more to improve care for children and young people and reduce the mortality rate.”

By signing the pledge, he committed the government to do everything it can to improve the health of children and young people, improve services from pregnancy to adolescence and beyond and reduce avoidable deaths.

Read the pledge Better health outcomes for children and young people: Our pledge and see the Children and Young People’s Health Outcomes Forum recommendations .

The Department of Health is asking organisations who have the power to make a difference to sign up alongside the government and do everything they can to improve the care that children and young people receive and reduce avoidable deaths. The following organisations have also signed up to the pledge with more organisations expected to follow:

  • Academy of Royal Colleges
  • Association of Directors of Children’s Services (ADCS)
  • Care Quality Commission
  • Faculty of Public Health
  • Healthwatch
  • Health Education England
  • NHS Commissioning Board
  • NHS Confederation
  • NHS Information Centre
  • NHS Trust Development Authority
  • NICE
  • MHRA
  • Public Health England
  • RCGP
  • RCN
  • RCPCH
  • RCPsych
  • Society of Local Government Chief Executives (SOLACE)

The pledge commits signatories to put children, young people and families right at the heart of decision making and improve every aspect of health services – from pregnancy through to adolescence and beyond.

System wide response

In the Department of Health’s response to the Children and Young People’s Health Outcomes Forum’s recommendations, the department has announced the beginning of a series of actions to improve children’s health. These include:

  • starting a data revolution so the NHS and local authorities get better information they can use to improve the health of young people
  • making sure children and young people are at the heart of the new health and care system and that their voices are heard.

Read the response document Improving Children and Young People’s Health Outcomes: a system wide response.

Better data will make it easier for doctors, nurses and local authorities to get all the information they need to help children. A new survey that will generate data on local health problems – like drug and alcohol use – as well as information on bullying will be piloted. New colour coded health maps similar to the existing Children’s Atlas of Variation means clinical staff, patients, their families and those who purchase services on behalf of patients will be able to look at local health outcomes for conditions like asthma and diabetes.

The Children and Young People’s Health Outcomes Forum was set up by the Government in January 2012 to identify the health issues that matter most to young people. Their work took into account the views of 2,000 people including children, young people, families and healthcare professionals. They highlighted the pressing need for big changes to be made, as well as the significant opportunities that exist in the new health system to make improvements.

The pledge and response to the forum are the start of a range of actions the government and others will take to improve the health of children and young people in the coming months.

Video: CMO welcome for the pledge and response

Dame Sally Davies, the Chief Medical Officer, has welcomed the government’s response to the Children and Young People’s Health Outcomes Forum Report and the new vision for children and young people’s health.

Article source: http://www.dh.gov.uk/health/2013/02/national-pledge-cyp/

Kids heart risk

February 01, 2013

Emotional behaviour in childhood may be associated with
adult cardiovascular disease risk, particularly in women,
researchers claim.

Psychologists measured behaviour such as
distress and attention problems in children aged
seven, before later comparing these ratings to their adult cardiovascular disease risk. 

Our Senior Cardiac Nurse, Maureen Talbot, said: “We know that a
child’s health can often have a bearing on their future
wellbeing
. For example, obese children are more likely to
become obese adults.

“However, this is a small study and we would
need to see more research before we were sure of
any possible link between emotions in childhood and risk of
cardiovascular disease in later life.

“There are positive steps
parents can take to protect their child’s future heart health. What
we learn when we’re young can often set the tone for our habits
later in life, so teaching children about physical activity and a balanced diet is a great place to start.”

This research was published by the British
Medical Journal.

Article source: http://www.bhf.org.uk/media/news-from-the-bhf/childhood-behaviours.aspx

Baseball Great Barry Bonds Strengthens Relationship with Children’s Hospital

Barry Bonds spent time with UCSF Benioff Children’s Hospital patients in the hospital’s renovated Barry Bonds Family Foundation Playroom during a surprise visit in 2011.

Home run king Barry Bonds has pledged to continue his support of the UCSF Benioff Children’s Hospital with a three-year grant through his Barry Bonds Family Foundation. 

“This is a special place full of special people, and I am honored to have been a witness to the extraordinary dedication put forth every day by the staff, doctors and nurses,” said Bonds. “I am simply blessed to have the opportunity through my family foundation, to be able to provide monetary and moral support towards the hospital’s efforts to make a child’s stay a little more comfortable.”

Bonds’ formal relationship with UCSF began in 2007 – the same year he made history, setting a new Major League Baseball home run record with the San Francisco Giants. In 2009, the seven-time MVP donated nearly $250,000 for a much-needed renovation of the hospital’s playroom.

Home Run King Barry Bonds visited with a patient in his room at UCSF Benioff Children’s Hospital during a surprise visit in 2011.

“Through the generosity of the Barry Bonds Family Foundation, we are able to provide a space for our pediatric patients of all ages to play, relax and socialize in a stress-free environment,” said Kimberly Scurr, executive director of UCSF Benioff Children’s Hospital. “It’s so important for us to normalize the hospital experience, and the playroom provides an outlet for them to just be kids.”

Bonds’ latest donation will support the playroom’s staffing and services. The room, which is stocked with toys, puzzles, books and craft materials, is staffed by the hospital’s child life specialists and trained volunteers. It is also staffed by the hospital’s full-time service dog Nilani, who eases patients’ anxiety and stress by letting them rub her tummy, giving a quick snuggle or just sitting nearby.

The playroom is just one of the services offered by the Child Life Department at UCSF Benioff Children’s Hospital. Child life specialists help children and families adjust to and understand illness and treatment through outlets such as music therapy, therapeutic clowning, poetry and journal writing and art therapy. Credentialed teachers also provide instruction to school-age children in the school room or at bedside.

“Over the years, I have spent many hours visiting with patients at UCSF Benioff Children’s Hospital,” said Bonds. “The children and parents I have met during my visits have always been filled with optimism and courage. On so many occasions I have drawn strength and inspiration from their courage.”

UCSF Benioff Children’s Hospital creates an environment where children and their families find compassionate care at the forefront of scientific discovery, with more than 150 experts in 50 medical specialties serving patients throughout Northern California and beyond. The hospital admits about 5,000 children each year, including 2,000 babies born in the hospital.

For more information, visit www.ucsfbenioffchildrens.org.

Photos by Andreas Neumann

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/S9Hu8bukuM8/baseball-great-barry-bonds-strengthens-relationship-childrens-hospital

FDA approves Gleevec for children with acute lymphoblastic leukemia

FDA NEWS RELEASE

For Immediate Release: Jan. 25, 2013
Media Inquiries: Stephanie Yao, 301-796-0394, stephanie.yao@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA

FDA approves Gleevec for children with acute lymphoblastic leukemia

The U.S. Food and Drug Administration today approved a new use of Gleevec (imatinib) to treat children newly diagnosed with Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL).

ALL is the most common type of pediatric cancer, affecting approximately 2,900 children annually, and progresses quickly if untreated. Children with Ph+ ALL have a genetic abnormality that causes proteins called tyrosine kinases to stimulate the bone marrow to make too many immature white blood cells. This leaves less room for healthy white blood cells needed to fight infection.

Gleevec, a tyrosine kinase inhibitor, blocks the proteins that promote the development of cancerous cells. It should be used in combination with chemotherapy to treat children with Ph+ ALL.

“We are pleased that the number of cancer medications for children are on the rise,” said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research. “Today’s approval is the result of continuous interactions among the FDA, the Children’s Oncology Group and the National Cancer Institute to provide new and better treatments to American children with cancer.”

Gleevec’s safety and effectiveness for this new indication were established in a clinical trial conducted by the Children’s Oncology Group, sponsored by the National Cancer Institute. The trial enrolled children and young adults 1 year and older with very high risk ALL, defined as patients with a greater than 45 percent chance of experiencing complications from their disease within five years of treatment. Ninety-two patients with Ph+ ALL were enrolled in the trial and divided into five treatment groups, with each successive group receiving a greater duration of Gleevec treatment in combination with chemotherapy.

Fifty of the Ph+ ALL patients received Gleevec for the longest duration, and 70 percent of these patients did not experience relapse or death within four years (event-free survival). Results also showed patient deaths decreased with increasing duration of Gleevec treatment in combination with chemotherapy.

The most common side effects observed in children with Ph+ ALL treated with Gleevec in combination with chemotherapy included decreased levels of infection-fighting blood cells called neutrophils; decreased levels of blood platelets, which assist in blood clotting; liver toxicity; and infection.

Gleevec was granted accelerated approval in 2001 to treat patients with blast crisis, accelerated phase or chronic phase Ph+ chronic myeloid leukemia (CML) who have failed interferon-alpha therapy. It has since been approved to treat several conditions, most recently regular approval to treat children newly diagnosed with Ph+ CML (2011) and regular approval to treat adults whose Kit (CD117)-positive gastrointestinal stromal tumors (GIST) have been surgically removed (2012).

Gleevec is marketed by East Hanover, N.J.-based Novartis.

For more information:

FDA Office of Hematology and Oncology Products 

FDA Approved Drugs: Questions and Answers 

NCI: Childhood Acute Lymphoblastic Leukemia 

Children’s Oncology Group   

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

#
 

Visit the FDA on Facebook, Flickr, YouTube and Twitter 



Article source: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm336868.htm

Irregular Heartbeat Elevates Risk of Kidney Failure

The risk of kidney failure is greater for people with chronic kidney disease who also have atrial fibrillation, one of the most common forms of irregular heart rhythm in adults, according to a new study by researchers at UCSF and the Kaiser Permanente Northern California Division of Research.

The finding opens the way for further studies into the relationship between the two factors, which could lead to new treatment approaches that would improve outcomes for people with chronic kidney disease.

Many people who suffer from chronic kidney disease progressively lose their kidney function over time and eventually develop a condition called end-stage renal disease – the complete failure of the kidneys – placing them in need of lifelong dialysis or a kidney transplant.

Doctors have known that patients with chronic kidney disease or end-stage renal disease commonly have atrial fibrillation and as a result are more likely to have a stroke or to die. However, the long-term impact of atrial fibrillation on kidney function among patients with known chronic kidney disease has been unknown.

The new study, published last month in the journal “Circulation,” involved 206,229 adults with chronic kidney disease who were drawn from members of Kaiser Permanente Northern California, a large integrated health care delivery system.. Over the course of about five years, approximately 16,400 patients developed atrial fibrillation, and those who did were 67 percent more likely to progress to end-stage renal disease compared with patients who had chronic kidney disease but did not develop atrial fibrillation.

Nisha Bansal, MD

Nisha Bansal, MD

“These novel findings expand on previous knowledge by highlighting that atrial fibrillation is linked to a worse kidney prognosis in patients with underlying kidney dysfunction,” said kidney specialist Nisha Bansal, MD, an assistant professor in the Division of Nephrology at UCSF.

“There is a knowledge gap about the long-term impact of atrial fibrillation on the risk of adverse kidney-related outcomes in patients with chronic kidney disease,” said senior author Alan S. Go, MD, director of the Comprehensive Clinical Research Unit at the Kaiser Permanente Division of Research. “This study addresses that gap and may have important implications for clinical management by providing better prognostic information and leading to future work determining how to improve outcomes in this high-risk group of patients.”

UCSF is one of the world’s leading centers for kidney disease treatment, research and education. Its Division of Nephrology is ranked among the best programs in the nation by U.S. News World Report.

Contributing Factors for End-Stage Renal Disease

People who have chronic kidney disease fall into a spectrum in terms of how severe their disease is.

At one end are those who have very minor loss of kidney function. They may not have any symptoms at all, and only by applying a simple blood test can doctors properly diagnose their disease.

At the other end of the spectrum are the people who have progressed to end-stage renal disease, which is basically complete kidney failure. They require lifelong dialysis or a kidney transplant. Some people progress rapidly to end-stage renal disease while others may live for decades without ever progressing.

Doctors are interested in understanding the factors that place patients at greater risk for end-stage renal disease, Bansal said, because it may be possible to address those factors through medications or lifestyle changes like diet or exercise.

Bansal added, however, that while the two conditions are intertwined, scientists do not know exactly which specific genes, pathways and biological mechanisms connect irregular heartbeat to declines in kidney function. Neither do they yet know the extent to which treating atrial fibrillation will improve outcomes for people with chronic kidney disease.

The article, “Incident Atrial Fibrillation and Risk of End-Stage Renal Disease in Adults with Chronic Kidney Disease” is authored by Nisha Bansal, Dongjie Fan, Chi-yuan Hsu, Juan D. Ordonez, Gregory M. Marcus and Alan S. Go. It was published online by the journal Circulation on Dec. 28, 2012.

This work was funded by the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) and the National Heart, Lung and Blood Institute (NHLBI) through grant #K23 DK088865, #K24 DK92291, #5U01 DK060902, #5U19 HL091179 and #5 RC2 HL101589. Both NIDDK and NHLBI are components of the National Institutes of Health.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/A82euQf-gGk/irregular-heartbeat-elevates-risk-kidney-failure

UCSF Teams Tackle Childhood Mortality and River Blindness

Thomas Lietman, MD, treats a young boy in Ethiopia, where communities that received mass doses of azithromycin to treat trachoma experienced an overall reduction in childhood mortality from all causes.

Two UCSF teams have received a total of $16 million from the Bill Melinda Gates Foundation to study new ways to significantly reduce childhood mortality and disease in developing nations.


Thomas M. Lietman, MD

Thomas M. Lietman, MD

An international team led by Thomas M. Lietman, MD, associate director of the UCSF Francis I. Proctor Foundation for Research in Ophthalmology, received $12 million for a multi-year trial to study the effectiveness of mass oral administration of the antibiotic azithromycin in reducing childhood mortality in Niger, Tanzania and Malawi – three nations with severe childhood mortality rates.

A second team, led by James H. McKerrow, MD, PhD, professor of pathology and pharmaceutical chemistry, received $4.3 million to identify and develop a drug that kills the parasitic roundworms known as filiariae that cause river blindness, the leading cause of blindness in parts of West Africa.

James H. McKerrow, MD, PhD

James H. McKerrow, MD, PhD

If successfully developed, the same drug will have a high probability of killing the closely related parasite that causes lymphatic filariasis, or elephantiasis, a crippling and disfiguring disease that affects millions of people in Africa, Asia, the Indian subcontinent and South America.

Expanding Prevention of Child Mortality

Lietman’s project is based on an earlier study in which communities in Ethiopia that received mass doses of azithromycin to treat trachoma – a strain of chlamydia that causes blindness – experienced an overall reduction in childhood mortality from all causes.

“Now we need to see whether that effect can be replicated in areas that don’t have a lot of trachoma,” said Lietman, a UCSF professor in the departments of Ophthalmology and Epidemiology Biostatistics. “If we want to make a public health difference, we have to show that we can reduce childhood mortality in areas that are not otherwise receiving mass antibiotics.”

Community-wide antibiotic administration is common in African nations where trachoma is usually found, he said.

Preschool children in Lietman’s study will be randomized to receive either a cherry-flavored oral suspension of azithromycin or a placebo every six months for two years. If there is a significant reduction in mortality in the communities that receive the antibiotic, the study will be extended for another two years and all communities will receive antibiotics.

CNN interviewed Thomas Lietman for this April 2011 story about his earlier study that looked at the effect of azithromycin in reducing childhood mortality from all causes.

Lietman and his team will closely monitor for development of antibiotic resistant diseases in the communities treated with azithromycin. “It’s a complicated question,” he said. “We think we will select for antibiotic resistance. However, many of us believe that might be a price worth paying if there is truly a reduction in childhood mortality.”

Lietman noted two mitigating factors with regard to antibiotic resistance. In communities treated with azithromycin for trachoma, resistance to the antibiotic gradually disappears over the two years after such treatments stop. In addition, he said, azithromycin belongs to a class of antibiotic that is rarely used in sub-Saharan Africa, so even if an infection is resistant to azithromycin, it could still be treatable by one of six other classes of antibiotics.

Finding New Drugs for Parasitic Disease

The goal of McKerrow’s study is to find a drug that kills the adult form of the parasitic filarial worm, which is spread by a fly that breeds near fast-flowing rivers.

When the fly bites, it deposits larvae under the skin that grow into worms several inches long. The parasite associated with river blindness attacks the eye, while its relative that is responsible for lymphatic filariasis blocks the lymphatic channels in the groin, resulting in extreme swelling of the lower extremities.

McKerrow’s research group will employ new software developed by UCSF research specialist Chris Marcellino that significantly speeds the screening of potential compounds. Conventional drug screening technology uses plates with many hollows, or wells, each of which contains a candidate compound that is screened individually for promising activity. The new software allows an entire plate to be scanned for results in seconds. Scanning and evaluating a whole plate rather than individual wells is necessary, McKerrow explained, because of the large size of the worms, which restrict each plate to dozens rather than hundreds of wells.

“With conventional, well-by-well scanning, it would take a long time to screen many compounds,” said McKerrow. “But if you can scan a whole plate and then move on to the next plate in a few seconds, you can filter through thousands of compounds much more efficiently.”

The compounds will come from two sources. The first is what McKerrow calls traditional drug discovery, which starts from chemicals that aren’t yet drugs. That research will take advantage of unique chemistry developed by Bay Area biotech company Anacor Pharmaceuticals. The second source is “repurposed drugs” that have already been approved by the FDA for human use. Working in collaboration with the UCSF Small Molecule Discovery Center, McKerrow’s group expects to create a library of approximately 1,700 FDA-approved drugs that can be used in this and similar screens.

Based on earlier research, the team already has identified a promising possibility: auranofin, a drug used for decades to treat rheumatoid arthritis, which has proven effective in animal models of filariasis. McKerrow said he expects to have one or two clinical candidates – drugs that are ready for final FDA testing and potential approval – in three years.

Lietman’s project will be administered by the Proctor Foundation and conducted in partnership with the Carter Center in Niger, Johns Hopkins University in Tanzania and the London School of Hygiene and Tropical Medicine in Malawi, as well as with Ministries of Health in the three countries. The group from UCSF includes Nicole Stoller, MPH; Sun Yu, MPH; Jeremy Keenan, MD, MPH; Travis Porco, PhD, MPH; Bruce Gaynor, MD; George Rutherford, MD; and Phil Rosenthal, MD.

The McKerrow research group is based at the UCSF Center for Discovery and Innovation in Parasitic Diseases, a consortium affiliated with Global Health Sciences and QB3 at UCSF. The group includes specialist Judy Sakanari, PhD; assistant professor of pathology Larissa Podust, PhD; postdoctoral fellow Alberto A. Rascon, Jr., PhD; and technical staff Brian Suzuki, Christina Bulman, K.C. Lim, Petrea Kells and Chelsea Bidlow. Aside from the UCSF Small Molecule Discovery Center, the CDIPD team is closely aligned with the research team at Anacor Pharmaceuticals, Sara Lustigman, PhD, of the New York Blood Center and Fidelis Cho-Ngwa, PhD, of the University of Buea, Cameroon.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/eL5hkapRC0k/ucsf-teams-tackle-childhood-mortality-and-river-blindness

Renowned Child Psychiatrist and Molecular Geneticist to Join UCSF

Matthew State, MD, PhD, a leading child psychiatrist and internationally recognized expert on the genetics and genomics of autism, Tourette syndrome and other neurodevelopmental syndromes, was recently named to lead UCSF’s psychiatric programs.

Matthew State, MD, PhD

As the new chair of the Department of Psychiatry and director of the Langley Porter Psychiatric Institute, State will play a key role in integrating psychiatry into the University’s preeminent neuroscience program. His appointment begins on March 18.

For State, it’s a return to California, where he earned his undergraduate and medical degree from Stanford University. He completed his residency and a fellowship at UCLA, before moving to Yale in 2001 for a PhD degree in genetics and to pursue his academic career.

State is currently the Donald J. Cohen Professor of Child Psychiatry in the Department of Psychiatry and Genetics at Yale’s School of Medicine. He also is deputy chairman for research in the Department of Psychiatry and co-director of the Program on Neurogenetics at Yale.

State, whose appointment was first announced in November, took some time while on sabbatical from Yale to answer these questions for UCSF.

Why did you decide to become a child psychiatrist?

I was interested in psychiatry as I entered medical school based both on experiences with family members and several good friends in college who suffered from serious mental illness. I did not enter residency training knowing that I was going to specialize in child psychiatry.

During my residency, I did a rotation on a child and adolescent inpatient service and left convinced that this was what I wanted to do. It was a combination of being inspired by my attending, loving the work with kids and families, the tremendous need for child psychiatrists, and my feeling that understanding development was going to be a key to better understanding the biology of serious psychiatric disorders.

How has gene discovery or genetics of Tourette syndromes and autism informed researchers in their quest for a cure?

It has been thrilling to be involved in studying the genetics of serious neurodevelopmental and neuropsychiatric disorders over the last several years. I have been working in this area since the late 1990s, and for the majority of that time, I felt that we were largely wandering in the dark. However, the field is now in the midst of a profound transition, where we finally have the tools in hand to identify risk genes and bring into focus the genetic architecture of disorders such as autism and Tourette syndrome.

As we identify multiple risk genes, this opens the door to deepening our understanding of the molecular and cellular mechanisms of disease, something that has been lacking in child psychiatry. This, in turn, is a critical first step to developing new and better therapeutics. In fact, this is the organizing theme of my lab: using gene discovery to illuminate the biology of mental illness and as a means to identify cures. 

Recent progress in the genetics and neurobiology of autism serve as a prime illustration of how this process can work. Over the last several years, progress in studying the biology of conditions that are accompanied by high rates of autism, such as fragile X syndrome, have transformed thinking about neurodevelopmental disorders. A series of recent studies have shown that it is at least theoretically possible to reverse symptoms even into adulthood, challenging long held notions that autism or intellectual disability are largely immutable after birth.

Similarly, recent results emerging from a collaboration between my lab and Joseph Gleeson’s [MD, professor of neurosciences and a Howard Hughes Medical Institute investigator] lab at UC San Diego have found a new, rare and potentially treatable form of autism and epilepsy caused by mutations in a gene regulating certain amino-acids. We are testing whether normalizing these amino acids will be helpful. If they are, this will apply to a small number of families carrying this very rare mutation, but it is an important illustration that understanding the causes of neuropsychiatric and neurodevelopmental disorders can open surprising new avenues to treatment.

What is the most important thing you would tell a parent whose child was recently diagnosed with TS or autism?

I would say that each family comes to this with its own experience, knowledge and questions. So the most important thing is to listen carefully and to try to respond to their particular concerns and fears. One of the wonderful things about child psychiatry is that we tend to have a bit more time to have these types of important conversations than other physicians in other medical specialties.

What has been the highlight of your academic career so far?

I feel extremely fortunate that there have been many. The lab has made good progress both in autism and Tourette syndrome after a long period of struggle, and this has been tremendously rewarding. For both disorders, some of our recent discoveries have pointed to novel approaches to treatment. This was a very distant goal 15 years ago when I started my lab. Seeing this come to fruition over the last several years has been truly wonderful.

Finally, I have a group of post-doctoral fellows and junior faculty in my lab that is doing absolutely stellar research. Our field is in desperate need of physician scientists and it is tremendously rewarding to see some of the next generation of leaders emerging from my group.

You’ve received numerous teaching awards. What teacher most influenced you?

I have been extremely fortunate to have a long list of outstanding teachers and mentors. I would say however, that two stand out in my professional life: Mark De Antonio, [MD, a professor of psychiatry who specializes in child and adolescent psychiatry at UCLA], was the attending physician on my first child and adolescent inpatient rotation. I have still never met a more gifted clinician or a more outstanding teacher. The experience inspired me to pursue child psychiatry as a career.  

At Yale, Richard Lifton, [MD, PhD, Sterling Professor of Genetics and professor of medicine; chair of the Department of Genetics at Yale and a Howard Hughes Medical Institute investigator], has been a pioneer in studying rare examples of common illnesses. I was fortunate to spend the vast majority of my PhD in his lab. From this time forward he has had a profound impact on my thinking how to approach the genetics of child psychiatric illnesses. I am certain that we would not have had the success we have had in the lab if it were not for his ongoing influence.

Why did you choose to join the faculty at UCSF?

I was attracted by the combination of exceptional science, exceptional patient care and exceptional training. I don’t believe there is any place that is doing a better job of integrating these missions at present than UCSF, and I care deeply about all three. In my case, this was particularly enticing with regard to the neurosciences, where I knew I would have the opportunity to work alongside great departments of neurology and neurosurgery and a phenomenal group of basic neuroscientists.

I also have to say that I could not be more excited about joining the Department of Psychiatry in a leadership role. The basic science of psychiatry is moving at light speed and yet there are very few places that are currently positioned to both lead in this area of research and, at the same time, to translate this knowledge into new and improved treatments. UCSF is poised to help transform science, clinical care and training in psychiatry in the next decade, and I thought it would be tremendously rewarding to participate in this effort.

UCSF is poised to help transform science, clinical care and training in psychiatry in the next decade, and I thought it would be tremendously rewarding to participate in this effort.

UCSF values its work in the community and its long-standing public mission. What experience at the community mental health center in Connecticut will shape your work here?

I am a molecular geneticist. I love the elegance of great sets of experiments and the thrill of discovering a risk gene. I am convinced that basic science is an important path to transforming psychiatric care in the coming decade.

At the same time, I am a clinician and my work with patients at a community mental health center is tremendously rewarding and the source of my conviction that clarifying the molecular underpinnings of serious illness will never be sufficient in isolation. 

Psychiatrists cannot ignore psychological, developmental and social issues that all have a profound impact on our patients and their families. These issues are not going to be resolved at the wet bench. One of the things that make psychiatry so interesting is that our field needs to understand pathophysiology at many levels and, at the same, must address broad policy issues that impact the risks for developing psychiatric illness and influence access to care for our patients.  

Lastly, what excites you the most about the future as the nation looks toward precision medicine to create individual treatment plans for any patient, anywhere?

There are many things that excite me about this prospect. Of course, effective precision medicine in psychiatry would have to be predicated on a deeper understanding of molecular and cellular mechanisms of disease than we have at present. As I mentioned above, this type of knowledge is critical to developing improved treatments. It has ushered in far more effective therapies for everything from cancer to immunological disorders, and I believe that psychiatry is on the cusp of benefiting from these advances just as these other fields have.  

I also expect that as precision medicine becomes a reality in psychiatry it will be accompanied by decreased stigmatization. Our field’s lack of understanding about what is causing serious mental illness has left open the door to our patients and their families being blamed and ostracized. This was the situation with cancer many years ago, and just as knowledge transformed that field, I am confident that research and improved understanding will transform the public perception of serious psychiatric illness as well.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/ZTuNOIDXYfA/renowned-child-psychiatrist-and-molecular-geneticist-join-ucsf

New child abuse alert system for hospitals announced

Hospitals will have a new system to help doctors and nurses spot children suffering from abuse and neglect, Health Minister Dr Dan Poulter announced today.

Work on the system will begin in early 2013 and it will start to be introduced to NHS hospitals in 2015.

Doctors and nurses using the system, known as ‘Child Protection – Information System’, in emergency departments or urgent care centres will be able to see if the children they treat:

  • are subject to a child protection plan or being looked after by the local authority
  • have frequently attended emergency departments or urgent care centres over a period of time.

Medical staff will be able to use this information as part of their overall clinical assessment, along with information about where and when children have previously been receiving urgent treatment. This will help them build up a better picture of what is happening in the child’s life so they can alert social services if they think something might be wrong.

Health Minister Dr Dan Poulter said:

“Up until now, it has been hard for frontline healthcare professionals to know if a child is already listed as being at risk or if children have been repeatedly seen in different emergency departments or urgent care centres with suspicious injuries or complaints, which may indicate abuse.

“Providing instant access to that information means vulnerable and abused children will be identified much more quickly – which will save lives.”

Dr Amanda Thomas, Officer for Child Protection at the Royal College of Paediatrics and Child Health, said:

“The Report of the Children and Young People’s Health Outcomes Forum highlighted that professionals working in different care settings need to communicate better with one another on child protection issues, and highlighted the proposed Child Protection – Information System solution as an encouraging move towards ensuring that clinical professionals have immediate access to important child protection information.

“This solution is a positive step and an important part of the overall solution. The college has been involved from an early stage and will continue to work with the Department of Health to ensure it is introduced effectively, integrates well with the working practices of NHS staff and makes a genuine contribution to improving child protection practice.”

Article source: http://www.dh.gov.uk/health/2012/12/abuse-alert-system/

Children and Young People’s Health Outcomes Forum final event

Health minister Dr Dan Poulter and Chief Medical Officer Professor Dame Sally Davies attended a reception this week with members of the Children and Young People’s Health Outcomes Forum, to thank them formally for  their work.

The independent forum was asked to help develop a new strategy for improving care for children and young people by the then Secretary of State Andrew Lansley. Its report was published during the summer and contained a number of recommendations about how to improve the way the health and care system should work for children and young people, these included:

  • a call for the key organisations in the new health system to listen to children and young people in the delivery of their work, and to set out how they have done so
  • new outcomes measures to test the effectiveness of the health and public health system’s success in improving health outcomes for children and young people, such as ‘time to diagnosis’, children and young people’s experiences of their care and the mental health of mothers during pregnancy and the first few years after delivery
  • making the revised NHS Constitution more overtly applicable to all children and young people.

A call for the NHS Commissioning Board to demonstrate leadership for children and young people through establishing a national clinical director post.

Speaking at the reception, Dr Dan Poulter praised the forums work. He said:

“I’m passionate about improving children and young people’s health outcomes and your work is so important in achieving that aim. Not only can we save money in the long term by providing more effective healthcare but also, more importantly, we can transform individual lives and those of their families.

I want to say what a pleasure it is to meet so many experts in the field of children’s healthcare. I know from meeting the chairs that they appreciated the contributions and support that they received from all forum members. Rest assured that I am absolutely committed to building on your hard work.”

Professor Dame Sally added:

“I would also like to take this opportunity to thank forum members for the contribution that they have made. This is the last Forum event but I hope that you have confidence that the Forum’s report will directly lead to changes being made that will improve health outcomes for children and young people.”

The event marked the formal end of the forum’s work. Its report is currently being used to inform the content of a new action plan for the improvement of children and young people’s health, which is due to be published early in 2013.

Article source: http://www.dh.gov.uk/health/2012/12/forum-final-event/

49ers Celebrate Win with Visit to Children’s Hospital

From left: 49ers Daniel Kilgore, Leonard Davis, Al Netter, Kenny Wiggins and Joe Staley visited UCSF Benioff Children’s Hospital to bring some holiday cheer to patients on Dec. 17.

The San Francisco 49ers had major cause for celebration after they defeated the New England Patriots on Sunday in what many call the best game of the NFL season. But instead of hitting the town, they boarded a plane and flew through the night to make sure they got back to San Francisco to support some of their smallest and most loyal fans.

49ers offensive linemen Daniel Kilgore, left, and Leonard Davis visit with J.J. Thompson and his mother.

With big smiles on their faces and not a hint of fatigue from their overnight flight, several offensive linemen from the San Francisco 49ers visited UCSF Benioff Children’s Hospital on Monday to spread a bit of good cheer.

Hulking linebackers Joe Staley, Anthony Davis, Daniel Kilgore, Leonard Davis, Al Netter and Kenny Wiggins signed just about everything in sight, from hospital gowns to diapers, and handed out toys with the 49ers logo.

But the visit wasn’t only about autographs. It was an opportunity for the players to get to know the patients at the 180-bed UCSF Benioff Children’s Hospital, talking to them about their strength while facing medical challenges, the holidays, and of course, football. They played video games with patients, sat at bedsides and answered questions from parents and grandparents.

49ers offensive linemen Leonard Davis, left, and Daniel Kilgore pose for a photo with patient Christopher Hagiwara.

“I cannot imagine how tired they must have been – Sunday’s game was grueling even for all of us fans – yet the 49ers came to UCSF and gave of themselves on their day off,” said Mark Laret, CEO of UCSF Medical Center and UCSF Benioff Children’s Hospital. “I cannot tell you how much that meant to the kids, families and our staff. What a class act.”

After several hours with patients and their families, the 49ers left the UCSF Benioff Children’s Hospital with hopes to return in the off-season. Maybe next time they’ll be wearing a new Superbowl ring.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/DOi6DrHpSQs/49ers-celebrate-win-visit-childrens-hospital

FDA expands Tamiflu’s use to treat children younger than 1 year

FDA NEWS RELEASE

For Immediate Release: Dec. 21, 2012
Media Inquiries: Stephanie Yao, 301-796-0394, stephanie.yao@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA

FDA expands Tamiflu’s use to treat children younger than 1 year
Parents, health care professionals must ensure proper dosing

The U.S. Food and Drug Administration today expanded the approved use of Tamiflu (oseltamivir) to treat children as young as 2 weeks old who have shown symptoms of flu for no longer than two days.

The drug is not approved to prevent flu infection in this population. In addition, the safety and efficacy of Tamiflu to treat flu infection has not been established in children younger than 2 weeks old.

Tamiflu was approved in 1999 to treat adults infected with flu who have shown symptoms for no longer than two days. It has since been approved to treat flu in children ages 1 year and older who have shown symptoms of flu for no longer than two days, and to prevent flu in adults and children ages 1 year and older.

Although there is a fixed dosing regimen for patients 1 year and older according to weight categories, the dosing for children younger than 1 year must be calculated for each patient based on their exact weight. These children should receive 3 milligrams per kilogram twice daily for five days. These smaller doses will require a different dispenser than what is currently co-packaged with Tamiflu.

“Pharmacists must provide the proper dispenser when filling a prescription so parents can measure and administer the correct dose to their children,” said Edward Cox, M.D., M.P.H, director of the Office of Antimicrobial Products in the FDA’s Center for Drug Evaluation and Research. “Parents and pediatricians must make sure children receive only the amount of Tamiflu appropriate for their weight.”

Tamiflu is the only product approved to treat flu infection in children younger than 1 year old, providing an important treatment option for a vulnerable population. According to the Centers for Disease Control and Prevention (CDC), children younger than 2 years are at higher risk for developing complications from the flu, with the highest rates of hospitalization in those less than 6 months of age.

The FDA expanded the approved use of Tamiflu in children younger than 1 year based on extrapolation of data from previous study results in adults and older children, and additional supporting safety and pharmacokinetic studies sponsored by both the National Institutes of Health and Roche Group, Tamiflu’s manufacturer.

Pediatric legislation permits efficacy to be extrapolated from previous study results in adults and older children if the illness being studied and the effects of the drug are sufficiently similar in adult and pediatric patients. Data on how the drug is metabolized in the body (pharmacokinetic data) indicated a dose of 3 mg/kg twice daily provided concentrations of Tamiflu similar to those observed in older children and adults, and is expected to provide similar efficacy in this very young age group.

Almost all of the 135 pediatric patients enrolled in the two safety studies had confirmed flu. Results from these studies showed the safety profile in children younger than 1 year was consistent with the established safety profile of adults and older children. The most common side effects reported with Tamiflu use in this age group include vomiting and diarrhea. Although not seen in the new studies, rare cases of severe rash, skin reactions, hallucinations, delirium, and abnormal behavior have been reported.

The FDA monitors drugs for side effects and believes reporting side effects is important. Health care professionals and patients should report any side effects associated with Tamiflu’s use to FDA’s MedWatch program.

Tamiflu is not a substitute for early, annual flu vaccination, as recommended by the CDC’s Advisory Committee on Immunization Practices. CDC recommends all persons aged 6 months and older receive an annual flu vaccine.

Tamiflu is distributed in the United States by South San Francisco-based Genentech, a member of the Roche Group.

For more information:

FDA Approved Drugs: Questions and Answers 

FDA: Influenza (Flu) Antiviral Drugs and Related Information

CDC: Seasonal Influenza (Flu) 

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

#
 

Visit the FDA on Facebook, Flickr, YouTube and Twitter 

 



Article source: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333205.htm

Kidneys and blood pressure

December 18, 2012

Inactivating nerves close to the kidney with focussed high
frequency energy waves could be used to reduce high blood pressure
in hard to treat patients, according to new research.

In a follow-up to their recent international multicentre study,
researchers have shown that this new treatment maintains
lower blood pressure for at least six months and
up to a year in patients with resistant hypertension.

High blood pressure is commonly
treated with medications. However, some patients have resistant
hypertension which means that even when taking up to four
different drugs
their blood pressure remains too high. The
new once only procedure shows promise as a useful additional way to
help patients whose blood pressure doesn’t respond well to the
drugs alone.

This will not be right for everyone and we don’t know yet whether the benefit and safety will be long-lasting

Our Associate Medical
Director Professor Jeremy Pearson said: “Many people don’t realise
that your kidneys play a part in controlling your blood pressure.
This study showed the potential of a new
treatment
, which tackles high blood pressure by blocking
the action of specific nerves near the kidney.

“These nerves are important in controlling blood pressure, and
this is a relatively simple procedure that could be
beneficial for people who don’t respond to treatments

currently available.

“It’s very important to find new treatments for high blood
pressure, because it leads to an increased risk of heart attack and stroke, and can be difficult to tackle.
However, this new treatment will not be right for
everyone
, and we don’t know yet whether the benefit and
safety will be long-lasting.

“In many cases, high blood pressure can be controlled by the
best combination of existing medications alongside
a healthy diet and lifestyle – so if you’re worried about your
treatment, speak to your GP.”

More information

Find out about how high blood
pressure can effect your heart and how you can control it.

Article source: http://www.bhf.org.uk/media/news-from-the-bhf/kidneys-and-blood-pressure.aspx

UCSF Child-Trauma Expert Offers Advice on How to Talk to Kids

Following the tragic shooting at an elementary school in Connecticut, UCSF child-trauma expert Patricia Van Horn, JD, PhD, says parents should be honest with their children about what happened.

A good source for parents, teachers and school administrators alike is the National Center for Traumatic Stress Network, which offers concrete advice on what to do in the aftermath of tragedies like the one at Sandy Hook Elementary School in Newtown, Conn.

Patricia Van Horn, JD, PhD

Patricia Van Horn, JD, PhD

Van Horn, director of the Infant, Child and Adolescent Services and associate director of the Child Trauma Research Program at the UCSF-affiliated San Francisco General Hospital and Trauma Center, says parents should provide the facts about such incidents within what’s developmentally age-appropriate for them to hear.

Parents should give their children an opportunity to express their feelings about what happened, she says. “Listen to what they have to say and validate their feelings.”

“It is very important that parents be as reassuring as they can realistically be,” Van Horn says. “I would talk to young children about the ways in which their families and their school is working to protect them.”

What Schools Can Do

At school, children gathered in group settings should be focused on sharing their feelings and not relaying gory details about what happened or their previous experiences with violence, Van Horn advises.

“The risk is that [in groups] kids can get their peers more and more aroused and it becomes a group contagion, generating more fear and alarm,” she says.

Schools should offer counseling and give children a place to express their feelings, she explains. Schools also should inform parents about their practices and policies they have in place that are designed to ensure the safety and security of the school community.

“It would be good for schools to reach out to parents in their communities so that administrators can explain what their emergency procedures are and parents can explain them to their kids. The more details parents can share about the various steps in place to enhance safety, the less frightened kids will be.”

Once parents are informed, they can then relay to their children how the school is working to protect them and use that information to offer reassurance “so children can relax and learn.”

“It’s good for parents to know from the school exactly what the school is doing to show that administrators are aware of the shooting and has a plan for keeping kids safe,” Van Horn says.

On Monday, parents may need to go to school with their young sons or daughters to provide extra comfort.

And while California is across the continent from Connecticut, parents and teachers should not shy away from broaching the subject, Van Horn says.

“The further away we are from the incident, the more tempting it is to just ignore it,” Van Horn says. “But some parents don’t do as good a job at filtering and sheltering kids from the news and then kids go to school and they talk to each other.”

For younger children, such as preschoolers and kindergartners, parents should keep details to a minimum. “If I had a young child, I would just say that a very sad and horrible and scary thing happened in another place, and people went to school with guns and many children were hurt.”

But don’t get more specific than that, she cautions. “Tell them if they have any questions or want to talk about it, I’m here and I want to listen.”

Pay Special Attention to Kids Previously Traumatized

Van Horn says for those children with prior experience with school shootings or police activity, parents and teachers should know that news like this may serve as a reminder of the previous trauma.

She says administrators in schools where there has been violence as well as those whose students live in violent communities should be very aware of how these kids are faring. They should give them opportunities to express their feelings.

“Teachers can give children opportunities to express their feelings by talking about them or by drawing,” Van Horn says. “Some classrooms of children might be helped by doing something proactive such as, for example, writing sympathy notes to the school where the shooting happened.”

The one lesson for all parents, Van Horn emphasizes: “Don’t ever let your child go out the door before telling them you love them.”

“Focus on all the precious time you share with them, and the love you give them and your belief in them,” she says.

Look for Warning Signs

In the days ahead, parents can look for warning signs such as changes in sleep, eating and behavior patterns. “A gregarious child who becomes withdrawn may need help.”

Parents can also look for setbacks in recent developmental achievements, such as new readers who struggle or toddlers who forget their toilet training.

Finally, Van Horn advises parents to keep their children away from violent video games and TV shows all the time because exposure to media like this can be a vehicle for aggression.

“Kids who play repetitively without relieving their anxiety are in danger of being more traumatized as they recreate it over and over without expressing their fears and anxiety,” she says, adding that parents should seek mental health counseling for these children.

“At least for a while, be very careful about monitoring the violent police shows and video games that involve a lot of shooting and watch for kids who become more pre-occupied with them.”

For more help, check out the Psychological First Aid principles [PDF] that help calm people after national tragedies like the one today.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/LTKwYfz8Wtk/ucsf-child-trauma-expert-offers-advice-how-talk-kids

As Asthma Rates Rise, Researchers Look at Effective Medicines for Children

Nearly 10 percent of American children under the age of 17 were diagnosed with asthma between 2008 and 2010. In many cases, the condition requires emergency care.

As asthma rates continue to rise in the U.S. — proportionally affecting more children than adults — experts at UCSF and across the nation continue to search for the best medicines for pediatric patients.

Nearly 10 percent of American children under the age of 17 were diagnosed with the condition between 2008 and 2010. In many cases, the condition requires emergency care.

To hone effective treatments, two related studies that include researchers from UCSF are underway to closely examine the effectiveness of pediatric asthma medicines. The studies are called APRIL, for Azithromycin for Preventing the development of upper Respiratory tract Illness into Lower respiratory tract symptoms, and OCELOT for Oral Corticosteroids for treating Episodes of significant LOwer respiratory Tract symptoms in children.

Michael D. Cabana, MD, MPH

Michael D. Cabana, MD, MPH

“We have many medications and therapies for asthma, but we need to better understand which medications are first-line for specific situations and for specific kids,” said Michael D. Cabana, MD, MPH, a professor of pediatrics in the UCSF School of Medicine who is leading UCSF’s efforts for the multi-site research.

The APRIL/OCELOT dovetailed studies, which follow 600 preschool-aged children with recurring wheezing, are investigating the antibiotic azithromycin to see if it can prevent asthma attacks and reduce the need for emergency care, essentially limiting the condition’s severity.

Prior research has shown that this class of antibiotics can reduce inflammation and is potentially useful for treating early asthma in adults. However, it is not yet known if these medications are effective in children.

Researchers are also looking into systematic corticosteroids to better understand how much of a difference they make after an asthma attack has begun. The steroid is known to stop attacks, but affects the entire body and can be associated with side effects for some children.

The APRIL/OCELOT studies are part of AsthmaNet, a clinical trial collaboration funded by the National Institutes of Health (NIH) that involves nine sites, including UCSF.

“AsthmaNet also tackles those questions that pharmaceutical companies might be reluctant to ask,” said Cabana. “For example, can we safely treat children with asthma with less medication or safely avoid giving a specific medication?”

The UCSF research team, which is working in partnership with Children’s Hospital and Research Center Oakland, is being assisted by the Clinical Research Services (CRS) program of UCSF’s Clinical and Translational Science Institute (CTSI). In particular, the CRS Pediatric Clinical Research Center, one of eight Bay Area clinical sites managed by CTSI, is providing hospital space for patient exams and assessments as well as helping with study coordination.

“CTSI helps us provide the best clinical care including state-of-the-art equipment and technical expertise necessary to conduct our careful assessments,” Cabana said. “CTSI has also helped us to reach out to many neighborhoods in the Bay Area to be able to include children from diverse backgrounds, making sure that what we learn is generalizable to the broader population.”

UCSF’s CTSI is a member of the Clinical and Translational Science Awards network funded through the National Center for Advancing Translational Sciences (grant Number UL1 TR000004) at the National Institutes of Health (NIH). Under the banner of “Accelerating Research to Improve Health,” CTSI provides a wide range of resources and services for researchers, and promotes online collaboration and networking tools such as UCSF Profiles

Related Link:

UCSF Chipper Website: Children Helping Improve Pediatric Practice, Education Research

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/xe1udcfeq3o/asthma-rates-rise-researchers-look-effective-medicines-children

Health visitors leading the way in transforming services for children and families

These case studies highlight innovations developed as part of the Health visiting programme.

These 20 case studies have been developed by organisations delivering services for children and families. The focus is on improvements in service quality and innovation, specifically along the strands of the ‘Health visiting service vision and family offer’.

They are intended as a resource for sharing and learning amongst NHS public health professionals and early years staff.

The case studies have been themed according to the following categories: Community, Universal services, Universal plus and Universal partnership plus.

Community

Community offers a range of services, including some ‘Sure Start Children’s Centre’ services and the services families and communities provide for themselves. Health visitors work to develop these and make sure local families know about them.

Universal services

Universal services from the health visitor team is working with general practice to ensure that families can access the ‘Healthy child programme‘, and that parents are supported at key times and have access to a range of community services.

Universal plus

Universal plus offers timely response from the local health visiting team when specific expert help is needed. Including postnatal depression, a sleepless baby, weaning or answering any concerns about parenting.

Universal partnership plus

Universal partnership plus provides ongoing support from the health visiting team including a range of local services to deal with more complex issues over a period of time. These include services from Sure Start Children’s Centres, charities and, where appropriate, the Family nurse partnership.

Open access health visitor support for refugee and asylum seeking families
One stop shop for health and wellbeing
SMS listening project
Health visitor Facebook
Family echo listening project
Preventative working and rapid response for parenting concerns
Community based perinatal mental health assessment
Productive community services
Early start team initial family health assessment
Utilisation of lean processes: redesign of healthy child pathway
Early attachment service
Increasing choice and access: the healthy child clinic
Post natal: parenting support, education
Working towards baby friendly accreditation
Health visitor contribution to youth and family early intervention
Raising the profile and duration of breastfeeding
The health visitor parenting support surgery
Development of the learning portfolio and delivery of training packages
Development of the learning portfolio (leaflet)
Development of health visitor services for homeless/ transient population
Constipation pathway
Constipation pathway (leaflet)

Article source: http://www.dh.gov.uk/health/2012/12/health-visitor-case-studies/

Severe Acute Kidney Injuries Rise Rapidly Nationwide

Severe acute kidney injuries are becoming more common in the United States, rising 10 percent per year and doubling over the last decade, according to a retrospective study at the University of California, San Francisco (UCSF).

The study, to be published online this week in the Journal of the American Society of Nephrology, analyzed information from a national database that monitors all causes of hospitalizations and used this data to estimate the total number of acute kidney injuries in the United States that were severe enough to require a patient to be placed on dialysis.

Raymond K. Hsu, MD

Raymond K. Hsu, MD

The results showed that these injuries, caused by such incidents as major infections, trauma, complications following surgery and adverse reactions to drugs, increased by 10 percent per year from 2000 to 2009, from 222 to 533 cases per million people. The study also showed that the total number of deaths associated with acute kidney injury more than doubled during that time, from 18,000 in 2000 to nearly 39,000 in 2009.

“That was a staggering revelation of how increasingly common and how life-threatening acute kidney injury has become over the past decade in the United States,” said Raymond K. Hsu, MD, a UCSF nephrologist who led the research.

The UCSF team estimated that about 30 percent of the increase can be attributed to commonly known causes, such as the rise in severe infections, ventilator usage, acute heart failure and cardiac catheterizations over the same time period. But doctors do not yet know what else accounts for the rise in acute kidney injury and what hospitals nationwide can do to address the problem, Hsu said.

UCSF is one of the world’s leading centers for kidney disease treatment, research and education, and its Division of Nephrology is nationally ranked among the best programs in the nation by U.S. News World Report.

Acute Kidney Injury: What’s Next

The epidemic of acute kidney disease is largely a silent one, because the organ itself is so redundant in structure and steadfast in function, according to Chi-yuan Hsu, MD, who is chief of the Division of Nephrology in the UCSF School of Medicine and senior author on the paper. Composed of more than a million identical structures called nephrons, which filter blood and produce urine, a single kidney can function even if a large part of it is damaged or shut down.

Chi-yuan Hsu, MD

Chi-yuan Hsu, MD

“Even if you were to lose 80 percent of your kidney function, you wouldn’t feel it,” said Chi-yuan Hsu, who is not related to Raymond Hsu. But once the insult to the kidneys becomes severe enough to require a patient to go on dialysis, he said, the result is often fatal – about one-fifth of patients with acute kidney injury requiring dialysis in the study died.

Analyzing a decade’s worth of data and coming up with national statistics on acute kidney injury is a first step towards discovering why this condition has been steadily rising and developing measures to prevent them in the future, the UCSF team said.

“We hope that clinicians, researchers and the general public can gain a higher appreciation of the devastating impact of acute kidney injury that is comparable to the near universal, basic understanding of other forms of acute organ injury, such as heart attack and stroke,” Raymond Hsu said.

The article, “Temporal Changes in Incidence of Dialysis-Requiring AKI,” by Raymond K. Hsu, Charles E. McCulloch, R. Adams Dudley, Lowell J. Lo and Chi-yuan Hsu will be published online by the Journal of the American Society of Nephrology on Dec. 6, 2012. After publication, the article can be accessed here

This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases, a component of the National Institutes of Health, through grants #F32DK093212, #T32DK07219, and #K24DK92291.

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/3jPtvZsMaMw/severe-acute-kidney-injuries-rise-rapidly-nationwide

Output based specification for child health information systems published

The ‘Output based specification’ is a child health specific supplement to existing NHS information standards documents.

The document contains high level technical requirements for information systems to be procured to underpin the delivery of child health services in England.

It incorporates policy, standards and guidelines for child health programmes, such as immunisation, screening and the healthy child programme detailed in the earlier published document Information requirements for child health information systems.

It can be used as a checklist for either procurement or development of child health systems and includes data that drives the statutory requirements for delivery of child health services.

This latest document will be of interest to those involved in the commissioning or delivery of child health information systems including those who rely on such systems to deliver effective services to children.

Read the document Output based specification for child health information systems

Article source: http://www.dh.gov.uk/health/2012/11/chis-requirements/

Funding allocations announced for new children’s hospice 2012/13 grant

The Department has announced details of the funding allocations for the additional £721,000 made available for new children’s hospices set up within the last 3 years.

Details of the  allocations are:

  • Alexander Devine Children’s Hospice, Slough, £63,360
  • Children’s Hospice South West, Little Harbour, £121,181
  • Demelza House Children’s Hospice, Eltham, £121,181
  • Forget Me Not Children’s Hospice, Huddersfield, £121,181
  • Noah’s Ark Children’s Hospice, Barnet, £121,181
  • The J’s Hospice, Chelmsford, £51,732
  • Zoe’s Place Baby Hospice, Coventry, £121,181

The £721,000 grant is in addition to the annual £10m children’s hospice and hospice at home grant. Applications for the additional £721,000 grant were open to new children’s hospices or hospice at home services not in receipt of funding through the annual £10m grant.

Information on the process and eligibility criteria for the additional grant was published in July 2012.

The government has committed to continuing the annual £10m funding for children’s hospices until a per patient funding system is established by 2015.

 

 

Article source: http://www.dh.gov.uk/health/2012/11/hospice-grant/

Children, Families and Maternity bulletin – October 2012

This month’s edition features information about:

  • more and more parents sign up to NHS Information Service for Parents
  • 2011 update of stillbirths in the West Midlands
  • healthy start vitamin distribution from April 2013
  • Children and Young People’s Outcomes Forum
  • new ChiMat JSNA Navigator
  • development of ePortal for children and young people’s mental health

CFM bulletin – October 2012

 

Article source: http://www.dh.gov.uk/health/2012/10/maternity-bulletin-oct-2012/

Join the Department of Health at this year’s National Children and Adult Services Conference

Find out more about the department of health’s work, the new ministerial team and meet those who are working directly on policy by joining the department at the National Children and Adult Services Conference (NCAS) 2012

Jeremy Hunt, Secretary of State for Health and Norman Lamb, Care Services Minister will both be speaking at NCAS 2012 this week.

The Department is also running a series of mini masterclasses at NCAS covering a range of current issues and priority policy areas, including:

  • An overview of the draft Care and Support Bill
  • Improving the quality of dementia care
  • Shared leadership – what’s your contribution?

These are running in addition to the programme of plenary sessions and workshops and will be short, informal, drop-in sessions run from the department’s stand at number 42.

In this video Shaun Gallagher, Acting Director General of Social Care, Local Government Care Partnerships talks about the NCAS 2012 conference and makes the following points:

  • The NCAS conference comes at a really important time for social care.
  • Earlier this summer, the government set out plans to reform social care in the Caring for our Future white paper and now we are busy working across the sector to make these changes happen.
  • We also published the draft Care and Support bill which is the biggest change in social care legislation for 60 years.
  • From April next year, local health and well being boards and Healthwatch are being established as part of new local leadership for health.
  • We are taking forward a range of work to progress better care for people with dementia.
  • We have a new ministerial team at the Department of Health.

The NCAS conference brings together health and care leaders and policy makers from across local and central government, voluntary and private sectors.

This year, the NCAS conference is taking place between Wednesday 24 and Friday 26 October at the Devonshire Park Centre in Eastbourne. A full programme and details of confirmed speakers are available on the NCAS conference webpage.

To find out more about the Department’s policies, you can follow us on Twitter where we’ll be tweeting live over the three days and signposting to further information on our Facebook page:

Article source: http://www.dh.gov.uk/health/2012/10/ncas/

Shuvo Roy to Receive BayBio Pantheon Award For Artificial Kidney Project

UCSF bioengineer Shuvo Roy, PhD, has been elected to the BayBio Pantheon, a group of 52 San Francisco Bay Area life sciences leaders who have made a significant contribution to the industry, for his work toward creating the world’s first implantable artificial kidney.

Shuvo Roy, PhD

Shuvo Roy, PhD

Roy is receiving the Pantheon Rising Star award, which BayBio will present Nov. 1 at its annual Pantheon Awards ceremony in recognition of his efforts to create new technology to address end-stage renal failure, which is both an unmet medical need and a huge burden on the Medicare system. The award recognizes Roy’s efforts as “work that is too uncommon” in tackling both a medical need and cost at the same time.

Roy, an associate professor in the Department of Bioengineering and Therapeutic Sciences, a joint department in the schools of Pharmacy and Medicine, is the seventh UCSF faculty member to be elected to the BayBio Pantheon since its inception in 2004 and the first from the UCSF School of Pharmacy. Previous recipients include Bruce Alberts, PhD; J. Michael Bishop, MD; Herbert W. Boyer, PhD; Joseph DeRisi, PhD; Susan Desmond-Hellmann, MD, MPH; and William J. Rutter, PhD.

The annual Pantheon Awards ceremony is a celebration of the contributions and achievements of the Bay Area to the life sciences and a time to reflect on the industry’s legacy over the past three decades, according to BayBio.

Roy also will be presenting an update on The Kidney Project at the annual American Nephrology Association conference in San Diego on November 3.

For more information on The Kidney Project, visit kidney.ucsf.edu.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/L7QT3nN1vi0/shuvo-roy-receive-baybio-pantheon-award-artificial-kidney-project

Pediatric Patients Show Off Their Creativity at Art Day

The courtyard of the UCSF Benioff Children’s Hospital was transformed for a red-carpet event last week to show off patient-designed hospital gowns at the Third Annual Art Day.

Models — better recognized in their day jobs as UCSF medical and administrative staff — strutted down the runway in creative designs inspired by superheroes and sea creatures to kick off an event showcasing the artistic creativity of the pediatric patients.

Organized as an opportunity to honor patients as artists and designers, Art Day features the work created through the hospital’s art therapy program, which provides patients and their families an artistic outlet to work through the stress of their illnesses and give a voice to unexpressed thoughts and emotions.

“Tapping into the creative process can help the children and their families find another way to communicate and better cope with their hospital experience,” said Suzanne Yau, UCSF art therapist and program director. Yau encourages patients to use creative tools for self-expression in group and one-and-one sessions.

As one of the featured events during Art Day, the hospital gown fashion show was conceived as a way to involve the entire hospital community. Patients prepared their designs “Project Runway” — style by first sketching ideas on paper then bringing their sketches to life by using various materials to make their own unique hospital gowns. The runway show was streamed live on patient room televisions, and models also paraded through the hospital to visit those patients not able to leave their rooms.  

Inspiration for the designs came from what is important to each child, according to Yau. This could be anything from capturing how they are feeling to favorite sports teams to favorite colors.  

Also featured during Art Day was the debut of newly framed patient art on the walls of the hospital. Covered in brightly colored wrapping paper, the self-portrait series was officially unveiled by patients and the UCSF Child Life Services staff after the hospital gown fashion show. In the series, patients captured themselves as healthy and playing with their siblings, as a future NBA star, as a video game designer and as a UCSF nurse — just to describe a few.

Additional drawings, photographs, paintings and sculptures created throughout the year were also on display in the All Stars technology room and playroom in the hospital.

The remainder of the day was dedicated to hands-on art activities for patients and families such as sidewalk chalk painting, mosaic art, badge making, photo booth sessions and rainbow wind chime making.

Photos by Susan Merrell

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/fZ_CplxW9n8/pediatric-patients-show-their-creativity-art-day

Artificial Kidney Project at UCSF Receives $3 Million in New Funding

A $750,000 gift from the John and Marcia Goldman Foundation is spurring a UCSF-led effort to create the first implantable artificial kidney for patients with kidney failure.

The new funds, which augment a $2.25 million grant for the project from the National Institutes of Health (NIH) this summer, will enable the team of bioengineers, physicians and scientists to conduct the critical research needed to bring the proposed device to clinical trials by 2017.

“Kidney failure takes a terrible toll on the world, both economically and in human suffering,” said Shuvo Roy, PhD, an associate professor in the UCSF School of Pharmacy who is leading the Kidney Project through the UCSF Department of Bioengineering Therapeutic Sciences. “These funds are a critical step in helping us move this project forward more quickly and ultimately bring real solutions to patients throughout the world.”

Working with the project’s medical director, William Fissell, MD, at Vanderbilt University, UCSF’s Roy is coordinating researchers in nine institutions nationwide to create an implantable device that aims to mimic the filtration functions of a kidney, as well as its ability to maintain water and salt balances, produce Vitamin D, and regulate blood pressure and pH.

Roy estimates that the project will require an additional $13 million to bring that technology through the range of tests needed to enter clinical trials in humans.

The Kidney Project has been identified as a campus priority by UCSF and the UCSF School of Pharmacy for its potential to develop a breakthrough therapy to help solve a pressing health need. The school focuses on therapeutics, including medical devices and diagnostic tests, in addition to medications.

The Goldmans said they contributed to this unique research because of the project’s specific goal of addressing the dire shortage of donated kidneys and eliminating the need for dialysis.

“We know how debilitating dialysis is, and how few options are available for people with kidney failure,” said Marcia Goldman, who directed the gift with her husband through the John and Marcia Goldman Foundation. “The opportunity to be part of a potential solution of this scale was very appealing to us.”

Roughly 2 million people worldwide live with end-stage renal disease (ESRD), commonly known as chronic kidney failure, including 600,000 Americans — a figure that is rising 5 percent per year in lockstep with the growing rate of diabetes. The disease is best treated via a kidney transplant, yet fewer than 18,000 of the 93,000 people on the transplant waiting list will actually receive an organ this year, and those who do are likely to need a replacement within 10 years.

Shuvo Roy, PhD

Shuvo Roy, PhD

As a result, roughly 400,000 Americans with ESRD survive on dialysis, which comes at a high price: the U.S. Medicare system spends upwards of $29 billion per year, or 6 percent of its total budget, to treat kidney failure, including $24 billion each year to pay for dialysis. Only 34 percent of dialysis patients survive beyond five years.

Silicon Technology Used for Nano-Filter

The UCSF team has used silicon technology from the computer industry to design a nano-filter for the first compartment of the device, which would offer the same level of filtration as dialysis in a box smaller than a coffee cup. A second compartment would hold live kidney cells that perform the other biological actions of a real kidney.

The entire device would be implanted in the abdomen and powered by the body’s blood pressure, without a need for external pumps or tubes. The device also is designed to be used without the immunosuppressant drugs needed in transplants.

Earlier this year, the project was selected by the U.S. Food and Drug Administration (FDA) as one of the first three pilots for a collaborative FDA review process, which aims to address potential regulatory obstacles for the device up front, before it enters the approval process. The Kidney Project was chosen for its transformative potential in treating chronic kidney failure, a major health concern.

The Goldman support is the largest philanthropic grant to date for the project, which has drawn support from a number of individuals throughout the world, as well as grants from the NIH, NASA and the U.S. Department of Defense.

The UCSF School of Pharmacy is the nation’s premier, graduate-level pharmacy school, the oldest of its kind in the western United States, and a wellspring for discovery and innovation in the therapeutic sciences, education, and the pharmaceutical care of patients. Go here for more information.

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. Visit www.ucsf.edu.

Photo by Susan Merrell

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/QQjHar8HjYA/artificial-kidney-project-ucsf-receives-3-million-new-funding

Special Programs Enhance Pediatric Cancer Care at UCSF

UCSF Survivors of Childhood Cancer Program receives an official check from 2011′s Swim Across America fundraiser, the program’s primary funding source. This year’s fundraiser, in which former Olympians and cancer survivors swim 1.5 miles from the Golden Gate Bridge to Crissy Field in San Francisco, is taking place Saturday, Sept. 29. Click here for event info.

September is National Childhood Cancer Awareness month, encouraging awareness and affirmation to the commitment of fighting pediatric cancer.

The UCSF Benioff Children’s Hospital not only is one of the nation’s best children’s hospitals, but it’s also a leader in the treatment of cancer and blood diseases. UCSF recognizes that pediatric cancer differs from adult cancer in the way it emerges and develops and ensures the cancer programs are designed specifically for its youngest patients.

About 12,060 children under the age of 15 will be diagnosed with cancer in the United States this year, according to the American Cancer Society. Thanks to recent treatment advances, more than 80 percent of children with cancer now survive five years or more. While survival rates vary depending on the type of cancer and other factors, this is a huge increase since the mid-1970s when the five-year survival rate was less than 60 percent.

With cancer treatment programs becoming more comprehensive, there now are more resources to help support the overall treatment process for patients. UCSF Benioff Children’s Hospital has created special programs to supplement the medical services pediatric cancer patients receive.  

Survivors of Childhood Cancer

Given the growing population of pediatric cancer survivors, the UCSF Survivors of Childhood Cancer Program is dedicated to helping them maintain optimal physical and emotional health for the rest of their lives.

“It is estimated that one in 500 young adults in the United States is a survivor of pediatric cancer,” said Robert Goldsby, MD, a UCSF pediatric oncologist and medical director of the Survivors of Childhood Cancer Program. “It is essential that we provide appropriate and comprehensive care addressing long-term consequences of therapy for cancer survivors.”

The Survivors Clinic consults patients on the impact of their cancer treatments in their childhood and their subsequent long-term healthcare needs in adulthood. Pediatric cancer survivors may face a host of issues including fertility problems, problems accessing health care and obtaining insurance, secondary cancers, psychological and emotional problems, treatment-related organ dysfunction, just to name a few.

An example of the UCSF Survivors Clinic health passport provided to pediatric cancer survivor patients. The passport serves as handy reference of personalized medical history.

Patients make their initial visit to the Survivors Clinic after being at least two years off therapy and then every five years subsequently. Over 400 visits have been held in the clinic.

A unique element is a pocket-sized “health passport” that contains an individualized treatment summary and follow-up care plan. Patients receive the passport at the time of their initial visit so they can have a concise summary of their medical information on hand at all times. Information is updated with each subsequent visit to the clinic.

“Once you go through treatment, you think you are done but there is so much follow-up work,” said Rachael Donaldson, 27, who first attended the clinic four years ago after extensive treatment for stage IV sarcoma. “The Survivors Clinic helped me to be aware of the importance of what to look out for later in life. So if anything feels weird or I notice anything different, I can use references they have given me to know what to be concerned about and when to contact the doctors.”

Donaldson is now a pediatric nurse with plans to eventually focus on oncology. She credits the success of the clinic to the UCSF staff, particularly Goldsby, whom she says she would still want as her oncologist if she ever had a reoccurrence — even though now she is in her late 20s.

Fresh off of his first visit this month, Jason Thornton, 24, also recognizes the clinic’s importance.

“It’s a great way to inform young survivors about treatments and procedures that they went through,” said Thornton who was diagnosed at age 17 with stage IV malignant germ cell tumor and again at 18 with non-germ cell malignant sarcoma.  “I believe for some of the younger patients who didn’t really understand or probably don’t remember much because they were treated at such a young age, it’s a great way to educate them now [that they are older].”

The clinic and overall program is funded primarily from monies raised at the annual Swim Across America event, where former Olympians and cancer survivors swim 1.5 miles from the Golden Gate Bridge to Crissy Field in San Francisco. This year’s event is taking place this Saturday, Sept. 29, and Thornton will share his personal story and clinic experience with attendees at the post-swim celebration.

Compass Care Program

UCSF’s Compass Care Program is one of the region’s first palliative care programs for children, focusing on maximizing quality of life for gravely and chronically ill infants and children all while providing cutting-edge medical care and support.

Initiated as a hospital-wide grassroots effort in 2000, it has since grown into a nationally recognized interdisciplinary program, recognizing the central role of family in the care of patients and works to help them cope with having a critically ill child who may need prolonged or repeated hospitalizations. A specialized team of doctors, nurses, social workers, child life specialists, spiritual care staff and pharmacists provide expert clinical care, education and guidance around difficult medical issues and decision-making.

Recent updates to the Comfort Care suites at UCSF Benioff Children’s Hospital will help provide pediatric cancer patients and their families a more comfortable environment during their treatment.

During pivotal, stressful times during cancer treatment, patients on the pediatric oncology unit often stay in the Comfort Care suites — larger, more private rooms located within the children’s hospital. Recently, updates to two of these were completed — thanks to funding from Go4theGoal, a pediatric cancer charity — adding new sleeper sofas, cheerful wall murals and furnishings, softer lighting and new wall colors.

“These room improvements allowed us to give our patients and their families an even more comfortable, warm and private environment to be together during a very stressful time,” said UCSF Compass Care Program Coordinator Robin Kramer.

Ongoing Research

In addition to these programs and more, ground-breaking research around pediatric oncology continues at UCSF.

Recently, Jean Nakamura, MD, a UCSF pediatric oncologist received a grant from St. Baldricks, a charity dedicated to raising money for childhood cancer research, for her research aiming to protect the long-term health of childhood cancer survivors by understanding who is at risk for developing therapy-associated malignancies, why these malignancies develop and how to prevent them.

Nakamura is using sophisticated genetic analyses to find the most important gene mutations that occur in therapy-induced cancers and then studying how these mutations work to produce a second cancer. This type of analysis has not been done before, she said.

“We are excited about the possibility of making major progress in an area that hasn’t seen the kind of advances that keep childhood cancer survivors healthy,” Nakamura said.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/gU9nYomMyxk/special-programs-enhance-pediatric-cancer-care-ucsf

Media Advisory: Swimming for UCSF Pediatric Cancer Care

UCSF Benioff Children’s Hospital staff receive the official check from the Swim Across America 2011 fundraising event. Funds raised through this cancer awareness charity and annual local swim event help to support the UCSF Survivors of Childhood Cancer Program.

 

WHAT: Swimming enthusiasts including former Olympians, cancer survivors and former patients will take part in Swim Across America’s seventh annual San Francisco Bay Area Open Water Swim benefiting UCSF Benioff Children’s Hospital Survivors of Childhood Cancer Program. This event is the primary funding source for the program, which helps pediatric cancer survivors maintain optimal physical and emotional health for the rest of their lives – through clinical care, education and research.

The 1.5-mile swim from the Golden Gate Bridge to Crissy Field will raise money for both UCSF Benioff Children’s Hospital and Children’s Hospital of Oakland through pledges collected by swimmers and through online donations. This year’s swim is expected to raise more than $300,000.

Upon completion of the swim, there will be a celebration and awards ceremony on the beach for participants, families and friends with speeches from former Olympians, doctors and former patients.   

WHEN:

Saturday, September 29, 2012
9-11 am (Swim)
11am – 1pm (Post-swim festivities)                  

WHERE:

Crissy Field East Beach
San Francisco, CA

Participating swimmers will board Hornblower’s San Francisco Spirit yacht from Pier 3 and head for the start of the swim at the Golden Gate Bridge. Post-swim festivities will take place at Crissy Field’s East Beach.

WHO: 

  • Robert Goldsby, MD, UCSF pediatric oncologist and medical director of UCSF Survivors of Childhood Cancer Program
  • Linda Li, UCSF clinical research coordinator
  • Jason Thornton, former patient, UCSF Survivors of Childhood Cancer Program
  • Susan Helmrich, Swim Across America SF Bay Area Event Co-Director
  • 200 swimmers including former Olympians: 2012 gold-medal water polo team members Heather Petri and Annika Dries; bronze-medalist Kim Vandenberg (2008); Dana Kirk (2004); silver and bronze-medalist Ericka Lorenz (2000,2004); silver-medalist Allison Wagner (1996); Katherine Starr (1984,1988); Susan Heon-Preston (1984); gold-medalist Mike Bruner (1976,1980); Kimberly Carlisle (1980), Craig Beardsley (1980)

CONTACT: Media planning to attend should RSVP to Abigail Mortimore at abigail.mortimore@ucsf.edu or (415) 476-8810.

###

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/zqhS3cXUu0U/media-advisory-swimming-ucsf-pediatric-cancer-care

Childhood obesity dangers

September 25, 2012

Being obese as a child or teenager may carry more risks for
future health than previously thought, a study suggests.

A review of past studies showed that obese
children are more likely to have risk factors for heart disease including raised
blood pressure, high cholesterol and blood sugar levels, and a
thickening of the heart muscle. Researchers predicted that obese
children could already be at a 30-40% higher risk
of stroke and heart disease in later
life.

Our Senior Cardiac Nurse, June Davison, said: “Unless action is
taken, childhood obesity is likely to cause future health
problems
for children. 

“Obese children are more likely to
become obese adults and with this comes a greater
risk of developing conditions such as heart disease, diabetes and high blood pressure.

“However, this problem can be solved by
teaching children about the importance of
lifestyle
at a young age. By highlighting the need to
eat healthily and stay active, we can help today’s children, and
tomorrow’s adults, to keep their hearts healthy.”

This study was published in the British
Medical Journal.   

Get more information

Article source: http://www.bhf.org.uk/media/news-from-the-bhf/obese-children.aspx

UCSF Benioff Children’s Hospital to Benefit from New Tony Robbins Book

Krishna Reddy, UCSF OR support assistant in Environmental Sciences, shares stories with Tony Robbins and Marc Benioff at UCSF Benioff Children’s Hospital.

UCSF Benioff Children’s Hospital is set to receive all donations associated with the download of the latest book from American best-selling author and peak performance strategist, Tony Robbins.  

Recognizing the efforts of UCSF Benioff Children’s Hospital, Robbins and co-author Walter Rogers, CEO of CloudCoaching International, a joint venture between Tony Robbins and Baker Communications, realized they could create an opportunity that would help pediatric patients. 

“I am excited about the upcoming release of “Pathways to Growth: 9 Disciplines to Create Sales Breakthroughs in Turbulent Times,” but nothing has me more excited than the knowledge that proceeds from this book are going to benefit programs that are doing such an amazing job of helping and healing kids,” said Robbins.

Tony Robbins and Walter Rogers receive special gifts created by patients at the

Tony Robbins and Walter Rogers receive special gifts created by patients at the UCSF Benioff Children’s Hospital.

“I am deeply committed to the proposition that regardless of stature, only those who have learned the power of sincere and selfless contribution experience life’s deepest joy; true fulfillment. I see that commitment being modeled by Marc Benioff, chairman and CEO of salesforce.com, through his support for the programs at UCSF Benioff Children’s Hospital, and I am honored that we can play some small part in advancing that work.”

On Tuesday, a group including Robbins, Rogers, Marc and Lynne Benioff, Lt. Governor of California Gavin Newson and Mark Laret, CEO of UCSF Medical Center and UCSF Benioff Children’s Hospital, had a chance to interact with staff and patients at the hospital who could benefit from the donations from downloading the book.     

“This is wonderful news for UCSF Benioff Children’s Hospital and the children and families we serve,” said Laret. “We continue to be inspired by the way people like Marc Benioff, Tony Robbins and Walter Rogers are stepping up to support our vision of providing the highest quality, safest care to our youngest patients.”

“Pathways to Growth” is written to help businesses ignite higher levels of performance and success by empowering sales managers with skills for coaching and directing their sales teams.  The book draws not only on the expertise and experiences of Robbins and Rogers, but it also leverages the insights of respected thought leaders in business, academia and private equity.

“Pathways to Growth” is now available where buyers can identify a donation value, if they choose, when downloading the book. In addition, a limited amount of hard copy versions will be available at the salesforce.com Dreamforce conference, held in San Francisco this week.

“I am grateful to Tony and Walter for supporting the UCSF Benioff Children’s Hospital,” said Benioff. “Tony Robbins has been a tremendous inspiration in my life, and my hope is that through this donation, Tony will inspire others to be a force for good.” 

UCSF Benioff Children’s Hospital creates an environment where children and their families find compassionate care at the forefront of scientific discovery, with more than 150 experts in 50 medical specialties serving patients throughout Northern California and beyond. It is one of the top children’s hospitals in the nation, according to a ranking by U.S. News World Report.

Photos by Susan Merrell

Group tours UCSF Benioff Children's Hospital

Sam Hawgood, dean of UCSF School of Medicine and vice chancellor for Medical Affairs; Tony Robbins, best-selling author and peak performance strategist, and his wife, Sage; Marc Benioff, chairman and CEO of salesforce.com, and his wife, Lynne; Mark Laret, CEO UCSF Medical Center and UCSF Benioff Children’s Hospital; Gavin Newsom, Lt. Governor of California, and Walter Rogers, CEO of CloudCoaching International, take a tour of the UCSF Benioff Children’s Hospital. Donations associated with the download of Robbins and co-author Rogers new book, “Pathways to Growth,” will benefit the hospital.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/igv9EPUEfME/ucsf-benioff-childrens-hospital-benefit-new-tony-robbins-book

More time to have your say on making the Nursery Milk Scheme more cost effective

The Department wants to maximise the opportunity for all interested parties to contribute to the Nursery Milk Scheme consultation, particularly all schools and nurseries across Great Britain.

Therefore, and in response to requests, the deadlines for responding to the consultation on Next Steps for Nursery Milk and the Childcare providers survey have both been extended.

The new closing dates are:

Article source: http://www.dh.gov.uk/health/2012/09/nursery-milk/

Is Male Baby Circumcision Justifiable?

Uk-med.co.uk carry an interesting article weighing up the risks for and against circumcision  in male children.

“A baby boy being circumcised for non-medical reasons has always carried a huge question mark as to whether it is ethical and safe to do so.
It has now made the American Academy of Paediatrics (AAP) have a change of opinion that has altered their medical advice, with regard to circumcision.”

However while the article is generally supportive of the findings, there may be the possibility of problems in later life.

“As this is generally done for non-medical reasons, the side effects are not apparent until adolescence or adulthood, when sexual relationships can be impaired. Some find using Viagra helpful as erectile dysfunction could be a consequence. Scaring can cause insensitivity and narrow the meatus, making it difficult to go to the toilet as well. There have not been any conclusive studies into the psychological complications, but this could be because a baby or a very young child has no recollection of the event.”

 

Article Source: http://www.uk-med.co.uk/Health/Male-Baby-Circumcision-Justifiable

FDA approves first drug formulated for children with rare brain tumor

FDA NEWS RELEASE

For Immediate Release: Aug. 29, 2012
Media Inquiries: Stephanie Yao, 301-796-0394, stephanie.yao@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA

FDA approves first drug formulated for children with rare brain tumor

The U.S. Food and Drug Administration today approved Afinitor Disperz (everolimus tablets for oral suspension), a new pediatric dosage form of the anti-cancer drug Afinitor (everolimus) used to treat a rare brain tumor called subependymal giant cell astrocytoma (SEGA). Afinitor Disperz is the first approved pediatric-specific dosage form developed for the treatment of a pediatric tumor.

Afinitor Disperz is recommended to treat patients ages 1 year and older with tuberous sclerosis complex (TSC) who are diagnosed with SEGA that cannot be treated with surgery. Prior to approval of this new dosage form, Afinitor was recommended for use only in patients ages 3 years old and older. Afinitor was granted accelerated approval in 2010 to treat SEGA in patients with TSC.

“Appropriate pediatric dosage forms, such as Afinitor Disperz, help to ensure the safe and effective use of oncology drugs in children,” said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in FDA’s Center for Drug Evaluation and Research. “In addition, today’s approval demonstrates the value of further studying a drug to better characterize its benefits and how it should be used in pediatric patients.”

Afinitor Disperz is available in smaller dose increments than the adult dosage form, Afinitor. Afinitor Disperz also dissolves easily in a small volume of water, making it easy to administer to patients who are unable to swallow whole tablets to take their medication.

Afinitor’s manufacturer, Novartis, also provided updated safety and efficacy data from the single-arm study of 28 pediatric and adult patients used to support the drug’s accelerated approval in 2010 for the treatment of SEGA in patients with TSC. The company also supplied new information from a more recent study of 117 pediatric and adult patients who were randomly assigned to take Afinitor or a placebo daily. Results showed 35 percent of patients treated with Afinitor experienced tumor shrinkage, compared with none who were treated with placebo.

Afinitor Disperz should be used only in patients with TSC who require treatment for SEGA that cannot be surgically removed. The most common side effects observed in patients with SEGA were mouth ulcers and respiratory tract infections.

TSC is a rare genetic disease that causes tumors to grow in the brain and other vital organs. SEGA is a slow-growing tumor that can cause life-threatening complications by blocking the flow of fluid in the brain. It is considered a major diagnostic feature of TSC and is seen in 6 percent to 9 percent of patients, generally pediatric and young adult patients.

Everolimus, the active ingredient in Afinitor and Afinitor Disperz, blocks the uncontrolled activity of a protein called the mTOR kinase, which plays a critical role in the development and growth of SEGA tumors occurring in patients with TSC.

Afinitor and Afinitor Disperz remain under accelerated approval for the treatment of SEGA in patients with TSC. Studies are ongoing to further evaluate the long-term safety and effectiveness of Afinitor and Afinitor Disperz in pediatric and adult patients with SEGA. Afinitor Disperz is classified as an orphan drug because it is intended to treat a rare disease or condition. Afinitor Disperz’s application was granted priority review, which FDA completed in six months.

The FDA has previously approved Afinitor to treat adults with advanced renal cell carcinoma that has progressed after treatment with other cancer therapies (2009); adults with progressive advanced neuroendocrine tumors of pancreatic origin (2011); adults with TSC who have renal angiomyolipomas not requiring immediate surgery (2012); and for use in combination with Aromasin (exemestane) to treat certain postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer (2012).

Novartis is based in East Hanover, N.J.

For more information:

FDA: Office of Hematology and Oncology Products 

FDA: Approved Drugs: Questions and Answers 

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

Read our Blog: FDA Voice

Visit the FDA on Facebook, Flickr, YouTube and Twitter 

RSS Feed for FDA News Releases

 




Article source: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm317385.htm

Children, Families and Maternity e-bulletin – August 2012

This month’s edition features information about:

  • Children and Young People’s Outcomes Strategy
  • NHS Commissioning Board Mandate
  • Family Nurse Partnership Procurement
  • Capital Grant Programme for Children’s and Adult Hospices
  • Extension of project on ‘Improving Access to Psychological Therapies’
  • Implementation Framework for Mental Health Strategy
  • New film informing midwives on potential harm to unborn children when pregnant women consume alcohol
  • Update on research and support on ‘Hypertension in Pregnancy’
  • Munro Review of Child Protection on impact of more flexible assessment practices

CFM e-bulletin – August 2012 (PDF, 185K)

Article source: http://www.dh.gov.uk/health/2012/08/children-families-and-maternity-e-bulletin-august-2012/

Former Olympians Help Celebrate UCSF Pediatric Transplant Surgery Success

By Abigail Mortimore on August 24, 2012

Sixteen years ago, former UCSF pediatric transplant nurse practitioner Chris Mudge organized a small picnic at McNears Beach in San Rafael as an opportunity to celebrate kidney and liver transplant pediatric patients, their families and the work of the Organ Transplant Service at UCSF Benioff Children’s Hospital. The event was a success, and Mudge vowed to help coordinate another one the following year at the same location. 

Now called the “Annual Chris Mudge UCSF Pediatric Transplant Picnic”, the celebration draws more than 300 children and their families in addition to UCSF doctors, nurses, social workers, child life specialists, research coordinators and transplant support employees, as well as donors and community volunteers. Families have attended from not only California but Hawaii, Oregon, Washington, Utah, Idaho and Rhode Island.

“The purpose of the picnic is to provide children and their families a chance to meet others who have undergone similar life-changing experiences and connect in a more informal setting with their health care providers,” said Mudge.

Mudge, who retired this past June, plans to continue to be involved. “It is such a joy for me to see the kids doing so well — some now even have their own kids,” she said.

UCSF is a leader in both adult and pediatric transplants for liver, kidney, pancreas and small bowel, attracting patients nationally and internationally. UCSF has performed more than 9,600 kidney transplants since 1964 and has the largest (in terms of volume) liver transplant program in Northern California.

The kidney and liver transplant programs at UCSF Benioff Children’s Hospital led by John Roberts, MD, a professor of surgery and chief of the Division of Transplantation, are among the oldest children’s transplant services in the country.

With advances in surgical technique and improved drugs to prevent infection and rejection, organ transplantation is now recognized as the most effective treatment for many diseases. Children who previously had little hope of survival in the event of organ failure, now thrive as healthy adults with transplanted organs.   

“Going to the picnic always is inspiring for me,” said Amy Peele, UCSF director of transplant services. “It’s a profound reminder of the courage of our patients and families, and how privileged we are to care for them. Life is so delicate, and our transplant team works hard to bring passion and commitment to every aspect of their jobs.”

The UCSF pediatric transplant community – notably the lasting relationships forged between the staff and their patients – also is recognized by others outside of UCSF.

“One of the things I really enjoyed at the picnic was observing how [the UCSF staff] connects so intimately with the pediatric transplant patients,” said Laura O’Neill, a transplant clinical associate at Kaiser who often refers her patients to UCSF. “These kids are in great hands under their loving care.”

And it’s those relationships that keep bringing former patients such as Ian Wong, 17, back to this annual event. Ian and his parents, Stan and Margaret Wong of San Francisco, have been attending the picnic for the past 14 years.  Ian received a liver transplant at 16 months old, and the family started attending and eventually helping with the planning of the annual event after he turned 2. The family designs the event T-shirt each year and now as he is older, Ian helps out at the picnic.

“As Ian got older and understood more about his organ transplant, he gained a sense of comfort seeing other children at the picnic healthy and happy. It gave him the assurance that he’s a normal kid just like everyone else,” said Margaret Wong. “This annual picnic is not just a party organized by people who take care of him medically but also a symbol of how much they care beyond providing great medical treatment.” 

Gold Medal Winners     

This year’s 17th annual picnic was held Aug. 11, and took on an Olympic theme in light of the recent Summer Games. Regular picnic attendees were joined by former Olympians, including swimmers Mark Henderson, Dan Veatch and Allison Wagner; equestrian athlete Gwen Stokebrand and triple jumper Erica McLain.  After speaking to the crowd, the athletes recognized each child individually with his or her own “gold medal.”

“It was an honor to participate in the picnic,” said Dan Veatch, a swimmer at the 1988 Olympics in Seoul. “I was overwhelmed by the kids’ enthusiasm and the families’ appreciation. Many of them have tough years ahead, but their families’ support and love was completely inspirational to me.”

Another family in attendance was the French family of Novato. 

After being diagnosed shortly after birth with biliary atresia, a blockage in the tubes that carry bile from the liver to the gallbladder, Miya French, now 8, was put on the transplant list in 2009. 

Miya’s parents, Merle and Kim French, could not be candidates for living donation due to their own medical histories. However, Miya’s oldest sister Miwa, then 18, voluntarily had herself tested and was determined to be a match. Miwa, a freshman at UC Davis at the time, took her last college final for the calendar year, then checked herself into UCSF to donate a piece of her liver to her little sister the very next day.

The transplant was a success, and both girls have been thriving and continuing on with their busy lives every since.

This is the fifth year the Frenches have attended the picnic. “It means so much to be able to see and interact with the doctors and nurses who have helped save your child’s life,” said Kim French. “We have met and bonded with other families and look forward to seeing them every year.”

A budding swimmer herself, Miya took extra pride in meeting the former Olympians at this year’s event, especially the swimmers. The highlight of her day was being able to wear a real Olympic gold medal as shared by the athletes.

“Someday I am going to bring my own [Olympic] gold medal to the picnic to share,” Miya said. 

The 18th annual picnic is already in the planning stages and will continue to be held at McNears Beach.

For more information about the pediatric transplant program, visit the UCSF Benioff Children’s Hospital website.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/HN8OdaOqVtY/former-olympians-help-celebrate-ucsf-pediatric-transplant-surgery-success

FDA warns of risk of death from codeine use in some children following surgeries

FDA NEWS RELEASE

For Immediate Release: Aug. 15, 2012
Media Inquiries: Morgan Liscinsky, 301-796-0397, morgan.liscinsky@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA

FDA warns of risk of death from codeine use in some children following surgeries

The U.S. Food and Drug Administration today issued a Drug Safety Communication concerning three children who died and one child who experienced a non-fatal but life-threatening case of respiratory depression after taking the pain reliever codeine following surgery to remove tonsils (tonsillectomy) and/or adenoids (adenoidectomy).

The surgeries were performed to treat obstructive sleep apnea syndrome, a condition that results in repeated episodes of complete or partial blockage of the upper airway during sleep. The children received doses of codeine that were within the typical dose range.

Health care professionals and parents should be aware of the risks of using codeine in children who have had their tonsils and/or adenoids removed to treat obstructive sleep apnea syndrome. When prescribing codeine-containing drugs, health care providers should use the lowest effective dose for the shortest time on an as-needed basis. If parents or caregivers notice signs of overdose in a child, such as unusual sleepiness, difficulty being aroused or awakened, confusion, or noisy and difficult breathing, they should stop giving the child codeine and seek medical attention immediately.

“The FDA is currently conducting a review of adverse event reports and other information to determine if there are additional cases of inadvertent overdose or death in children taking codeine, and if these adverse events occur during treatment of other kinds of pain, such as post-operative pain following other types of surgery or procedures,” said Bob Rappaport, M.D., director of the Division of Anesthesia, Analgesia and Addiction Products in FDA’s Center for Drug Evaluation and Research. “The FDA will update the public when more information is available.”

Codeine is an ingredient found in prescription medicines used to relieve pain or cough. Once in the body, codeine is converted to morphine in the liver by an enzyme called cytochrome P450 isoenyme 2D6 (CYP2D6).

Some people metabolize codeine much faster and more completely than others. These people, known as ultra-rapid metabolizers, are likely to have higher-than-normal levels of morphine in their blood after taking codeine. These high levels can lead to overdose and death. The three children who died after taking codeine exhibited evidence of being ultra-rapid metabolizers.

The estimated frequency of ultra-rapid metabolizers is generally 1 to 7 out of every 100 people. However, in certain ethnic groups, the frequency may be as high as 28 out of every 100 people. The only way to know if someone is an ultra-rapid metabolizer is to do a genetic test. There are FDA-cleared tests to check for ultra-rapid metabolism.

For more information:

  • FDA Drug Safety Communication: Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death
  • FDA Consumer Update: Is Post-Surgery Codeine a Risk for Kids?

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by ensuring the safety, effectiveness, and security of human and veterinary drugs, vaccines, other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

#

Visit the FDA on Facebook, Flickr, YouTube and Twitter

 




Article source: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm315601.htm

New Curriculum Teaches Pediatric Residents Proper Handoffs to Maximize Patient Safety

UCSF Medical Center

How patients are transferred, or “handed off” between medical providers can have a major impact on medical errors. National data suggest that up to 70 percent of the most serious errors in hospitals are due at least partially from miscommunications, including those that occur during the transition of care.

In response to mounting evidence that these events often could be prevented, the UCSF Benioff Children’s Hospital is participating in the nine-center I-PASS study to determine how to best teach residents how to hand off pediatric patients properly to reduce errors. The I-PASS initiative was developed at Boston Children’s Hospital, and is supported by a $3 million grant from the US Department of Health and Human Services.

Currently, there is no national standard for the transition of care of patients. Hospital hand-offs occur upon admission, at shift changes, before and after procedures, upon unit changes, and at discharge. Most residents are never taught how to hand off patients, but simply learn it by observing senior residents without any formal protocol.  

Glenn Rosenbluth, MD

Glenn Rosenbluth, MD

“This new handoff curriculum has been developed, and because of it we now have measures to document that our residents are acquiring these new skills,” said Glenn Rosenbluth, MD, the I-PASS site director at UCSF and director of Quality and Safety Programs for the UCSF School of Medicine’s Graduate Medical Education team. “It is really unique as an NIH [National Institutes of Health]- funded study, in that we put together a combination of health service researchers, medical educators and clinicians all collaborating to increase patient safety.”

The I-PASS protocol provides a framework for the patient handoff process, and stands for:

  • I: Illness severity
  • P: Patient summary
  • A: Action list
  • S: Situation awareness and contingency planning
  • S: Synthesis by receiver

During an I-PASS handoff, the “giver” of the patient first communicates key information to the “receiver,” starting with an assessment of the patient’s illness severity, for example whether a patient is medically stable, needs to be watched or is medically unstable. Then the giver shares a standard patient summary and an action list of to-do items that need to be accomplished while under the receiver’s care. This is supplemented with “situation awareness” in the form of contingency plans, which are if-then statements to prepare the receiver for what might happen. Finally, the receiver synthesizes information and says it back to the giver, a step that according to Rosenbluth rarely happened before implementing this new model.

“That second ‘S’ in I-PASS is very important because it helps build a shared mental model which ensures the giver and receiver are mentally on the same page,” he said.

Now that it is part of the curriculum it has become a standard of care for these transitions.

The new curriculum, which was developed by a team of educators from nine residency programs across North America, was taught through a variety of workshops integrating role plays and simulations designed to effectively teach the handoffs. Additionally, a visual ad campaign with posters and screen frames about the curriculum was launched in the children’s hospital. 

UCSF completed data collection in early June, and though the formal analysis is not complete, it was already found in the pilot study that residents spent more time with patients after they learned how to hand off.

“We had a research assistant doing time motion studies following a resident around for 12 hours straight and logging how he spent his time, whether it was interacting with patients, on the computer or doing something else,” said Rosenbluth.

“The pilot study demonstrated that having a more streamlined and efficient way to hand off patients freed up residents to spend more time interacting with the patients, and, more importantly, there were fewer medical errors,” she said.

Analysis will begin once the final I-PASS center completes its data collection in April 2013.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/WvLRnp7636M/new-curriculum-teaches-pediatric-residents-proper-handoffs-maximize-patient

Helping Kids Describe Cancer Symptoms Through Cartoons and Digital Technology

How are you sleeping? Any nausea? How about pain? Monitoring symptoms is an important part of cancer care, as it guides treatment decisions.

But tracking the symptoms of children with cancer, especially young kids, is particularly challenging because they may not understand the questions, or their importance, says Christina Baggott, PhD, RN, assistant professor at the UCSF School of Nursing.

FOCUS ON:

  • Enabling Science Advances at UCSF
  • Helping Multiple Sclerosis Patients Face Dizzying Medication Decisions
  • Easing Complex Medication Management with Computer Tools
  • Revealing the Importance of Culture in Latino Dental Health
  • Helping Kids Describe Cancer Symptoms Through Cartoons and Digital Technology

Colorful cartoon characters and interactive digital technology may help. Preliminary results of a recent study by Baggott, a trained oncology nurse, found that children with cancer were significantly more likely to weigh in on their symptoms when using a kid-friendly touch-screen computer assessment tool, than the standard written checklist.

“From a clinical standpoint, it’s very important to catch these symptoms early, so we can intervene at an early stage,” says Baggott, who collaborated on the study with Norwegian colleagues who designed the program, known as Sisom.

The traditional written checklist, the Memorial Symptom Assessment Scale or MSAS, was used for comparison. It asks patients to rate their experience with a number of symptoms.

“But children may feel uncomfortable discussing certain concerns with clinicians or their parents and may be reticent to report these issues via interview,” Baggott says. To find a better solution, she worked with 100 pediatric cancer patients and their parents at UCSF Benioff Children’s Hospital and Stanford Medical Center to compare the answers between the checklist and the computer program.

Baggott looked at a variety of comparisons — how responses by children and by parents differ between the two methods, and how pediatric responses compare to their parents.

“Analyzing the data is complicated because it is being collected from the symptom checklists and from the computer software, entered into a central database,” says Baggott. At each step of the way, all information must be protected by patient privacy laws.

Looking for help, she turned to Consultation Services, a program of UCSF’s Clinical and Translational Science Institute (CTSI), specifically RedCap, a Research Electronic Data Capture System that enables researchers to quickly and easily develop data capture forms, reports, and surveys housed for investigators by CTSI.

“I was impressed that UCSF faculty and senior staff provide expert advice,” Baggott says. She was matched with one of them to help her create efficient ways to merge results from the two response methods into one database that can be analyzed in a variety of ways.

Christina Baggott, PhD, RN

Christina Baggott, PhD, RN

With her study, Baggott found out that children acknowledged significantly more concerns using Sisom than the checklist. “Sisom may promote children to acknowledge issues and may lead to an improved understanding of pediatric oncology patients’ emotional and physical concerns,” she says.

Now Baggott is examining factors such as the child’s age, gender, spoken language and time since diagnosis.

CTSI is a member of the National Institutes of Health-funded Clinical and Translational Science Awards network focusing on accelerating research to improve health. The Institute provides services for researchers at every stage, and promotes online collaboration and networking through UCSF Profiles.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/KZRRebJ0-_4/helping-kids-describe-cancer-symptoms-through-cartoons-and-digital-technology

Kid-Friendly Environment at Visual Center Allows For Better Eye Exam

When new patients are brought to the UCSF Visual Center for the Child, eye examinations begin even before they enter the doctor’s room.

Tina Rutar, MD

Tina Rutar, MD

In the center’s waiting area, colorful murals and toys engage children and allow doctors to observe them first in a casual setting, checking for warning signs such as a tilted head or squinting eyes.

“When we examine young children in a nonthreatening way, we get information we might not get otherwise,” said ophthalmologist Tina Rutar, MD, the center’s director.

The center, which opened in 2010, is designed specifically with the aim of providing more comprehensive exams and treatment for children.

Before that, children visiting the Department of Ophthalmology had to use adult-sized equipment in scary exam rooms that didn’t necessarily cater to their unique needs, even though the department was considered one of the nation’s best facilities for pediatric ophthalmology. The challenges inspired the creation of a separate clinic devoted to serving their youngest patients.

“The developmental ages between 0 and 6 are a sensitive period for vision. If the brain doesn’t learn how to see then, there can be permanent damage, including blindness,” she said.

Like the waiting rooms, toys and videos also are present in the exam room to put children at ease and distract them from doctors looking at the retina and optic nerve using a cordless, indirect ophthalmoscope. The interactive, kid-friendly setting is key to identifying problems as early as possible, according to Rutar.

“We are lucky to have this unique space,” she said.

Pediatricians generally refer patients to the Visual Center whenever they fail basic vision exams or have conditions such as blocked tear ducts, congenital cataracts, or outward drift of the eyes. If a child is suspected of having a rare disease, the center’s doctors have access to advanced imaging tools and all the resources of the adult ophthalmology department.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/N-HBgw9Ln1A/kid-friendly-environment-visual-center-allows-better-eye-exam

Child’s Illness Fuels Search for Early-life Epilepsy Diagnostics

Postdoctoral fellow Ramon Birnbaum, PhD, and his daughter Ruth

When Ramon Birnbaum, PhD, came to UCSF three years ago to do his postdoctoral work on the role of genetic regulation in human disease in the lab of School of Pharmacy faculty member Nadav Ahituv, PhD, epilepsy was barely on his radar.

Once, while serving in the Israeli military, he saw a fellow soldier suffer a seizure. Upon arriving on campus, just out of curiosity, he attended a presentation by Daniel Lowenstein, MD, director of the UCSF Epilepsy Center. That was the sum total of Birnbaum’s experience with this spectrum of seizure disorders, which affect an estimated 50 million people worldwide.

Then, in 2010, his daughter Ruth was born, and everything changed.

The parents of three healthy boys, Birnbaum and his wife, Adva, immediately noticed when three-week-old Ruth exhibited “subtle but unusual repetitive movements.” Following her intuition, Adva took their newborn to the pediatrician, who suspected Ruth was having seizures.

According to Birnbaum, the first neurologist they consulted thought it was probable that Ruth had Ohtahara syndrome, a severe disorder with a grim prognosis. Indeed, despite prescribed medications, Ruth’s seizure rate worsened, he recalls. She suffered several clusters per day, with some involving hundreds of convulsions over the course of an hour.

“It’s hard to imagine and even harder when, as a parent, you can’t do anything to help her,” Birnbaum says. “Her brain was on fire 24/7 with no chance to develop normally.”

But a second opinion by Joseph Sullivan, MD, director of the UCSF Pediatric Epilepsy Center, was more optimistic.

While abnormal electrical activity in Ruth’s brain was similar to that seen in Ohtahara, after viewing a homemade video of her seizures, Sullivan diagnosed her as having infantile spasms, a different type of early onset epilepsy.

For Birnbaum and his advisor, Ahituv, a geneticist in the UCSF Department of Bioengineering and Therapeutic Sciences, the experience fueled a drive to discover a genetic diagnosis for infantile spasms, and potentially for other epilepsies and complex diseases. Then, if an infant like Ruth Birnbaum develops a seizure disorder, physicians would know what it is sooner in order to treat it faster.

Read the full story on the UCSF School of Pharmacy website

Photos by Ramon Birnbaum

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/joOcYJgH5Jk/childs-illness-fuels-search-early-life-epilepsy-diagnostics

Dozens of Kids Get Free Oral Exams at Bayview Sunday Streets

UCSF School of Dentistry residents performed free dental screenings for dozens of children during a sunny Bayview Opera House Sunday Streets last weekend.

As part of the Family Health and Wellness Fair, 21 residents conducted oral exams and applied fluoride varnishes for children on a walk-in basis. The five-hour event, done in partnership with the California State Assembly and San Francisco Board of Supervisors, drew a total of 89 kids. District 10 Supervisor Malia Cohen brought her niece in for a screening.

Denti-Cal advisors also were on hand to educate families about oral health. Tooth decay is one of the most common childhood diseases – five times more prevalent than asthma – and early detection is key to making sure children don’t lose a permanent tooth to decay.

The dental exams were part of UCSF’s public mission of “advancing health worldwide.” From free children’s health screenings to innovative partnerships attacking the roots of poor health care, UCSF is committed to serving its community on a local and global level.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/v47h1Ra2eWY/dozens-kids-get-free-oral-exams-bayview-sunday-streets

Children and Young People’s Health Outcomes Forum heads speak about their work

The joint chairs of the Children and Young People’s Health Outcomes Forum, Professor Ian Lewis, Medical Director at the Alder Hey Children’s NHS Foundation Trust, and Christine Lenehan, Director at the Council for Disabled Children, speak about the work of the Forum and what they hope its recommendations will achieve.

One of the most important messages we’ve got is that outcomes currently for children and young people in England are poor – Professor Ian Lewis

For children and their families, the system often feels completely fragmented – they have to tell their stories repeatedly and they don’t receive joined up care in the way that they should – Professor Ian Lewis

How do we build a system that meets the needs of children and families rather than them having to fit a system not designed to meet their needs? – Christine Lenehan

We want everyone who has an interest in the health of children…to use the report and use the evidence to make the change we’re looking for – Christine Lenehan

We have taken the views of children, young people and their families and put them at the centre of our recommendations – Professor Ian Lewis

Article source: http://www.dh.gov.uk/health/2012/07/forum-interviews/

Independent experts set out recommendations to improve children and young people’s health results

The Children and Young People’s Health Outcomes Forum has today published its proposals on how health-related care for children and young people can be improved.

The independent Forum, which was asked by the Secretary of State to help develop a new strategy for improving care for children and young people, identified several themes that it says are key to making the improvements needed:

  • putting children, young people and their families at the heart of what happens
  • acting early and intervening at the right time
  • integration and partnership
  • safe and sustainable services
  • workforce, education and training
  • knowledge and evidence
  • leadership, accountability and assurance
  • incentives.

Read Report of the Children and Young People’s Health Outcomes Forum

The Forum recommends a number of new outcomes measures and the strengthening of existing indicators and makes specific recommendations for different organisations within the health and care system to ensure the improvements are achieved.

Forum joint chair Christine Lenehan, Director at the Council for Disabled Children, said:

“The Forum is clear that the implementation of these recommendations is key to improving health outcomes for children and young people, which was the ambition of the Secretary of State when he established us to do this work.

“This Report needs to form the basis of a wider children and young people’s health outcomes strategy, which needs to be owned by all organisations in the health system and beyond who have a responsibility for improving the health and wellbeing for this group.” 

The Forum’s starting point for identifying what outcomes matter most for children and young people were the existing NHS and Public Health Outcomes Frameworks.

The Forum recommends four new outcome indicators for inclusion within the NHS Outcomes Framework. These are:

  • time from first NHS presentation to diagnosis or start of treatment
  • integrated care – developing a new composite measure
  • effective transition from children’s to adult services
  • age-appropriate services, with particular reference to teenagers.

The Forum also makes recommendations about strengthening patient experience measures and says the Department of Health and the NHS Commissioning Board should incorporate the views of children and young people into existing national patient surveys in all care settings.

Within the Public Health Outcomes Framework, the Forum recommends a total of 9 new indicators across each of the domains, including measuring the proportion of mothers with mental health problems, including postnatal depression.

The Forum makes a large number of recommendations on how the health and care system can help deliver the necessary improvements. These include:

  • with immediate effect, all data about children and young people should be presented in 5-year age bands through childhood and the teenage years – this will allow relevant international comparisons as well as national or local comparisons
  • the revised NHS Constitution to be applicable to all children, young people and their families
  •  the use of the NHS number as the unique identifier, bringing together health, education, social care and criminal justice records for children and young people.

Theme reports

In addition to its main report, the Forum has also produced reports on specific themes:

  • Report of mental health subgroup
  • Report of public health and prevention subgroup
  • Report of acutely ill children subgroup
  • Report of long-term conditions, disability and palliative care subgroup
  • Inequalities in health outcomes and how they might be addressed

Factsheets

The Forum has also published the first four of a range of factsheets they are producing to help children, young people and their families be effectively involved in decisions about their health care, and help organisations and individuals in different parts of the system understand whether they are meeting the needs of children and young people.

  • Read Making data and information work for children and young people
  • Read factsheet for school governors
  • Read Health and wellbeing boards and children, young people and families
  • Read Commissioning in the new NHS for children, young people and their families

Forum letter to Secretary of State

Forum joint chairs Professor Ian Lewis, Medical Director at the Alder Hey Children’s NHS Foundation Trust, and Christine Lenehan, Director at the Council for Disabled Children, have written a letter to Secretary of State Andrew Lansley to accompany the report.

Article source: http://www.dh.gov.uk/health/2012/07/cyp-report/

Child’s Illness Fuels Lab Team’s Search for Early-life Epilepsy Diagnostics

Postdoctoral fellow Ramon Birnbaum, PhD, and his daughter Ruth

When Ramon Birnbaum, PhD, came to UCSF three years ago to do his postdoctoral work on the role of genetic regulation in human disease in the lab of School of Pharmacy faculty member Nadav Ahituv, PhD, epilepsy was barely on his radar.

Once, while serving in the Israeli military, he saw a fellow soldier suffer a seizure. Upon arriving on campus, just out of curiosity, he attended a presentation by Daniel Lowenstein, MD, director of the UCSF Epilepsy Center. That was the sum total of Birnbaum’s experience with this spectrum of seizure disorders, which affect an estimated 50 million people worldwide.

Then, in 2010, his daughter Ruth was born, and everything changed.

The parents of three healthy boys, Birnbaum and his wife, Adva, immediately noticed when three-week-old Ruth exhibited “subtle but unusual repetitive movements.” Following her intuition, Adva took their newborn to the pediatrician, who suspected Ruth was having seizures.

According to Birnbaum, the first neurologist they consulted thought it was probable that Ruth had Ohtahara syndrome, a severe disorder with a grim prognosis. Indeed, despite prescribed medications, Ruth’s seizure rate worsened, he recalls. She suffered several clusters per day, with some involving hundreds of convulsions over the course of an hour.

“It’s hard to imagine and even harder when, as a parent, you can’t do anything to help her,” Birnbaum says. “Her brain was on fire 24/7 with no chance to develop normally.”

But a second opinion by Joseph Sullivan, MD, director of the UCSF Pediatric Epilepsy Center, was more optimistic.

While abnormal electrical activity in Ruth’s brain was similar to that seen in Ohtahara, after viewing a homemade video of her seizures, Sullivan diagnosed her as having infantile spasms, a different type of early onset epilepsy.

For Birnbaum and his advisor, Ahituv, a geneticist in the UCSF Department of Bioengineering and Therapeutic Sciences, the experience fueled a drive to discover a genetic diagnosis for infantile spasms, and potentially for other epilepsies and complex diseases. Then, if an infant like Ruth Birnbaum develops a seizure disorder, physicians would know what it is sooner in order to treat it faster.

Read the full story on the UCSF School of Pharmacy website

Photos by Ramon Birnbaum

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/yFVQKSkpmqk/childs-illness-fuels-lab-teams-search-early-life-epilepsy-diagnostics

Childhood obesity

July 23, 2012

Two
in three severely obese children already have at least one risk
factor for heart disease, new research shows.

The study findings revealed 67 per cent of 307
severely obese children had at least one risk
factor
for heart disease. Over
half had high blood pressure and a
similar proportion had high levels of low
density (LDL), or bad, cholesterol
. Fourteen per cent had high
fasting blood glucose and just under one per cent had type 2 diabetes.

Type 2 diabetes, high blood cholesterol and
high blood pressure are all modifiable risk factors for heart disease.

The researchers’ definition of severe obesity
started at a body mass index (BMI) of 20.5 for a 2-year-old, 31 for
a 12-year-old, and 35 for an 18-year-old. They found only one
child’s obesity was attributable to medical rather than
lifestyle factors.

This is a problem that can be addressed by stopping young people becoming overweight and obese in the first place

Doireann Maddock, our
Senior Cardiac Nurse, said: “Although it was a small study,
the findings leave a bad taste in the mouth.

“It’s a huge concern so many
obese children were identified as already having at least one risk
factor for heart disease, including high blood pressure, high blood
glucose and problems with cholesterol levels.

“However, this is a problem that can be
addressed by stopping young people becoming overweight and obese in
the first place. Highlighting the importance of healthy eating and physical activity from an early age will help
protect the heart health of future
generations.”

Our Food4Thought
campaign
aims to help tackle childhood obesity
and encourage children to lead a healthier lifestyle.

The study was published online in the BMJ
journal, Archives of Disease in
Childhood
.

Article source: http://www.bhf.org.uk/media/news-from-the-bhf/childhood-obesity-risks.aspx

New Lipid Screening Guidelines for Children Overly Aggressive, UCSF Researchers Say

Recent guidelines recommending cholesterol tests for children fail to weigh health benefits against potential harms and costs, according to a new commentary authored by three physician-researchers at UCSF.

Thomas Newman, MD, MPH

Thomas Newman, MD, MPH

Moreover, the recommendations are based on expert opinion, rather than solid evidence, the researchers said, which is especially problematic since the guidelines’ authors disclosed extensive potential conflicts of interest.

The guidelines were written by a panel assembled by the National Heart, Lung and Blood Institute ( NHLBI) and published in Pediatrics, in November 2011. They also were endorsed by the American Academy of Pediatrics.  The guidelines  call for universal screening of all 9 to 11-year-old children with a non-fasting lipid panel, and targeted screening of 30 to 40 percent of 2 to 8-year-old and 12 to 16-year old children with two fasting lipid profiles. Previous recommendations called only for children considered at high risk of elevated levels to be screened with a simple non-fasting total cholesterol test.

Mark Pletcher, MD, MPH

Mark Pletcher, MD, MPH

The call for a dramatic increase in lipid screening has the potential to transform millions of healthy children into patients labeled with so-called dyslipidemia, or bad lipid levels in the blood, according to the commentary by Thomas Newman, MD, MPH, Mark Pletcher, MD, MPH and Stephen Hulley, MD, MPH, of the UCSF Department of Epidemiology and Biostatistics and e-published on July 23 in Pediatrics.

“The panel made no attempt to estimate the magnitude of the health benefits or harms of attaching this diagnosis at this young age,” said Newman. “They acknowledged that costs are important, but then went ahead and made their recommendations without estimating what the cost would be.  And it could be billions of dollars.” 

Stephen Hulley, MD, MPH

Stephen Hulley, MD, MPH

Some of the push to do more screening comes from concern about the obesity epidemic in U.S. children.   But this concern should not lead to more laboratory testing, said Newman.

“You don’t need a blood test to tell who needs to lose weight. And recommending a healthier diet and exercise is something doctors can do for everybody, not just overweight kids,” he said.

The requirement of two fasting lipid panels in 30 to 40 percent of all 2 to 8-year olds and 12 to 16 – year-olds represents a particular burden to families, he said.

“Because these blood tests must be done while fasting, they can’t be done at the time of regularly scheduled ‘well child’ visits like vaccinations can,” said Newman.  “This requires getting hungry young children to the doctor’s office to be poked with needles on two additional occasions, generally weekday mornings. Families are going to ask their doctors, ‘Is this really necessary?’   The guidelines provide no strong evidence that it is.”

The authors note that the panel chair and all members who drafted the lipid screening recommendations disclosed an “extensive assortment of financial relationships with companies making lipid lowering drugs and lipid testing instruments.” Some of those relevant relationships include paid consultancies or advisory board memberships with pharmaceuticals that produce cholesterol-lowering drugs such as Merck, Pfizer, Astra Zeneca, Bristol-Myers Squibb, Roche and Sankyo.

“The panel states that they reviewed and graded the evidence objectively,” said Newman. “But a recent Institute of Medicine report recommends that experts with conflicts of interest either be excluded from guideline panels, or, if their expertise is considered essential, should have non-voting, non-leadership, minority roles.”  

Evidence is needed to estimate health benefits, risks and costs of these proposed interventions, and experts without conflicts of interest are needed to help synthesize it, according to Newman. He said that “these recommendations fall so far short of this ideal that we hope they will trigger a re-examination of the process by which they were produced.”

Newman and Hulley have no disclosures. Pletcher has NIH funding to support research on targeting of cholesterol-lowering medications to prevent cardiovascular disease.

About UCSF
UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. For further information, please visit http://www.ucsf.edu/.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/yUmPPB8BCzw/new-lipid-screening-guidelines-children-overly-aggressive-ucsf-researchers-say

Viagra used to treat single ventricle abnormality in Children

New Study Into Post-Operative Paediatric Cardio Treatment Using Viagra by Uk-Med.co.uk

Dr David J Goldberg attained his qualifications as a paediatric cardiologist from Yale; he is now a fellow of The Children’s Hospital of Philadelphia and leader of the research team into maintenance support for children with ventricle defects.

Volunteers that took part in the analysis had the Fontan procedure as a very young child, giving an average of eleven years lapse. Also the even age range for the participants was fourteen years. The medication being used is Sildenafil (sold as Viagra) which is widely used for pulmonary hypertension and was found during its first trials in the early 90’s that it helped males with erectile dysfunction problems.

Article Source:

http://www.uk-med.co.uk/Health/New-Study-Into-Post-Operative-Paediatric-Cardio-Treatment-Helped-By-Viagra

New grants to support children’s hospice and hospice at home services

The Government has announced it is making a further £721,000 available to support new children hospices in England. This is in addition to the existing annual revenue grant of £10m that is available to 40 children’s hospices in England.

Eligible hospices for the new grant should be voluntary sector organisations that are providing children’s hospice and hospice at home services to children and young people between 0-19 years old.

The new grant, which begins this financial year, will support new children hospices to make hospice care available locally, that meets with the Government’s policy for choice of high-quality child and family-centred services.

The Government is committed to a fairer and more transparent system of funding palliative care for both children and adults. It committed to continuing the annual revenue stream to children’s hospices until a new per patient funding system is in place. Work has begun to collect the information and cost data needed to introduce a new palliative care funding system in 2015.

The closing date for applications for the new grant is 16 September, 2012. Eligibility requirements, guidance notes and an application form are attached below:

  • Guidance Notes and Eligibility Requirements (PDF, 89K)
  • Application form (Doc, 198K)

Article source: http://www.dh.gov.uk/health/2012/07/childrens-hospice-new-grants/

Media Advisory: UCSF Hosts Free Children’s Dental Screenings at Sunday Streets

WHAT: UCSF, in partnership with the California State Assembly and San Francisco Board of Supervisors, will offer free children’s dental screenings as part of the Bayview Opera House Sunday Streets Family Health and Wellness Fair. UCSF School of Dentistry residents will perform the screenings and apply fluoride varnishes to prevent cavities.

Early detection is key to diagnosing potential tooth decay, which remains one of the most common diseases of childhood – five times as common as asthma.  By age 17, more than seven percent of children have lost a permanent tooth to decay, according to the U.S. Department of Health and Human Services.

No appointment is necessary, and screenings will take approximately 15 minutes. Oral health education and Denti-Cal advisors will be onsite.

Additional Sunday Streets activities will include mural painting, dance lessons, free bike rentals and a bookmobile. For more information on Bayview Opera House Sunday Streets, see: http://www.sundaystreetssf.com/.

WHEN:
Sunday, July 22, 2012
11 a.m. to 4 p.m.
Photo and interview opportunities for media 12 p.m. to 2 p.m.

WHERE:
Bayview Opera House
4705 Third Street @ Oakdale
Muni 23, 24, 44, T-Third

INTERVIEW, PHOTO AND VIDEO OPPORTUNITIES:

  • Malia Cohen, San Francisco Board of Supervisors, District 10 (1- 1:30 p.m.)
  • Jeremy Horst, DDS, UCSF pediatric dentistry resident
  • Individuals undergoing screenings if consented by UCSF on site

MEDIA CONTACT:
Karen Knowles-Pearce, UCSF University Relations, 415-476-8431. Day of event cell phone: 415-613-8727.

About UCSF
UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. http://www.ucsf.edu/

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/b6NMAyw-lHU/media-advisory-ucsf-hosts-free-childrens-dental-screenings-sunday-streets

Kids With Chest Wall Deformities Get Comprehensive Care at Clinic

Six months ago Justin Rosales’s chest dipped deep into his sternum. The 14-year-old was too embarrassed to ever take off his shirt or show his friends how he looked. But rather than undergoing a major invasive operation, he and his parents chose UCSF’s groundbreaking Magnetic Mini Mover Procedure, a minimal surgery where two magnets are implanted in his chest — part of a novel approach to correcting sunken chest syndrome.

Justin is being treated at the UCSF Comprehensive Center for Chest Wall Deformities, a new interdisciplinary pediatric clinic at UCSF Benioff Children’s Hospital that offers a wide range of interventions for children with all types of chest wall deformities, from common to complex. Justin has the most common chest wall deformity called pectus excavatum, a congenital disorder which causes the chest to have a sunken or “caved in” appearance.

“The new clinic is one stop shopping in terms of surgical options,” said Shinjiro Hirose, MD, a pediatric surgeon at UCSF Benioff Children’s Hospital and its Fetal Treatment Center, and director of the new chest wall deformities clinic. “Any kid with a chest wall deformity can come to the clinic and get access to comprehensive care, ranging from pulmonologists to cardiologists to orthopedists. From the clinical standpoint, that really is unique and offers parents streamlined access without having to travel to several different clinics.”

At present, pectus excavatum, or sunken chest disorder, can be repaired only by an invasive operation requiring a stay of three to seven days in the hospital. More than 4,000 patients worldwide undergo this operation every year.

“Kids are in agony with the traditional surgery,” said Hirose, who implanted the Magnetic Mini Mover in Justin’s chest in a 30-minute surgical procedure where one magnet, encased in titanium, is attached to the sternum. The small incision then is closed, and the patient usually leaves the hospital on the same day. Afterward, the patient continues to wear an orthotic brace that contains another embedded magnet.

As the magnets slowly are drawn together, the chest wall reforms to its normal position within a two-year-period. “Our new intervention could change the whole approach to this disease,” said Hirose.

UCSF Team Pioneers Pediatric Procedure

The procedure was devised through the UCSF Pediatric Device Consortium — a group of physicians, engineers, scientists and others — all inventors collaborating and sharing ideas to create pediatric medical devices. The team is led by Michael Harrison, MD, director emeritus and co-founder of the Fetal Treatment Center at UCSF Benioff Children’s Hospital, and UCSF bioengineer Shuvo Roy, PhD, an associate professor in the UCSF School of Pharmacy.  

The device currently is being studied in a clinical trial funded by the U.S. Food and Drug Administration, and early results are very promising. The trial is only for children ages eight to 14 and is still is accepting new patients.

Typically children with chest wall deformities are treated with a focus on mere survival, with minimal tracking of these patients over time. But the UCSF clinic is taking a new approach, evaluating patients and following them long term, from infancy into adulthood in order to better evaluate the progression of the disorder and the success of the interventions.

“One of UCSF’s biggest strengths is its mission of integrating patient care, teaching and research,” said Hirose. “The key to research is following up and realizing it’s no longer simply a matter of survival but quality of life.”

Justin returns to UCSF from his home in Stockton on a monthly basis to meet with doctors and have his brace adjusted by Darrell Christensen, CO, an orthotist in the UCSF Department of Orthotics and Prosthetics, who has worked with him since his surgery. “For the first time we’re seeing the shape of his chest start to change,” said Hirose. “It’s definitely flatter and wider. Justin is diligent about wearing his brace. Kids who participate in clinical trials are usually motivated.”

The magnets also contain a monitoring chip that is downloaded at each visit to measure compliance. A big challenge in pediatric devices is making sure the kids actually wear them. But for Justin, it’s a challenge he is excited to take on since he knows the chip is keeping track of when the external device is worn. He takes pride in his compliance score and always asks how it compares to other kids wearing the brace.

“He’s taking responsibility for it and is excellent with compliance,” said Jill Imamura-Ching, RN, a clinical research nurse in the UCSF Department of Pediatric Surgery. 

“There is a big difference in his confidence since before the surgery,” said Carlos Rosales, Justin’s dad. Now Justin is preparing for a week-long camping trip in Yosemite, part of his work towards becoming an eagle scout. During the trip he’ll swim, fish and participate in all of the activities with his troop. His parents encourage physical activity, including martial arts, with the exception of one.

“Football is out of the question,” said Rosales.

Photos by Susan Merrell

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/PPyVpPiTiHA/kids-chest-wall-deformities-get-comprehensive-care-clinic

Legendary Grateful Dead Drummer Offers Music as Medicine to Children

He’s rocked out in front of as many as 600,000 fans at concert venues all over the country. As a Grateful Dead drummer, Mickey Hart and his band mates have headlined more than 2,300 concerts while developing a cult following among devotees who proudly call themselves “Deadheads.”

After being a professional drummer for more than 45 years, Hart has changed his focus to smaller venues, this time performing for an audience of patients at UCSF Benioff Children’s Hospital, where children and their families find compassionate care at the forefront of scientific discovery.

On a sunny afternoon in June, Hart, his daughter Raya Sunshine, and a team of half a dozen hip musicians laid out colorful, psychedelic drums of various shapes and sizes for a carefully orchestrated drum circle. The goal was to use music as part of the healing process for children who are hospitalized with serious illnesses.

Grateful Dead drummer Mickey Hart performs at UCSF

Grateful Dead drummer Mickey Hart lead a percussion jam session at the UCSF Benioff Children’s Hospital as part of Music Day.

“The Grateful Dead made people smile, and we had rhythm, melody and harmony,” said Hart, now 68 years old. “It was medicine to many people, just like music is medicine to these kids.”

Hart appeared for “Music Day” at UCSF Benioff Children’s Hospital, part of a UCSF program using music to help patients reduce stress, anxiety and depression. Playing music for patients, and offering them the instruments and skills to play themselves, provides children with a sense of empowerment, distracts them from discomforts of treatments, and gives them a sense of normalcy in an otherwise unfamiliar environment. Music Day was spearheaded by the Child Life Department, which recognizes the integral role hospital child life programs play in the healing process.

“Music is fundamental to who we are as people,” said Michael Towne, manager of Child Life Services at UCSF Benioff Children’s Hospital. “So music education and music therapy provide an amazing outlet for children here. It helps them deal with their hospitalization. It helps them cope; it helps them understand; and it helps them have joy while they’re here.”

Healing with Music

Patients ranging in ages from four to 18 gradually filled the sixth floor patio of the hospital, the site for the festive drum circle. Many walked in unassisted with their attentive nurses just a few steps behind. Others walked hesitantly, tightly holding onto their parents’ hands while dragging a clunky but necessary IV pole.

Kids play drums at UCSF Benioff Children's Hospital

Kids learn to play drums during Music Day at UCSF Benioff Children’s Hospital.

As each child entered the patio, Hart greeted them with sincere enthusiasm. “Come on in!” he said. “Let’s make some music!”

It didn’t take long for Hart and his team to start the drum circle. Each soulful beat resonated deeply, gradually going from tribal to festive. He captivated the children’s imagination, and slowly they joined in. At first they patted the drums, the way one would pat a big dog, but they gradually — with Mickey’s supportive guidance — beat the drums with zest and rhythm, momentarily forgetting their illness and overcoming their shyness at the same time.

“This certainly stimulates the brain for sure,” Hart said. “Music takes you to a whole other world, a spirit world, and a world of opportunities, whether it be math, science, or technology. It’s a great inspirer. It’s a superhighway to the soul.”

Rick Munoz’s four-year-old son Jamison — who has leukemia — took part, enjoying hitting the drums, too young to recognize the man who is giving him pointers.

Eileen McCree, Jameson Munoz and his father Richard

Eileen McCree, CCLS, left, a Child Life Services specialist, Jameson Munoz, 4, and his father Richard enjoyed a jam session and professional instruction with Grateful Dead drummer Mickey Hart at UCSF Benioff Children’s Hospital.

“It was pretty cool just to have Jamison get some exposure to a renowned drummer like Mickey,” said Munoz, who owns a karaoke business in the East Bay. “It was interesting just to see my son actually attempting to find a rhythm with him. When I get upstairs, I need to download a bunch of Grateful Dead music and show Jamison this is who you were playing with.”

Drumming and Dancing

As the sound from the drum circle got louder and louder, the children’s smiles got bigger and bigger. It didn’t take long before every child there was either beating a drum or dancing to the beat created by the impromptu band. Hart circled the venue and, like a dedicated coach, encouraged the young musicians.

“I’m actually playing with them as opposed to an audience who is just listening,” Hart said. “We’re actually playing together so this is a rhythmic experience that I’m having and they’re having, and I’m noticing how much rhythm they actually do have. I mean there were a few kids today who were exactly on the groove, exactly on the beat.”

For Hart, this is a way of continuing his parents’ legacy. Both were musicians who encouraged him from an early age to express himself through drumming on pots and pans. Hart’s daughter Raya Sunshine, 19, is a music studies major who credits her dad for her professional passion.

“Music is everything in my life. I grew up on the road drumming with my dad,” she said. “And to see him now playing with these amazing kids, it’s great. He’s a really great support system for young people. He loves them and they obviously love him so much.”

The team at UCSF Benioff Children’s Hospital is grateful to Hart for making time to help heal the children through music.

“Mickey Hart is not only an amazing musician, he has an amazing spirit about him,” Towne said. “He’s fun, he’s creative and he brought his passion for music and his passion for drumming. He not only created an amazing drum circle here, he also took drums to children’s bedsides and brought joy to them through music on a one-on-one setting.”

Hart says he had as much fun as the kids did. He believes in the healing power of music, so he’s happy to share his passion with those who need it the most.

“I had a great time and the smiles were worth it,” Hart said, grinning from ear to ear. “Those were million-dollar smiles.”

Photos by Susan Merrell

Patsy Longo, and her son Brad, visited with Grateful Dead drummer Mickey Har

Patsy Longo, and her son Brad, 11, visited with Grateful Dead drummer Mickey Hart after he led a percussion jam session at UCSF Benioff Children’s Hospital.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/Jx1ZOovvNDw/legendary-grateful-dead-drummer-offers-music-medicine-children

Children, Families and Maternity e-bulletin – June 2012

This month’s edition features information about:

  • Healthy Child Programme and Early Years
  • Child Health
  • Vulnerable Children
  • Ill and Disabled Children
  • Children and Young People’s Mental Health and Emotional Wellbeing
  • Conferences and Events
  • Sources of information
  • Feedback and Contributions

CFM bulletin, June 2012 (PDF 127K)

Article source: http://www.dh.gov.uk/health/2012/06/cfm-bulletin-june-2012/

Children’s Hospice and Hospice-at-Home Grant 2012/13

The Government recognises the importance of the palliative care sector in supporting children and families with palliative care needs.

The Department of Health has continued its commitment to providing £10m annually to 40 children’s hospices in England through the Children’s Hospice and Hospice-at-Home Grant.

Allocation Grants for Children’s Hospice and Hospice-at-Home (PDF, 27K)

 

Article source: http://www.dh.gov.uk/health/2012/06/childrens-hospice-grants/

Views sought on making Nursery Milk Scheme more cost effective

A consultation on how the Nursery Milk Scheme operates launches today. The current nursery milk scheme has been running since the 1940s and the government is committed to continuing to provide free milk for all nursery children. But analysis shows modernising the operation of the scheme could save up to £20 million each year.

Figures show that the government is spending up to 92p for a pint of milk through the scheme, while most consumers can pay 45p – almost half the price.

In its current form, the legislation covering the scheme provides for full reimbursement of the cost of the milk.  While childcare providers are encouraged to seek value for money, there are cases where this is not happening.

Around 1.5 million under-5s in the UK in 55,000 childcare settings receive free milk.

The consultation explores 4 different options to reform the scheme:

  • leave the scheme as it currently exists
  • cap the price that can be claimed for milk by childcare providers
  • issue e-voucher cards which childcare providers can use to purchase milk
  • introduce a government contract with an external provider to directly supply and deliver milk to all childcare providers

The consultation also seeks views on the price, access, voucher schemes, supply and claims procedures.

Public Health Minister Anne Milton said:

“Milk has many benefits to children’s health and is important for their development – we are committed to continuing to provide free milk for all under-5s.

“But the current scheme has not changed operationally since it began and costs have ballooned. In 4 years, costs have jumped from £27 million in 2007 to a staggering £53 million in 2011.  

“Everyone is encouraged to take part in this consultation and share their views on the proposed changes.”

Childcare providers survey

A simple survey is running alongside the consultation until 14 August, asking all childcare providers currently registered with the scheme about how it works for them now and how they and the children they care for might be affected by any changes.

Any decision on the future operation of the scheme will be taken after full consideration is given to the consultation responses and other relevant information.

The consultation runs until 11 September.

Article source: http://www.dh.gov.uk/health/2012/06/nms/

Media Advisory: UCSF to Present Artificial Kidney Update at Conference

WHAT: UCSF bioengineer Shuvo Roy, PhD, will be presenting an update on the status of the Implantable Artificial Kidney device during the 58th Annual Conference of The American Society for Artificial Internal Organs (ASAIO) in San Francisco. The artificial kidney project, for which Roy is leading a team of 40 scientists in nine laboratories nationwide, has achieved several scientific milestones in the past two years in the effort to create an implantable solution to replace kidney dialysis, and has been selected among three projects nationwide for a new, streamlined approval process through the U.S. Food Drug Administration. Members of Roy’s team also will present new developments during the conference.

Media are welcome to attend the presentation and to speak with Dr. Roy independently.

WHEN:

Saturday, June 16, 2012
10:45 a.m. – 12:00 a.m.

WHERE:

The Fairmont San Francisco Hotel
950 Mason Street, San Francisco
California Room Lobby, Mezzanine Level

WHO: Shuvo Roy, PhD, is an associate professor of bioengineering and therapeutic sciences in the UCSF School of Pharmacy. A specialist in micro-electromagnetic sensors (MEMS) and former aerospace engineer, Roy is applying silicon technologies used in the computer industry to solve some of the most intractable and costly health issues, including end-stage renal failure, diabetes (through an artificial pancreas) and child-focused devices.

WHY: UCSF is leading a national project to create the world’s first implantable, artificial kidney eliminating the need for dialysis for patients suffering from acute kidney failure. Nearly 2 million people worldwide suffer from kidney failure. Most rely on kidney dialysis, at a huge cost: dialysis typically requires three, three-hour sessions per week connected to a machine, and replaces only 13 percent of kidney function, with a five-year survival rate of 35 percent. Treatment for kidney failure costs $35 billion/year in the United States alone. The device is expected to enter clinical trials in four to six years.

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/nuYUPq-Uh-I/media-advisory-ucsf-present-artificial-kidney-update-conference

FDA approves new combination vaccine that protects children against two bacterial diseases

<!–

    –>

    <!–

  • Page Last Updated: 06/14/2012
  • –>
    Page Last Updated: 06/14/2012
    <!–

–>

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.

Article source: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm308350.htm

Routine Care for Crohn’s Disease in Children Should Include Measurement of Bone Age

Measuring bone age should be a standard practice of care for pediatric patients with Crohn’s disease, in order to properly interpret growth status and improve treatment, according to a new study from the UCSF Benioff Children’s Hospital.  

Neera Gupta, MD

Neera Gupta, MD

“Not only is bone age helpful in  predicting a child’s  remaining growth potential, our study demonstrates that bone age is necessary to correctly interpret a patient’s growth status in pediatric Crohn’s disease,” said lead study researcher Neera Gupta, MD, MAS, a pediatric gastroenterologist at the UCSF Benioff Children’s Hospital.

Impaired growth and delayed puberty are common complications in children with Crohn’s disease, with up to 80 percent of patients showing compromised growth. Typically, growth is interpreted based on a patient’s chronological age, and growth status is one of the key factors driving therapeutic decisions.

In the study, researchers measured bone age with a left hand/wrist x-ray in 49 pediatric patients with Crohn’s disease whose ages ranged from five to 17 years-old.  Bone age is a measure of skeletal maturity, and, as a people grow, their bones change in shape and size.  Based on the appearance of the bones and growth plates on the X-ray, a doctor can determine the bone age. Results can be given as a Z- score, either as average which is zero, or as a number of standard deviations above or below zero, taking into account the sex and chronological age of the patient.  High bone age is defined as having a bone age Z- score (BA-Z score)  2, and low bone age is defined as a BA-Z score -2.

The study, “Determination of Bone Age in Pediatric Patients with Crohn’s Disease Should be Part of Routine Care,” is currently online in the journal Inflammatory Bowel Diseases.

“One of our findings that surprised me was that 41 percent of our patients had BA-Z scores that were less than -2. I did not expect that such a large proportion of patients would have this degree of delay,” said Gupta.  

Crohn’s disease is a chronic disorder characterized by inflammation in the gastrointestinal tract. It is one of the two main disease subcategories of inflammatory bowel disease, along with ulcerative colitis. About one quarter of the more than one million Americans with inflammatory bowel disease are diagnosed in childhood and adolescence. In pediatric patients, the inflammation characteristic of the disease may lead to an inability to grow normally. Poor growth may be the only presenting sign of Crohn’s disease in children and adolescents.

Facts on Pediatric Crohn’s Disease

The disease is marked by an abnormal response by the body’s immune system. The cause is not well understood but probably has a genetic component and an unknown trigger, according to the researchers.

The interpretation of a patient’s growth changes when his or her bone age, rather than just chronological age, is taken into consideration. The added information is also useful for properly interpreting height increments following therapeutic interventions.

“We need further studies to understand the effects of disease activity on bone age advancement and to determine which patients require more frequent monitoring of bone age,” Gupta said.

Females in the study had significantly lower average BA-Z scores (-2.0) than males (-1.1). Interestingly, the research team previously had reported that males with Crohn’s disease have more growth impairment than females.  The researchers are continuing to investigate the underlying reasons for sex differences in growth.  Certain factors — Caucasian  race, exposure to steroids, colonic disease location, earlier pubertal stage, and current treatment with the immunomodulator azathioprine/6-mercaptopurine — also were associated with lower average BA-Z scores.

“It’s important to know that active inflammation may be present even without classic intestinal symptoms such as abdominal pain, rectal bleeding, or diarrhea, said Gupta. “Poor growth may be the only sign of active disease. Including the X-ray as part of routine care allows a more clinically meaningful interpretation of statural growth and therefore enables us to improve our treatment recommendations.”

The team of study researchers includes Eric Vittinghoff, PhD, professor in the UCSF department of epidemiology and biostatistics; Robert Lustig, MD, pediatric endocrinologist at UCSF Benioff Children’s Hospital; and Michael Kohn, MD, MPP, associate professor in the UCSF department of epidemiology and biostatistics.

Funding was provided by grants from the National Institutes of Health, Crohn’s and Colitis Foundation of America, and Children’s Digestive Health and Nutrition Foundation (now known as the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Foundation).

UCSF Benioff Children’s Hospital creates an environment where children and their families find compassionate care at the forefront of scientific discovery, with more than 150 experts in 50 medical specialties serving patients throughout Northern California and beyond. The hospital admits about 5,000 children each year, including 2,000 babies born in the hospital. For more information, go here.

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. For further information, go here.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/NVgZV6KaVHw/routine-care-crohns-disease-children-should-include-measurement-bone-age

Teens Enjoy Prom Night at UCSF Benioff Children’s Hospital


More than 100 teenagers filled UCSF’s Moffitt Café on April 20 for the second annual UCSF Benioff Children’s Hospital prom – the only hospital prom for teens in the San Francisco Bay Area.

Teens arrived on a red carpet leading into the hospital, where the cafeteria was transformed into a club-like dance party, complete with photo booth, DJ, dance floor, fresh flowers, and food and drinks.

Teens at UCSF Benioff Children's Hospital

Patient Erin Miller and her boyfriend Michael DeMasters, both 15, were outfitted for a prom held at the Benioff Children’s Hospital with $50,000 in clothing and stylists donated by Banana Republic.

Many of the teens had missed their own high school proms because they were hospitalized, and treasured the opportunity to feel like a teenager and not a patient, even if for only a night.

“Even with IV poles and wheelchairs, this is the exact same kind of prom that every teen experiences as he or she goes through life,” said Michael Towne, Child Life Services Manager. “It’s a right of passage.”

It was the second UCSF Benioff Children’s Hospital teen prom for Rachel Hale, 17. Last year Hale was hospitalized during prom while being treated for a combination of gastrointestinal and orthostatic conditions. While she has returned home to Walnut Creek, she still wouldn’t miss the annual hospital event.

Sayareh Farsio, director of Special Services, Banana Republic Flagship, left, meets with patient Amy Martinez to outfit her for the teen prom at UCSF Benioff Children’s Hospital.

“I look forward to this all year,” said Hale. “We don’t get to dress up very often, and to have something fun to go to like a party. Not a lot of these kids get that chance.”

And in true prom tradition, no parents are allowed. If patients do require a caregiver, they are encouraged to bring a trusted adult other than a parent.

Prom attendees danced until 10 p.m. while dressed to the nines thanks to Banana Republic, which donated $50,000 worth of clothes.  Through a collaboration with Banana Republic Merchants, 150 outfits including suits, dresses and accessories were donated for the teens. Sayareh Farsio with Special Services from Banana Republic Flagship store and her team Nanci Milton Fitterman and Toni Encarnacion helped fitting the kids for their special night.

The prom is a continuation of a teen-focused, multi-year project at the UCSF Benioff Children’s Hospital. The Child Life Department recognizes the integral role hospital child life programs play in the healing process and works with children, teens and their families to ensure that each child’s developmental and emotional needs are met during their hospital stays.

The major supporters for this event are Banana Republic and Salesforce.com Foundation.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/yDTbkFTKiEE/teens-enjoy-prom-night-ucsf-benioff-childrens-hospital

Event to Benefit Art Therapy at UCSF Benioff Children’s Hospital

Title: My Hand.

Title: My Hand.
By: Althea Patchett, Age: 10

WHAT: UCSF Benioff Children’s Hospital is holding its second “Art with a Heart” benefit art sale and auction, featuring a collection of art created by young hospital patients, some of whom will be on hand to talk with media about their work.

The partial gallery of artwork can be previewed here: http://artwithaheart.gotoroyalag.com/

All proceeds from the special art sale and auction will go toward the hospital’s art therapy program. Sponsored by Royal Motor Sales of San Francisco, the event will include cocktails, hors d’oeuvres and the unique kid-created art gallery, with some pieces developed specifically for the evening.

The art therapy program at UCSF Benioff Children’s Hospital provides a creative process for children and their families to communicate and better cope with their hospital experience. Art therapy offers a means for patient engagement, expression, and an increased understanding of the emotional impact of illness and medical treatment.

WHEN:

Thursday, May 24, 2012, 6-8 p.m.                 

WHERE:

Royal Motor Sales

280 South Van Ness Avenue, San Francisco

WHO:

  • Andy Hansen, COO, Royal Motor Sales
  • Kim Scurr, Executive Director, UCSF Benioff Children’s Hospital
  • Suzanne Yau, Art Therapist, UCSF Benioff Children’s Hospital
  • Michael Towne, Manager, Child Life Services, UCSF Benioff Children’s Hospital
  • Patient Artists and Their Families

CONTACT:

Media interested in covering the event must RSVP to Juliana Bunim at juliana.bunim@ucsf.edu or 415-476-8810.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/jsSgtRy2b5E/event-benefit-art-therapy-ucsf-benioff-childrens-hospital

New Ads for the UCSF Benioff Children’s Hospital Tell Patient Stories

Translating pioneering research into exceptional care for young patients and their families is the heart of UCSF Benioff Children’s Hospital. For that reason, UCSF has launched a new consumer advertising campaign highlighting some of the thousands of children treated every year.

“Pediatrics is a major priority for UCSF, and we want to make sure we’re building awareness for the UCSF Benioff Children’s Hospital as we prepare to open the new hospital in Mission Bay in early 2015,” said Erika Smith, director of marketing for the UCSF Medical Center and UCSF Benioff Children’s Hospital. 

The premise of the campaign is “Pioneering Care for Kids,”  showcasing the groundbreaking work that makes UCSF Benioff Children’s Hospital one of the top children’s hospitals in the nation, according to a ranking by U.S. News World Report.    

“We felt the best way to tell our story was through parents talking about their children’s treatment at UCSF and how it changed their lives,” said Smith. “We know through our research that patients like to hear from other patients about their experiences because it feels more relevant to them.” 

The advertisements will run for six weeks on local television, online, print media and outdoor locations including billboards. The ads are targeted at Bay Area parents, with television emphasizing the emotional component of the stories, print offering more space for longer stories, online being so easily accessible and outdoor providing more exposure for commuters.

Filming the ads also provided a unique opportunity for parents and families to come together and share their experiences. As parents met one another they recounted what it was like to receive life threatening diagnoses for their kids, their connection to UCSF and how their lives have changed.”

“The best part of the day was seeing these parents looking at their kids who are healthy and happy in recovery,” said Smith. “These amazing families feel very connected to UCSF and wanted to tell their stories.”

The theme of pioneering care was a natural fit, as doctors at the UCSF Benioff Children’s Hospital have been pioneers for decades. They were the first in the world to successfully perform surgery on a baby still in the womb, and they also developed life-saving treatments for premature infants whose lungs aren’t fully developed.

With programs designed specifically for young patients, such as a 50-bed Neonatal Intensive Care Nursery, recreational therapy for recovering kids and 60 outreach clinics throughout Northern California, the UCSF Benioff Children’s Hospital offers customized services for its young patients.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/6-rvoCmxudk/new-ads-ucsf-benioff-childrens-hospital-tell-patient-stories

FDA proposal aims to help reduce unnecessary radiation exposure for children

FDA NEWS RELEASE

For Immediate Release: May 9, 2012
Media Inquiries: Erica Jefferson, 301-796-4988, erica.jefferson@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA 

FDA proposal aims to help reduce unnecessary radiation exposure for children

Today, the U.S. Food and Drug Administration announced that it is seeking public comment on a proposal encouraging manufacturers to consider the safety of children in the design of new X-ray imaging devices. In the draft guidance, FDA is recommending that manufacturers design new X-ray imaging devices with protocols and instructions that address use on pediatric patients.

It also proposes that manufacturers who do not adequately demonstrate that their new X-ray imaging devices are safe and effective in pediatric patients should include a label on their device that cautions against use in pediatric populations.

To help health care providers more safely use their current equipment on pediatric patients, the FDA is collaborating with the Alliance for Radiation Safety in Pediatric Imaging (ARSPI) and manufacturers, through the Medical Imaging and Technology Alliance (MITA), to develop pediatric imaging radiation safety training materials.

The FDA has also launched a pediatric X-ray imaging website that provides information on the benefits and risks of imaging using ionizing radiation, recommendations for parents and health care providers to help reduce unnecessary radiation exposure, and information for manufacturers of X-ray imaging devices.

The guidance, website, and ongoing collaborations with ARSPI and MITA are part of FDA’s Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging, launched in February 2010.

When used appropriately, X-ray imaging, such as a CT, fluoroscopy, and conventional X-ray, can provide valuable information to help with diagnosis, treatment planning, and surgical intervention in adults and children. At the same time, these types of exams expose patients to ionizing radiation, which can be of particular concern in pediatric patients.

The cancer risk per unit dose of ionizing radiation is generally higher for younger patients than adults, and younger patients have a longer lifetime for the effects of radiation exposure to manifest. Also, the use of X-ray equipment settings designed for adults can result in a larger radiation dose than necessary to produce a useful image for a smaller pediatric patient.

“The risk from a medically necessary imaging exam is quite small when compared to the benefit of accurate diagnosis or intervention. There is no reason for patients who need these exams to avoid them,” said Jeffrey Shuren, M.D., director of the FDA’s Center for Devices and Radiological Health. “Parents should engage in a discussion with their child’s physician about benefits and risks of X-ray, computed tomography (CT), and fluoroscopy exams.”

A workshop scheduled for July 16, 2012, will bring together industry, X-ray imaging equipment users (e.g., physicians, radiologic technologists, and physicists), and patient advocates to discuss FDA’s draft guidance.

For more information:

Draft Guidance: Pediatric Information for X-ray Imaging Device Premarket Notifications

Public Meeting: Device Improvements for Pediatric X-ray Imaging

Pediatric X-Ray Imaging

Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging

Medical Devices

Radiation-Emitting Products

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

###
 

Visit the FDA on Facebook, Flickr, YouTube and Twitter

 




Article source: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm303386.htm

UCSF Clinicians Get New Ammunition in Fight Against Childhood Cancers

Steven DuBois, assistant professor of pediatrics, and Kate Matthay, professor of pediatrics and chief of the pediatric division, talk with nurse Kate Mantis at UCSF Benioff Children’s Hospital.

By Steve Tokar on May 4, 2012

It’s a real challenge to treat a patient with relapsed cancer, because the cancer has outsmarted initial treatment and has become more resistant, says Steven DuBois, MD, assistant professor of pediatrics at UCSF’s School of Medicine and a specialist in childhood cancers.

Now, DuBois and his colleagues at the UCSF Helen Diller Family Comprehensive Cancer Center have access to a vastly expanded array of potential resources in their battle against childhood cancers.

The extra firepower comes from UCSF’s recent acceptance into the Children’s Oncology Group (COG) Phase 1 Consortium, an elite National Cancer Institute consortium of institutions selected to lead Phase 1 studies of potential pediatric cancer drugs. UCSF is one of only two COG Phase 1 institutions in California, and one of only 21 centers in the United States and Canada.

Phase I testing, the first step in a drug’s translation from the laboratory to possible approval by the Food and Drug Administration (FDA), is designed to assess safety and appropriate dosage in a specific population — in this case, children.

As in adult Phase I trials, the patients recruited for pediatric Phase I studies have typically not responded well to initial treatment or have had a recurrence of their cancer. Many have been told that they have no other therapeutic alternatives.

Thanks to the variety of experimental treatments available through COG, says DuBois, “we are now able to offer these patients a wider array of novel agents across the spectrum of childhood cancers, from leukemia to brain tumors to other types of solid cancers.”

Most of the agents are targeted molecular therapies, which are designed to short-circuit the biological pathways that cancers depend upon to grow. “If you can find the right molecular target that is driving the growth of a cancer and then block it, you can control the cancer,” says DuBois. Others are oncolytic viruses, which infect and then dissolve tumors.

DuBois recently concluded a Phase I pediatric study for sunitinib, an oral drug that blocks angiogenesis, the process of new blood vessel growth that is integral to the development of solid cancers.

Steven DuBois, MD, and Kate Matthay, MD

The study successfully identified the safest dose for children. In addition, since not all children can swallow pills, DuBois and his team developed and tested a more child-friendly formulation, where the drug powder is sprinkled onto yogurt or apple sauce.

Such studies are “quite intensive,” DuBois says. Patients are monitored not only for toxic reactions, but for pharmacokinetics—how the drugs are metabolized by the body. “There are frequent visits to the outpatient PCRC for blood draws, which have to be done in a really precise, standardized way.

“We couldn’t do this type of work without the infrastructure and personnel of the Pediatric Clinical Research Center,” a unit of the Clinical Research Services program managed by UCSF’s Clinical and Translational Science Institute (CTSI).

Such clinical studies call for nursing care that is “totally specialized,” says Katherine Matthay, MD, professor of medicine and Mildred V. Strouss Endowed Chair in Translational Research in Pediatric Oncology at UCSF. For example, patients might need pharmacokinetics studies at very specific times after a drug is administered, as well as special lab studies for pharmacodynamics, “where we look at the effects of the drug on cancer cells and their molecular pathways,” Matthay says.

Blood samples are drawn by highly skilled nurses and rushed, sometimes in the middle of the night, to the CTSI core lab, where they are processed and stored. “These are not things that can be done on a regular pediatric oncology unit,” notes Matthay.

Side effects are a particular challenge. “Many of these inhibitors are oral medications, which don’t have the same obviously terrible side effects as intravenous chemotherapy, so we tend to think of them as benign,” says Matthay.

“But in Phase I therapy, we’re constantly running into unexpected or unusual side effects, and patients can die from them.” Parents, she says, “have to be willing to take that risk in enrolling their children in these trials. They usually are, because they have incurable cancers.”

“When we offer studies to patients, we’re offering them hope for more time,” says DuBois, who also notes that “some of the drugs that we’re testing now in children with relapsed cancer will become the future cornerstones of treatment for children with newly diagnosed cancer.”

“Ultimately, our participation in the COG Phase 1 Consortium will allow us to facilitate the translation of new drugs into the clinic from our rich pipeline of laboratories here at UCSF — and we can improve outcomes in pediatric oncology,” he says.

CTSI is a member of the National Institutes of Health-funded Clinical and Translational Science Awards network focusing on accelerating research to improve health. The Institute provides services for researchers at every stage, and promotes online collaboration and networking through UCSF Profiles.

Photos by Cindy Chew

Related Links:

UCSF’s Pediatric Oncology Phase 1 Program

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/snLNdhZJm2k/ucsf-clinicians-get-new-ammunition-fight-against-childhood-cancers

300 former child migrants reunited with their families

Almost 300 former child migrants have been reunited with their families in the UK thanks to the Family Restoration Fund.

The £6m Family Restoration Fund, which covers the practical costs of travel, is available to any former child migrant who was sent under school-leaving age with their relatives from Great Britain and Northern Ireland to Commonwealth countries.

The fund, which was launched by Health Secretary Andrew Lansley in July 2010, is administered and supported by the Child Migrants Trust.

Health Secretary Andrew Lansley said:

“Thirteen years ago as a member of the Health Select Committee, I heard evidence, often tragic and disturbing, of how children had been separated from their mothers and families, and taken overseas, often not knowing their mothers and families were alive. 

“Almost two years ago I launched the three-year fund on behalf of the UK Government, in recognition of the years of struggle and heart ache suffered by child migrants. I am very glad now to have met some of the families reunited as a result of the fund.”

Read the former child migrants reunited press release

Article source: http://www.dh.gov.uk/health/2012/05/child-migrants/

Baby tests recommended

May 02, 2012

A simple test that
measures blood oxygen levels is the most accurate way of screening
newborn babies for congenital heart defects, according to a new
meta-analysis.

Analysis of 13 previous studies concluded that
this screening method, called pulse oximetry,
should be adopted internationally as part of routine tests on all
newborns.

Expert screening before and after birth should provide a powerful strategy for identifying babies with serious heart defects

Professor Peter
Weissberg, our Medical Director said: “This analysis provides a
compelling case for the wider use of pulse oximetry to screen for
congenital heart defects in newborn
babies. It is a simple, cheap and non-invasive test, but it will
have to be supported by echocardiography
services to determine the nature of the heart
defect
in babies with low oxygen levels.

“The BHF has funded specialist training for
people who perform ultrasound scans during
pregnancy, so they are able to spot congenital heart defects in the
womb before the baby is born.

“The combination of this expert screening
before and after birth should provide a powerful
strategy
for identifying babies with serious heart
defects, so that they can be promptly treated.”

This study was published in The Lancet.

Article source: http://www.bhf.org.uk/media/news-from-the-bhf/newborn-screening.aspx

Information requirements for child health information systems

Published today, this document sets out the information requirements for the delivery of child health services as part of the future health and care system announced in the Health and Social Care Bill.

It aims to:

  • support the delivery of child health services as part of the transition of children’s services
  • deliver consistency in functionality of these important information systems in order to promote better, safer and more effective care for children

It should be of interest to those involved in the commissioning or delivery of child health information systems and to those who rely on such systems to deliver effective services to children. It should also be of interest to the suppliers of such systems.

The next step for the Department in supporting this work will be to develop these information requirements into an outline business specification, detailing the technical requirements of a child health information system.

Read the Information requirements for child health information systems

Article source: http://www.dh.gov.uk/health/2012/05/chis-01-may-2012/

UCSF Chancellor Recounts Path to Realizing Her Childhood Dream

By Lisa Cisneros on April 30, 2012


Chancellor Susan Desmond-Hellmann, MD, MPH, received a standing ovation on April 19 after sharing a heart-felt story about her life and lessons learned to students, faculty, staff and alumni gathered to hear what was billed as UCSF’s inaugural “Last Lecture.”

“I think the most important thing for me, and I suspect for many others — at least the people who I respect and admire have in common — make a decision to be happy and healthy,” she said toward the end of her hour-long speech. “Make a decision that you will be. Then do everything in your power to be happy and healthy.” 

And by all accounts, Desmond-Hellmann has achieved just that.

A young Susan Desmond-Hellmann stands with her father, Frank Desmond

Now in her third year at the helm of UCSF, Desmond-Hellmann was selected for the honor of delivering the inaugural “last lecture” by UCSF students who were emailed a voting ballot consisting of faculty members from across the four professional schools in January.

Hundreds of students voted for Desmond-Hellmann, who admitted that she was a little anxious about what to say if this was truly her last lecture. She said she drew inspiration from great speeches delivered by the late Randy Pausch, Carnegie Mellon professor and alumnus, and Steve Jobs, co-founder of Apple Computers, both of whom died of different types of prostate cancer. She appreciated hearing their stories about childhood dreams and the meaning of life.

2012 Commencement

Read last lecture transcript

UCSF Ushers in 2012 Commencement Season

Born in Napa, California, Desmond-Hellmann reflected on her life as a self-described “nerdy kid,” one of seven children raised in Reno, Nevada. During her talk, she said she realized her childhood dreams of becoming a doctor, a profession influenced in part by her father, Frank Desmond, who was a retail pharmacist, and their family physician, Noah Smirnoff, MD. She fondly recalled Smirnoff making a morning house call to their home to check in on her father one rare day when he called in sick with the flu.

Desmond-Hellmann talked about her parents, both role models in her journey to become UCSF’s ninth chancellor and the first woman appointed to the post.

Susan Desmond-Hellmann and her husband, Nick Hellmann, stand with M. Biddle in Uganda, where she worked from 1989 to 1991.

“Mom, like my dad, was the first in her family to go to college,” she told the audience in a nearly full Cole Hall Auditorium. “But not only the first in her family to go to college; my mom is truly a coalminer’s daughter. Her dad died in the coalmines in Wyoming when my mom was 14. My mom went to school not speaking English. She spoke Slovenian, being the first in her family born in the United States, and later became an English teacher, which I’ve always thought is really remarkable.

“Grandpa was a San Francisco police detective, and grandma was a maid and then worked at JC Penney’s and lived down in the Sunset.”

“So this was a terrific childhood,” Desmond-Hellmann said pausing to show family photographs in her PowerPoint presentation. “And I cannot explain on the surface how this crazy kid — that’s me again; this is at age 10 — decided my childhood dream was to be a doctor. That’s what I was going to be. Now, my sister Teresa, who’s seen this picture more often than she’d like, is convinced that — I think this picture shows how early I wanted to be a doctor. She thinks it shows how early I was bossing everyone around. And she’s probably right.”

Throughout her life as a medical student, chief resident, clinical scientist, visiting faculty member in Uganda, biotech leader and now chancellor, Desmond-Hellmann has learned what it takes to succeed. “The most important lesson I learned overall was the power of aiming big and establishing a culture that brings out the best in everyone.”

Related Links:

Steve Jobs Stanford Commencement Speech
2005

Randy Pausch’s Last Lecture
Sept. 18, 2007

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/e2AM7jlNhgY/ucsf-chancellor-recounts-path-realizing-her-childhood-dream

Teens Enjoy Prom Night at UCSF Benioff Children’s Hospital

April 27, 2012


More than 100 teenagers filled UCSF’s Moffitt Café on April 20 for the second annual UCSF Benioff Children’s Hospital prom – the only hospital prom for teens in the San Francisco Bay Area.

Teens arrived on a red carpet leading into the hospital, where the cafeteria was transformed into a club-like dance party, complete with photo booth, DJ, dance floor, fresh flowers, and food and drinks.

Patient Erin Miller and her boyfriend Michael DeMasters, both 15, were outfitted for a prom held at the Benioff Children’s Hospital with $50,000 in clothing and stylists donated by Banana Republic.

Many of the teens had missed their own high school proms because they were hospitalized, and treasured the opportunity to feel like a teenager and not a patient, even if for only a night.

“Even with IV poles and wheelchairs, this is the exact same kind of prom that every teen experiences as he or she goes through life,” said Michael Towne, Child Life Services Manager. “It’s a right of passage.”

It was the second UCSF Benioff Children’s Hospital teen prom for Rachel Hale, 17. Last year Hale was hospitalized during prom while being treated for a combination of gastrointestinal and orthostatic conditions. While she has returned home to Walnut Creek, she still wouldn’t miss the annual hospital event.

Sayareh Farsio, director of Special Services, Banana Republic Flagship, left, meets with patient Amy Martinez to outfit her for the teen prom at UCSF Benioff Children’s Hospital.

“I look forward to this all year,” said Hale. “We don’t get to dress up very often, and to have something fun to go to like a party. Not a lot of these kids get that chance.”

And in true prom tradition, no parents are allowed. If patients do require a caregiver, they are encouraged to bring a trusted adult other than a parent.

Prom attendees danced until 10 p.m. while dressed to the nines thanks to Banana Republic, which donated $50,000 worth of clothes.  Through a collaboration with Banana Republic Merchants, 150 outfits including suits, dresses and accessories were donated for the teens. Sayareh Farsio with Special Services from Banana Republic Flagship store and her team Nanci Milton Fitterman and Toni Encarnacion helped fitting the kids for their special night.

The prom is a continuation of a teen-focused, multi-year project at the UCSF Benioff Children’s Hospital. The Child Life Department recognizes the integral role hospital child life programs play in the healing process and works with children, teens and their families to ensure that each child’s developmental and emotional needs are met during their hospital stays.

The major supporters for this event are Banana Republic and Salesforce.com Foundation.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/yDTbkFTKiEE/teens-enjoy-prom-night-ucsf-benioff-childrens-hospital

Update on adults’ and children’s palliative care and funding for children’s hospices

The Government is supporting children’s hospices with an annual revenue grant of £10m. In 2010/11, the Department of Health made a further non-recurrent grant of £30m available to the children’s palliative care sector to support local projects to improve services, this information is now updated to include a summary of the individual allocations. Around £19m was claimed by children hospices, other children’s palliative care organisations and children palliative care networks.

The ACT 30 million stars website contains more detailed information on the projects.

The Government is committed to introducing a fairer and more transparent per patient funding system for adult and children’s palliative care. This is expected to be established in 2015. The eight pilot sites announced include a consortium for children’s palliative care.

 

Article source: http://www.dh.gov.uk/health/2012/04/update-on-funding/

Operational guidance for Child Measurement Programme published

National operational guidance published provides advice for commissioners and providers of the National Child Measurement Programme (NCMP). A parental feedback tool and letter templates that can be edited to meet local needs in delivery of the NCMP are published along side the guidance.

The NCMP operational guidance includes:

  • arrangements for measuring the height and weight of primary and middle school children as part of the NCMP
  • sharing a child’s results with their parents, whether routinely, on a request only basis, or proactivel
  • submitting data to the NHS Information Centre for inclusion in the national database.

Parental feedback tool and results letter

This letter is designed to be used when sending the NCMP results to parents. The NCMP sample version of the results letter should be used with the parental feedback tool, which will be available from 30 September 2012 for the 2012/13 school year. Once height and weight data are entered into the tool, letters can be mail merged so that the blank fields will be populated with each child’s details.

Template letters

The following template letters can be edited to meet local needs in the delivery of the NCMP for 2012/13:

  • headteacher and governor letter raises awareness of the NCMP with headteachers and school governors (annex 1)
  • letter to primary care practioners letter can be sent to GP practices in the local area to help raise awarenesss of the NCMP (annex 3)
  • pre-measurement letter can be used to send to parents before implementing the weighing and measuring (annex 4)
  • letter to parents of children unable to be weighed and measured unaided  (annex 6).

 

Article source: http://www.dh.gov.uk/health/2012/04/ncmp-2012-13/

Childhood primary immunisation rate at record levels

With the highest childhood immunisation rates in the UK since the current data set collection began in 1995, this weekend sees the start of the European Immunization Week which this year runs from 21 to 27 April.

The latest issue of Vaccine Update has more information.

For advice and information on immunisation, visit www.nhs.uk

Article source: http://www.dh.gov.uk/health/2012/04/childhoodimmunisation/

Team Approach to Individualized Childbirth at New Mission Bay Women’s Hospital

The Women’s Specialty Hospital at UCSF Medical Center at Mission Bay will set a new standard for patient- and family-centered care when it opens in 2015.

By Kate Vidinsky on April 10, 2012

To the midwife who will deliver babies there, the new Women’s Specialty Hospital at UCSF Medical Center at Mission Bay will offer abundant opportunities to build on the collegiality UCSF already fosters between patient and provider.

To the nurse who will care for new mothers there, the new hospital will provide a comfortable space where families can gather to celebrate the joy of new life while learning valuable parenting skills.

To the physician who will care for patients there, the hospital will offer the most sophisticated technical capabilities so that every single patient, from the lowest to the highest risk, will receive the best available care.

Judith Bishop

All of them look forward to opening day in 2015, when they can proudly offer women in the Bay Area and beyond comprehensive health services tailored to their unique needs in a warm and beautiful setting.

Elena Gates

With expansive two-story atriums, intimate meditation spaces, beautiful gardens and patient rooms that maximize natural light, the Women’s Specialty Hospital at UCSF Medical Center at Mission Bay will set a new standard for patient- and family-centered care.

A major focal point will be the 36-bed birth center, where expectant mothers will receive the care and support they need for the labor and delivery experience they desire. Each birth room will promote a sense of calm for the intimate, anxious and joyful birthing experience, paired with a functional environment for physicians and caregivers to safely perform their services.

Mari-Paule Thiet

A unified group of UCSF doctors, nurses and midwives will bring their shared philosophy of care to the new women’s hospital, in which the best evidence-based medicine is combined with a tailored approach for the individual patient. This philosophy, which governs all UCSF obstetric care, has led to some of the lowest C-section rates and highest breastfeeding rates among Bay Area hospitals.

Sharon Wiener

Here, several members of the obstetrics team provide their thoughts on UCSF’s approach to pregnancy, labor and delivery, and what the life-altering experience of childbirth will look like at the new UCSF Women’s Specialty Hospital at Mission Bay. They are:

  • Judith Bishop, CNM, MPH, certified nurse midwife and professor in the Division of Maternal-Fetal Medicine
  • Elena Gates, MD, chief of general gynecology in the Department of Obstetrics, Gynecology and Reproductive Sciences
  • Mari-Paule Thiet, MD, chief of obstetrics at UCSF Medical Center and director of the Division of Maternal-Fetal Medicine and
  • Sharon Wiener, RN, MPH, CNM, certified nurse midwife and professor in the Division of Maternal-Fetal Medicine

Q: How would you describe UCSF’s overarching approach to pregnancy and childbirth?

A: Thiet: The UCSF obstetrics team welcomes and encourages an open dialogue for patients’ birth experiences, and we invite and seek to acknowledge everyone’s unique perspective. Our labor and delivery nurses and personnel are dedicated to providing an individualized birth experience that focuses on family-centered care. We look forward to bringing this team approach to the new UCSF Women’s Specialty Hospital at Mission Bay, where collaboration will be at the core of everything we do.

A: Gates: One of the things that is special about UCSF is our expertise across so many areas. This depth of expertise — from midwives and doulas to neonatologists and fetal surgeons — makes us comfortable allowing women to labor their way, because we know we can handle anything that comes up. Labor is not a disease, and while things can happen to complicate the matter, most of the time it is a perfectly natural process.

A: Bishop: We like to think of ourselves as a “one-stop shop,” of sorts, meaning we are equipped to care for everything from the low-risk to the very highest-risk pregnancies. This means that if you start with us, you never have to go anywhere else. Patients at the new hospital can rest assured that they will receive the best possible care no matter what develops.

Q: How will the new women’s hospital at Mission Bay help facilitate this approach?

A: Thiet: The Mission Bay hospital will enable us to continue doing everything we do now but even better in a beautiful new facility. The on-site helipad — a first for San Francisco hospitals – will ensure pregnant women experiencing major complications receive the best available care faster. As part of a fully integrated hospital complex, patients will have access to multidisciplinary teams offering patient-centered treatments, and there will be a seamless transition for babies needing care at UCSF Benioff Children’s Hospital. And as an academic hospital, we will continue to have the great advantage of involving some of the best medical residents in the country.

A: Gates: The obstetrics program at Mission Bay will benefit from being part of the larger UCSF Women’s Specialty Hospital, which will offer complex reproductive and gynecological services with a focus on minimally invasive surgery. Every aspect of the new hospital has been designed to be patient and family-centered, with lovely gardens right outside the rooms, spa tubs in every labor room and space to accommodate whomever patients choose to support them during their stay. Women who need to be hospitalized during pregnancy will be on a special unit with green space and lounge areas, so patients can meet one another and build community.

Q: What are some programs that set UCSF apart from other facilities?

A: Wiener: Our nurse midwife group has created several programs that increase patient satisfaction and deliver excellent care. The Centering Pregnancy Program takes women out of exam rooms and into groups for their prenatal care. The program enrolls groups of eight to 12 women with similar due dates and has them come to the clinic at the same time. The magic occurs when we sit in a circle and discuss anything and everything related to pregnancy, breastfeeding, labor pain and coping during the postpartum period. This really empowers our patients and can lead to a better pregnancy and birth experience overall. We also have a lactation task force, an outpatient lactation clinic and lactation consultants at the hospital to support breastfeeding mothers. These services have helped UCSF become the hospital in the area with the highest exclusive breastfeeding rates. Finally, we designed the voluntary doula program to offer support for patients who are alone during labor and cannot afford to pay for private doula support. We look forward to expanding and building upon all of these programs at the new hospital.

A: Bishop: We also are the only hospital in California and one of very few in the country to offer nitrous oxide as an option for labor pain. This is a less-invasive and lower-tech alternative to an epidural that can be self-administered. It is something that has been routinely used for decades in Great Britain, Canada, Australia and Scandinavia. We will continue to have this option available in every labor room at Mission Bay.

Q: How does the OB team determine what interventions will be used during labor?

A: Wiener: If intervention is needed, it is available here, from the most routine to the most complex. When interventions are used, there is not one person who makes the decision. We have ongoing discussions about the progress of each patient and closely collaborate with our anesthesia and nursing staff. In case of emergency, we have an anesthesiologist on the unit at all times so we can act very quickly. But we get as excited about healthy normal birth as we do when a high-risk mom goes through pregnancy and delivery in stable condition and has a healthy baby.

A: Gates: We offer the full range of intervention options, such as epidurals and other pain medication, however our deep expertise makes us comfortable not pushing intervention. We are very committed to vaginal birth, and we are very successful doing vaginal deliveries after C-sections.

Q: How does a patient’s family factor into the labor and delivery experience?

A: Wiener: We can only deliver the excellent care that we do because of the importance we place on communication. Respecting the time needed to make plans with patients and families is key to successful outcomes. We have patients who come in to labor and delivery with detailed birth plans, and yet even when things don’t go according to plan, they feel great because they were heard and respected.

A: Thiet: We are all-inclusive and recognize the importance of including the family in the childbirth experience. We have established a culture here that truly respects birthing women and their families as key members of the decision-making process. We are committed to partnering with our patients from the time they come in for their first prenatal visit to the time they leave the hospital with a healthy newborn. We are so excited to continue nurturing this partnership in a brand new world-class facility.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/BIEEET3zK5g/team-approach-individualized-childbirth-new-mission-bay-womens-hospital

UCSF Artificial Kidney Project Tapped for Accelerated FDA Program

By Kristen Bole on April 9, 2012

A UCSF-led effort to create an implantable artificial kidney for dialysis patients has been selected as one of the first projects to undergo more timely and collaborative review at the Food and Drug Administration.

The FDA announced today (April 9) that it had chosen three renal device projects to pilot a new regulatory approval program called Innovation Pathway 2.0, intended to bring breakthrough medical device technologies to patients faster and more efficiently.

The artificial kidney project, which is targeted for clinical trials in 2017, was selected for its transformative potential in treating end stage renal disease and for its potential to benefit from early interactions with the FDA in the approval process.

The FDA effort will involve close contact between the federal agency and device developers early in the development process to identify and address potential scientific and regulatory hurdles and create a roadmap for project approval. The goal is to improve the projects’ overall chance of success, while reducing the time and cost of FDA review and maintaining safety. Lessons, the agency said, will inform approvals in other areas.

Shuvo Roy, PhD, is leading a project to develop an implantable artificial kidney.

The artificial kidney project has brought together 40 researchers in nine laboratories nationwide under the guidance of Shuvo Roy, PhD, a bioengineer on the faculty of the UCSF School of Pharmacy. It aims to combine nano-scale engineering with the most recent advances in cellular biology to create an implantable device that would enable patients with chronic kidney failure to lead healthier and more productive lives, without external dialysis or immune suppressant medication.

“The new Pathway program is a clear signal to researchers that innovations in how we treat disease are needed and supported by the FDA,” said Mary Anne Koda-Kimble, PharmD, dean of the UCSF School of Pharmacy. “We’re so pleased the Kidney Project is in the vanguard as the program launches.”

End-stage renal disease, or chronic kidney failure, affects nearly 2 million people worldwide, including more than 570,000 in the United States, and costs the nation almost $40 billion each year for treatment. The most effective treatment is kidney transplantation, but those organs are in short supply; last year, only 16,812 kidneys were available for transplant, leaving 92,000 patients on the waiting list, according to the Organ Procurement ant Transplant Network.

For projects like the artificial kidney, inclusion in the program could also build confidence among investors.

“This will help us with investors and funding agencies,” said Roy, who has met with several possible investors and granting agencies to fund the expected $20 million it will cost to bring the artificial kidney through clinical trials. “One of the questions we always get is, ‘How will the FDA handle this?’ With the Innovative Pathway program, we will know the answer to that question.”

The UCSF artificial kidney, or implantable Renal Assist Device (iRAD) would include thousands of microscopic filters as well as a bioreactor to mimic the metabolic and water-balancing roles of a real kidney.

The combined treatment has been proven to work for the sickest patients using a room-sized external model developed by a team member at the University of Michigan. Roy’s goal is to apply silicon fabrication technology, along with specially engineered compartments for live kidney cells, to shrink that large-scale technology into a device the size of a coffee cup. The device would then be implanted in the body, allowing the patient to live a more normal life.

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. For more information, visit www.ucsf.edu.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/tmCaM3kI0xY/ucsf-artificial-kidney-project-tapped-accelerated-fda-program

FDA announces plans to pilot end-stage kidney disease technology in new program

FDA NEWS RELEASE

For Immediate Release: April 9, 2012
Media Inquiries: Erica Jefferson, 301-796-4988, erica.jefferson@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA

FDA announces plans to pilot end-stage kidney disease technology in new program
Innovation Pathway aims to reduce time and cost of bringing safe and effective, breakthrough technologies to patients

Three products for patients with end stage renal disease (ESRD) have been chosen to participate in the FDA’s Innovation Pathway, an evolving system designed to help medical devices reach patients in a safe, timely and collaborative manner.

The FDA selected three from 32 product applications ranging from an artificial kidney to devices that assist kidney function that were submitted in response to a January 2012 request from FDA’s device center.

The three products are:

  • An implantable Renal Assist Device (iRAD) being developed by the University of California, San Francisco.
  • A Wearable Artificial Kidney (WAK) in development by Blood Purification Technologies Inc. of Beverly Hills, Calif.
  • A Hemoaccess Valve System (HVS) that has been designed by Greenville, S.C.-based CreatiVasc Medical.

The majority of the 32 applications came from small, start-up business or academic institutions. 

 “The response from innovators exceeded our expectations and demonstrates that there is a desire from developers of innovative technologies for earlier and more collaborative agency interaction,” said Jeffrey Shuren, M.D., director of the Center for Devices and Radiological Health (CDRH).

The ESRD products will be the focus of the second version of the Innovation Pathway, first announced in 2011, to shorten the time and cost it takes for the development, assessment and review of medical devices, in particular breakthrough medical devices.

ESRD is the progressive loss in kidney function over a period of months or years. The kidneys play an essential role, filtering and removing waste from the body and producing hormones that are responsible for calcium absorption and red blood cell production.

The FDA chose ESRD because more than half a million Americans suffer from the disease. Management of the disease is largely dependent upon medical device technology, such as hemodialysis (process for removing waste products) equipment. Most dialysis patients spend long hours in specialized outpatient clinics, impacting their quality of life and reducing productivity. Medicare alone covers some 75 percent of ESRD health care costs, which in 2009 topped $29 billion.

 “We found ESRD a natural fit given that patients have few options. We think this process could impact the lives of patients by providing access to innovative new technologies they so desperately need. In turn, this could also have a positive impact on health care, encouraging innovation through smarter regulation that could potentially save companies time and money,” said Shuren.

Developers who participate in what FDA now calls Innovation Pathway 2.0 have an opportunity to collaboratively discuss their technology with FDA, work with the agency on the development of a benefit-risk profile for their product that will help guide future studies and map out a regulatory path forward for their product.

This approach is intended to deepen collaboration between FDA and innovators early in the process, prior to pre-market submission, with the goal of making the regulatory and product development process more efficient and timely.
CDRH constructed the Innovation Pathway with help from the Entrepreneurs in Residence (EIR) program, which brings together professionals with diverse talents from inside and outside government to work together as a team on solution-oriented outcomes in a short and focused time frame. These outside experts worked alongside agency staff and leadership to address impediments to efficient and timely review processes and construct Innovation Pathway 2.0.

For more information:

Innovation Pathway

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

####
 

RSS Feed for FDA News Releases [what is RSS?]




Article source: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm299339.htm

Supporting partnership working for delivery of Healthy Child Programme

A range of documents designed to support partnership working for those who deliver the Health Child Programme 0-19 years old (HCP) are published. The documents including guidance, health visiting attributes, health visiting factsheets and questions and answers  aim to strengthen consistant seamless support for care for families.

They are aimed at the NHS, as part of the desire to improve service delivery and to support enhanced inter professional working. There is no new policy in the Healthy Child Programme documents but instead they build on existing guidance such as HCP, NICE guidance and professional bodies standards including best practice from the service.

Article source: http://www.dh.gov.uk/health/2012/03/supporting-partnership-working/

Forty children’s hospices to benefit from grant

Forty children’s hospices will receive a share of the Department’s annual £10 million Children’s Hospice and Hospice-at-home grant.

The Government pledged to provide £10 million annually to support voluntary sector provision of children hospices and hospice at home care until 2015 when new funding arrangements are expected to be in place. The new funding system will be informed by pilots, announced today, which have been set up to gather evidence and test the recommendations of the Independent Palliative Care Funding Review by Tom Hughes-Hallett and Professor Sir Alan Craft which was published last July.

The children’s hospice sector has received £57 million through the grant funding since 2006, £20million in the last two years following the Government’s commitment.

The Government has increased to £10.7 million to support increased provision for children and young people in recognition of more new service providers in this area since 2008.

Article source: http://www.dh.gov.uk/health/2012/03/announcement-of-grant-for-40-children%E2%80%99s-hospices/

Take part in webchat to improve children and young people’s health and care

If you’re interested in improving health and care for children and young people, join our webchat with the co-chairs of the Children and Young People’s Health Outcomes Forum today, Tuesday 20 March at 2.30pm.

Professor Ian Lewis, Medical Director at the Alder Hey Children’s NHS Foundation Trust, and Christine Lenehan, Director at the Council for Disabled Children, are particularly keen to hear about those areas where people think that additional health outcomes for children and young people are needed.

The Children and Young People’s Health Outcomes Forum is an independent group of experts from local government, the NHS and charities that is helping to develop a new strategy for improving care for children and young people.

Find out more and take part in the webchat

 

Article source: http://www.dh.gov.uk/health/2012/03/forum-webchat/

Regulation of foods for young children to be simplified

The Department is publishing responses received to the public consultation, which ended on 30 September 2011, to gather views of interested parties on the EU Commission’s proposal to simplify and clarify the rules that apply to products previously regulated as PARNUTS or ‘dietetic foods’.

In total 47 responses were received: 25 from industry, 4 from consumer organisations, 5 from health professional bodies, 5 from individuals and 8 from local Government.

Following the Government’s consultation, discussions with interested parties and their written responses to the consultation exercise have informed policy decisions on this proposal. Overall the Government is in agreement with interested parties that the proposal represents a good solution to resolve the current confusion in defining a PARNUT food and reduce the regulatory burden in this area.

Read the responses to this consultation

Read the Original consultation

Article source: http://www.dh.gov.uk/health/2012/03/consultation-responses-parnuts/

UCSF Patients Part of Nation’s Longest Living Kidney Transplant Chain

By Juliana Bunim on March 15, 2012

Gabriel Baty and Olivo Cienfuegos probably never would’ve crossed paths if they each didn’t need a new vital organ to survive.

Baty, 40, is a scientist for the pharmaceutical company Novartis and lives in Albany. Cienfuegos, 61, is a retired factory worker who lives 80 miles away in Stockton.  

But on December 7 they were lying just a few feet apart at UCSF Medical Center awaiting kidney transplants as part of the longest living kidney donation chain in history.

Neither man had a donor who was a match. But each had a family member willing to donate a kidney to a stranger, allowing them all to be part of chain which would, in turn, give Baty and Cienfuegos kidneys from other strangers. With 17 participating hospitals in 11 states, the chain consisted of 30 people willing to give up their kidney, matched with 30 more who needed one to survive.

UCSF surgeons Andrew Posselt, MD, PhD and Ryutaro Hirose, MD, performed the transplants on Baty and Cienfuegos – just two of the 300 or so kidney transplants performed at UCSF every year, or twice as many as any other transplant program in Northern California, according to the United Network of Organ Sharing (UNOS). Established in 1964, the Connie Frank Transplant Center at UCSF has performed more kidney transplants than any other medical center in the world. The kidney transplant chain, formally known as Chain 124 by the National Kidney Registry, was recently highlighted in the New York Times and the San Francisco Chronicle.

Finding a Needle in a Haystack

This was Cienfuegos’ second kidney transplant, and according to UCSF transplant coordinator Janine Sabatte-Caspillo, RN, finding him a donor was like “finding a needle in a haystack.”

“Olivo is at a high risk for rejection because he has a lot of antibodies in his blood, which also makes it difficult to find a match,” she said. “He’s very lucky and it will be at least six months before we’re secure that the kidney won’t be rejected.” The first kidney, donated by his wife, failed due to diabetes and hypertension. He was relisted in 2009. His son Adrian, 29, donated his kidney to a 49-year-old Bakersfield woman on his behalf.

Baty’s story began 13 years earlier when his wife insisted he get a physical. As a seemingly healthy 27-year-old, Baty thought it was totally unnecessary. But that trip to the doctor ended up saving his life. Baty learned he not only had a torn bicuspid valve, but also a rare autoimmune disorder that ultimately results in kidney failure. The nurse, he said, told him she couldn’t believe he hadn’t already dropped dead.

Baty had his heart repaired and later spent two years on dialysis. His wife Christy was unable to be a donor for medical reasons, but her mother, Yvonne Gordon, qualified. A stage four Hodgkins Lymphoma survivor, Gordon was inspired to donate her kidney after hearing a radio broadcast about another cancer survivor becoming a donor.  

“I have a sticker on my refrigerator that says ‘She lives by what is the right thing to do,’” she said. “And that’s what I do every day of my life. It’s given me such a wonderful gift to be able to help my children. I couldn’t love Gaby more if he was my own son.”

While Baty and Cienfuegos waited for their transplants, Cienfuego’s son Adrian was in surgery, donating his kidney to a stranger. Gordon had to wait another week to donate her kidney, which was flown to UCLA. “It’s given me such a wonderful gift to be able to help my children,” Gordon said. “It just takes one bridge donor to set up a lot of good. You can’t get more wonderful than that.”  

Photos by Cindy Chew

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/SDYH724bjfA/ucsf-patients-part-nations-longest-living-kidney-transplant-chain

Have your say on children and young people’s health

The independent Children and Young People’s Health Outcomes Forum is gathering views on the health outcomes that matter most for children and young people and how the different parts of the health system will work together to deliver these.

It wants to hear from from children, young people, parents, carers, doctors, nurses and other professionals involved in providing care to children.

The Forum is asking questions about four particular areas of children and young people’s health:

  • acutely ill children
  • mental health
  • children with disabilities and long-term conditions
  • public health.

Find out how to have your say

The Forum will report to the Government with independent advice that will inform the Children and Young People’s Health Outcomes Strategy.

  • Share:

Article source: http://www.dh.gov.uk/health/2012/03/children-views/

100 countries get involved with World Kidney Day

With almost 7,000 people in the UK on the waiting list for a kidney transplant, the Department of Health welcomes the focus on raising awareness about kidney transplantation and organ donation by this year’s World Kidney Day.

Chronic kidney disease affects 1 in 10 people and isn’t reversible, but lifestyle changes can slow its progression.

Since 2006, World Kidney Day has been raising awareness about the importance of our kidneys in relation to overall health and seeking to reduce the impact of kidney disease worldwide.

Over 100 countries will be involved this year, including people with kidney disease, their friends and relatives, researchers and healthcare professionals.

Kidney transplants

About 10,000 people in the UK are on the waiting list for a transplant: 6,800 of these are waiting for kidneys.

Approximately 1,000 people die each year – 3 people every day – either waiting for a transplant or after being removed from the list because they become too ill.

And currently only 29% of people in the UK are on the organ donation register.

About kidneys

The main function of the kidneys is to produce urine, which allows the removal of waste products from the blood.

The kidneys also have a role in maintaining blood pressure, fluid balance, vitamin D production, and producing healthy red blood cells.

  • Share:

Article source: http://www.dh.gov.uk/health/2012/03/kidney/

Is Snoring Linked to Child Behaviour Problems?

A study published in the US journal Pediatrics, looked at data on 11,000 children living in the UK. According to the study, children who snore or have other night time breathing conditions are at risk from behavioural problems.Lead researcher Dr Karen Bonuck said sleep problems could be harming the developing brain.One estimate suggests one in 10 children regularly snores and 2% to 4% suffer from sleep apnoea, which means the breathing is obstructed and interrupted during sleep.

Often enlarged tonsils or adenoids are to blame for the conditions.

In adults, the result can be severe day-time tiredness and some studies have linked behavioural problems such as attention deficit hyperactivity disorder might be linked to the condition in children.Marianne Davey, from the British Snoring and Sleep Apnoea Society, said that sleep problems in the young were an under recognised reason for poor behaviour.

Often parents will not make the connection with their child’s poor sleeping pattern and do not mention it to their G.P. and often the child is diagnosed with ADHD and sometimes in extreme cases children are even prescribed drugs.

This is wrong – if sleep problems are addressed then behavioural problems will usually improve almost immediately.Parents should pay close attention to their child’s breathing even as early as the first year of like and if they have a concern, they should raise it with their G.P.  Catching a disorder early may reduce the risk of problems later.

Sleeping and dreaming, play an important role in our emotional psychological and physical heath.  We all dream, what we may not realise is that dreams are common across cultures and their seemingly bizarre content is both important and meaningful.

Until the 1950’s when scientists started studying sleep in a laboratory, most people thought sleeping and dreaming were a passive part of our day to day lives.

We now know that our brains are very active while we sleep.  Science is now uncovering that dreams play a central role in our emotional health, our memory our learning and as a way to help us find solutions to our problems.

There is now convincing evidence that dreaming is important for our psychological wellbeing.  A dream dramatizes people’s daily emotional concerns and waking issues.  Dramatization during REM (rapid eye movement) sleep is linked to the restoration of mental wellbeing.

 

Article Source:
http://www.uk-med.co.uk/Health/Is-Snoring-Linked-to-Child-Behaviour-Problems

£22 million for ground-breaking children’s mental health programme

Up to £22m will be pumped into a pioneering programme to give children with mental health problems access to the best available services in a wider range of places. The new investment in the Children and Young People’s Improving Access to Psychological Therapies (IAPT) project will be spent over the next three years to expand state-of-the-art psychological therapies and extend training for people working with youngsters outside of health settings, such as in schools or youth groups.

Mental health problems

One in ten children aged 5-16 years has a clinically diagnosable mental health problem and, of adults with long-term mental health problems, half will have experienced their first symptoms before the age of 14. Self-harming and substance abuse are known to be much more common in children and young people with mental health disorders – with ten per cent of 15-16 year olds having self-harmed.

Early diagniosis

Failure to treat mental health disorders in children can have a devastating impact on their future, resulting in reduced job and life expectations. Encouraging people to be open about mental illness and extending available therapies will help to ensure intervention is available at the earliest opportunity giving young people the best chances in life.

Care Services Minister Paul Burstow said:

‘We broke new ground last year investing in children’s mental health – this additional funding will help deliver services specific to young people. We’re working with young people and staff to start to change the way mental health is delivered by the NHS.’

Article source: http://www.dh.gov.uk/health/2012/02/22-million-for-ground-breaking-children%E2%80%99s-mental-health-programme/

FDA approves first Helicobacter pylori breath test for children

FDA NEWS RELEASE

For Immediate Release: Feb. 24, 2012
Media Inquiries: Erica Jefferson, 301-796-4988, erica.jefferson@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA

FDA approves first Helicobacter pylori breath test for children

The first breath test for use in children ages 3 to 17 years to detect Helicobacter pylori (H. pylori) bacterial infections, responsible for chronic stomach inflammation (gastritis) and ulcers, was approved by the U.S. Food and Drug Administration (FDA) on Feb. 22, 2012.

The FDA first cleared the BreathTek UBT test for adults in 1996. The U.S. Centers for Disease Control and Prevention (CDC) estimates that approximately two-thirds of the world’s population is infected with H. pylori. Most people with this infection never have any symptoms but have a two- to six-fold increased risk of developing gastric cancer and mucosal-associated-lymphoid-type lymphoma compared with uninfected people.

“Results from this test, when considered with a physician’s assessment of the patient’s history, other risk factors, and professional guidelines, can quickly indicate infection, which allows a physician to initiate appropriate health measures in a timely manner,” said Alberto Gutierrez, Ph.D., director of the Office of In Vitro Diagnostic Device Evaluation and Safety in FDA’s Center for Devices and Radiological Health.

The FDA based its approval of the BreathTek UBT test for children on a multi-center study of 176 patients, comparing its performance to a composite reference method and demonstrating 95.8 percent sensitivity and 99.2 percent specificity. An additional study was done at 1 to 6 months after therapy to support use for post-treatment monitoring of patients.  The sensitivity was 83.3 percent and the specificity was 100 percent. 

BreathTek UBT is manufactured by Otsuka America Pharmaceutical based in Rockville, Md.

For more information:

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

#
 

Visit the FDA on Facebook

RSS Feed for FDA News Releases [what is RSS?]




Article source: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm293278.htm

UCSF School of Dentistry to Offer Free Dental Care for Children

By Leland Kim on February 17, 2012

Brent Lin, DMD, examines patient Moses Peralta at the UCSF School of Dentistry Dental Clinic at Parnassus.

Stephanie Peralta brings her four children to the UCSF School of Dentistry Clinic at Parnassus all the way from Livermore, California.

The family makes the 45-mile journey across the bridge to get free dental care provided by UCSF dental students and clinical faculty members. This year, the trek to San Francisco will take longer since the Bay Bridge will be closed until Tuesday morning for construction work.

“I constantly tell them their teeth are going to fall out if they don’t brush their teeth,” she said. “It’s hard to get them to get in good habits of brushing their teeth and continue doing it every day.”

This Saturday, the UCSF School of Dentistry is hosting its annual “Give Kids A Smile” program from 9 a.m. to 3 p.m., offering free dental care to kids ages 4-17 – the same age range as Peralta’s children.

Brent Lin, DMD

“The older ones are definitely role models for my youngest daughter,” Peralta said. “So if my older ones are brushing their teeth, the little one will want to get in the bathroom and do it herself.”

The goal of the community outreach program is to not only to provide dental services, but also to educate children and their parents about proper brushing and flossing techniques.

“Some common misconceptions of dental health include that tooth decay is a natural part of getting older,” said Brent Lin, DMD, clinical professor at the UCSF School of Dentistry. “That’s not true. Tooth decay is not inevitable.”

Impact of Dental-Related Illnesses

Approximately 45 million people, or more than a quarter of all Americans, have no dental health care coverage. Dental decay is one of the most common chronic illnesses among children. Although most dental diseases are preventable, many children unnecessarily suffer from dental disease because of inadequate home care, and lack of access to dental services, according to the U.S. Centers for Disease Control and Prevention (CDC).

“Good oral health starts when the patient is very young,” Lin said. “We suggest that expectant mothers get their teeth checked because their oral health could impact their child’s health while he or she is still in the womb.”

Brent Lin, DMD, cleans a patient’s teeth at the UCSF School of Dentistry Dental Clinic as two dental students observe.

An estimated 51 million school hours per year are lost in the U.S. because of dental-related illness. Poor oral health has been related to decreased school performance, poor social relationships and less success later in life, according to the CDC.

“Children miss a lot of school because of toothache or dental appointments and they have a hard time focusing on their work because of discomfort from dental pain. It can greatly impact one’s quality of life,” Lin said. “We take this opportunity to make the public aware of the importance of good oral health and how we can prevent teeth-related diseases.”

And this opportunity can make a world of a difference for many Bay Area families.

“Especially being a low income parent I think it’s important there are programs like this out there that can offer free services,” Peralta said. “We’re grateful to UCSF.”

Photos by Leland Kim

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/fp_KvLfeKkQ/ucsf-school-dentistry-offer-free-dental-care-children

Children, Families and Maternity e-bulletin February 2012

This is a bi-monthly e-bulletin for internal and external stakeholder groups designed to provide them with regular updates on activities that are supporting the delivery of the Be Healthy outcome for children, young people and families through the Every Child Matters: Change for Children agenda.

This month’s edition features information about the Launch of New Children and Young People’s Health Outcomes Strategy

Download CFM bulletin, February 2012 (PDF 169K)

 

 

Article source: http://www.dh.gov.uk/health/2012/02/cfm-2/

Tenofovir, Leading HIV Medication, Linked with Risk of Kidney Damage

By Steve Tokar on February 10, 2012

Tenofovir, one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time, according to a study of more than 10,000 patients led by researchers at the San Francisco VA Medical Center and the University of California, San Francisco (UCSF).

Michael G. Shlipak, MD, MPH

The researchers call for increased screening for kidney damage in patients taking the drug, especially those with other risk factors for kidney disease.

In their analysis of comprehensive VA electronic health records, the study authors found that for each year of exposure to tenofovir, risk of protein in urine – a marker of kidney damage – rose 34 percent, risk of rapid decline in kidney function rose 11 percent and risk of developing chronic kidney disease (CKD) rose 33 percent. The risks remained after the researchers controlled for other kidney disease risk factors such as age, race, diabetes, hypertension, smoking and HIV-related factors.

For individual patients, the differences in risk between users and non-users of tenofovir for each year of use were 13 percent vs. 8 percent for protein in urine, 9 percent vs. 5 percent for rapidly declining kidney function and 2 percent vs. 1 percent for CKD. “However, these numbers are based on the average risks in our study population, and patients with more risk factors for kidney disease would be put at proportionately higher risk,” said principal investigator Michael G. Shlipak, MD, MPH, chief of general internal medicine at SFVAMC and professor of medicine and epidemiology and biostatistics at UCSF.

Patients were tracked for an average of 1.2 years after they stopped taking tenofovir. They remained at elevated risk for at least six months to one year compared with those who never took the drug, suggesting that the damage is not quickly reversible, said Shlipak. “We do not know the long-term prognosis for these patients who stop tenofovir after developing kidney disease,” he cautioned.

Q A


Tenofovir, for Patients and Providers

The implications for patients already on or starting antiretroviral therapy are “mixed,” said Shlipak. “The best strategy right now is to work with your health care provider to continually monitor for kidney damage. Early detection is the best way to determine when the risks of tenofovir begin to outweigh the benefits.”

Shlipak noted that HIV, itself, increases the risk of kidney damage, while modern antiretroviral treatments clearly reduce that overall risk. “Patients need to be aware of their kidney disease risks before they start therapy, and this should influence the medications that they choose in consultation with their doctor,” he said. “For an otherwise healthy patient, the benefits of tenofovir are likely to exceed the risks, but for a patient with a combination of risk factors for kidney disease, tenofovir may not be the right medication.”

Tenofovir is used to decrease viral load and increase immune cell count in people infected with the virus. It is currently considered the preferred first line treatment for HIV because of its potency, overall low toxicity, and convenience of dosing. It is sold under a variety of names, by itself and in combination with other medications.

The study examined the medical records of 10,841 HIV-positive veterans in the national VA health care system who were new users of antiretroviral therapy from 1997 to 2007. It was published electronically in the journal AIDS on January 9.

Lead author Rebecca Scherzer, PhD, a researcher and statistician at SFVAMC and UCSF, said that the observational study was the largest and most conclusive indication so far of tenofovir’s association with kidney damage. “There have been a number of previous, smaller studies suggesting that this drug might be associated with kidney disease, but the results were mixed,” she said. “Those studies may have missed this association because they were too small, lacked appropriate lab data or excluded subjects with pre-existing renal impairment or risk factors for kidney disease.” 

To be sure that tenofovir was the culprit, Scherzer and her colleagues looked for associations between 18 other antiretroviral medications and the same three measures of kidney disease:  protein in urine, rapid decline in function and progression to CKD. None were associated with higher risk.

Shlipak noted that the study results are particularly strong because two of the risk factors – decline in function and CKD – indicate kidney function, while protein in urine indicates physical damage to the kidney. “These are independent markers,” he said. “To see the same drug cause both types of kidney disease gives you a very objective signal that something real is happening here.”

Shlipak emphasized that, despite tenofovir’s association with progressive kidney disease, it is an important component of effective antiretroviral therapy that may be required in many patients to control viral load.

The VA is the largest provider of HIV care in the United States, said Shlipak. “We could not have done this work without access to the VA’s system of electronic medical records,” he said. “In particular, the data kept by the VA Clinical Care Registry, located at the VA Palo Alto Health Care System, were essential to this study.”

Co-authors of the study are Michelle Estrella, MD, of Johns Hopkins School of Medicine; the late Andy I. Choi, MD, MAS, of SFVAMC and UCSF; Steven G. Deeks, MD, of San Francisco General Hospital; and Carl Grunfeld, MD, PhD, of SFVAMC and UCSF.

The study was supported by funds from the National Institutes of Health, the National Center for Research Resources, the American Heart Association and the Department of Veterans Affairs, some of which were administered by the Northern California Institute for Research and Education.

NCIRE – The Veterans Health Research Institute – is the largest research institute associated with a VA medical center. Its mission is to improve the health and well-being of veterans and the general public by supporting a world-class biomedical research program conducted by the UCSF faculty at SFVAMC.

SFVAMC has the largest medical research program in the national VA system, with more than 200 research scientists, all of whom are faculty members at UCSF.

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/s42XAd_1P_c/tenofovir-leading-hiv-medication-linked-risk-kidney-damage

Pediatric Dentist Applies Science to Prevent Cavities

Kate Rauch on February 10, 2012

Pediatric dentist Ling Zhan, DDS, is also a dental scientist who wants to apply basic science to prevent cavities.

Pediatric dentist Ling Zhan, DDS, PhD, an assistant professor in the UCSF School of Dentistry, is building a path to something children and parents the world over welcome: fewer cavities.

Cavities are the number one infectious disease in children in the U.S. Every year, nearly $4.5 billion is spent to treat them and about 1.6 million school days are missed annually related to dental decay. The prevalence of this disease is five times higher than asthma.

Zhan is an emerging leader in the use of xylitol, a naturally occurring sugar alcohol, to prevent tooth decay in children. Research shows that the sweet-tasting substance, which is extracted from the fibers of fruits, vegetables and other vegetation, have the potential to prevent cavities. Xylitol, commercially used as a sugar substitute, is lower in calories than sucrose and appears to diminish the negative dental effects of oral bacteria.

Many of the children Zhan sees in her research and clinic are suffering from significant tooth decay.

“In the traditional dental clinic, we’re normally only fixing the cavities, but not treating the cause,” Zhan said. “I’m a dentist, but also a dental scientist. Cavities can be readily prevented, and I want to see if there’s anything I can apply from basic science to fix this.”

In a recent study, Zhan and her team found that xylitol can prevent cavities in infants. In the findings, which Zhan presented in the 2nd International Conference on Novel Anticaries and Remineralizing Agents, infants whose gums were wiped daily with xylitol by their parents had nearly eight times fewer dental carries after one year than those who used wipes without xylitol. The study will be published in the Journal of Dental Research later this year.

Read the entire story on the Clinical and Translational Science Institute’s website

Article source: http://feedproxy.google.com/~r/UCSF_News/~3/mRVLrQ_XzVs/pediatric-dentist-applies-science-prevent-cavities